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QKI-MEDIATED CHOLESTEROL BIOSYNTHESIS IN EYE LENS AND MYELIN OF
THE CENTRAL NERVOUS SYSTEM
Seula Shin.
Advisory Professor: Jian Hu, Ph.D.
Cells obtain cholesterol in two ways, de novo biosynthesis and uptake from circulation.
While most tissues utilize both sources, eye lens and brain depend extensively on
cholesterol biosynthesis due to the limited supply from circulation. Lens cell membrane
consists of highest portion of cholesterol. Brain is the most cholesterol-rich organ, which
accounts for 23% of total cholesterol. Genetic mutations of cholesterol biosynthesis
enzymes in humans and animal models present cataracts and hypomyelinating
disorders linked to neurological impairment. Yet, it remains unclear how gene
expression of cholesterol biosynthesis is regulated in lens and brain. Therefore,
studying cholesterol biosynthesis in both tissues could potentially provide insights into a
tissue-specific gene regulation of cholesterol biosynthesis. We found Quaking (Qki) is a
novel transcriptional activator of cholesterol biosynthesis. Using transcriptomic profiling,
we found cholesterol biosynthesis was the most downregulated pathway in Qki-depleted
lens and brain. Indeed, mRNA and protein levels of cholesterol biosynthesis genes were
reduced in Qki-depleted lens cells and oligodendrocytes. Consistently, total cholesterol
level was also decreased upon Qki depletion in both tissues. Qki-depleted mice
displayed progressive accumulation of protein aggregates, eventually leading to
cataracts, which was greatly attenuated by supplying sterol to the eye. In addition, Qki
depletion in brain significantly impaired myelin formation, leading to motor deficits,
namely ataxia. Mechanistically, we demonstrated that Qki enhanced cholesterol
biosynthesis by recruiting Srebp2 and Pol II in the promoter regions of cholesterol
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biosynthesis genes. Supporting its function as a transcription co-activator, we found that
Qki directly interacted with single-stranded DNA. Together, we propose that QkiSrebp2–mediated cholesterol biosynthesis is essential for maintaining high demand for
cholesterol in lens cells and oligodendrocytes. Our finding potentially provides tissuespecific mechanisms to modulate cholesterol biosynthesis to prevent cataracts and
various neurological diseases.
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Chapter 1: Introduction
1.1 Maintenance of cellular cholesterol homeostasis.
De novo
synthesis

Uptake

SREBP2-mediated transcription

LDLR-mediated endocytosis

Figure 1. Cellular cholesterol homeostasis.
Figure modified from Elina Ikonen, “Cellular cholesterol trafficking and
compartmentalization” Nat Rev Mol Cell Biol 2008 Feb;9(2):125-38.
Permission to use this figure was acquired from the journal.
Permission
to useisthis
wasbuilding
acquired
fromofthe
journal. cell membranes and
Cholesterol
an figure
essential
block
mammalian
plays an important role in multiple cellular functions, such as membrane raft signaling
transduction (Simons and Toomre, 2000), intracellular vesicle trafficking (Ikonen, 2008),
and cell growth (Nohturfft and Zhang, 2009). Cells obtain cholesterol through de novo
biosynthesis transcriptionally regulated by sterol regulatory element-binding protein 2
(Srebp2) and uptake from the blood mainly mediated by low density lipoprotein receptor
(LDLR)-dependent endocytosis (Espenshade and Hughes, 2007; Ikonen, 2008) (Figure
1). When cellular cholesterol level exceeds the capacity of the physiological level, the
rapid coping mechanism occurs to reduce the active cholesterol by storing as
cholesteryl esters in lipid droplets, catalyzed by acyl coenzyme A:cholesterol
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acyltransferases (ACATs) (Nohturfft and Zhang, 2009). In the long term, accumulation
of excess cholesterol results in increase of cholesterol derivatives such as oxysterol,
which triggers liver X receptors (LXR)-mediated cholesterol efflux via lipid transporters
such as ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette
transporter G1 (ABCG1) (Nohturfft and Zhang, 2009). As most tissues utilize the
mechanisms above in concert to maintain cellular cholesterol level at steady state,
dysregulation of cholesterol homeostasis in different tissues leads to various human
diseases including cardiovascular disorders, neurodegenerative diseases, cataracts,
and many types of cancer (Cenedella, 1996; Luo et al., 2019).
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1.2 Transcriptional regulation of cholesterol biosynthesis pathway.
S1P

Cholesterol
S2P

Golgi

INSIG
SCAP
SREBP2

ER

Mature SREBP2
Cholesterol
Biosynthesis Genes

Mature
SREBP2

SRE

Nucleus

Figure 2. Transcriptional regulation of SREBP2-mediated cholesterol
biosynthesis.
SREBP2 is embedded in ER as a precursor form bound by SCAP. SREBP2-SCAP
complex is stabilized by INSIG and retained in ER in a cholesterol-sufficient
condition. When cellular cholesterol is low, SREBP-SCAP complex is transported to
Golgi apparatus, and SREBP2 is cleaved to the mature form. The mature SREBP2 is
translocalized to the nucleus to transcriptionally activate the gene expression of
cholesterol biosynthesis genes.

Sterol regulatory element-binding protein 2 (SREBP2) is the master transcription
factor that regulates cholesterol biosynthesis (Horton et al., 2002a). SREBP2 is initially
localized in the endoplasmic reticulum (ER) membrane as a precursor form (Goldstein
et al., 2006) and regulated by the abundance of cholesterol (Figure 2). When
cholesterol level is high, SREBP cleavage-activating protein (SCAP) detects the
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cholesterol and retains SREBP2 in the ER. In a cholesterol-low condition, SREBP2SCAP complex is released to the Golgi apparatus, and SREBP2 is cleaved to a form of
functional transcription factor (mature form) by site-1 protease (S1P) and site-2
protease (S2P) in two-step processing, which is translocalized to the nucleus (Figure 2)
(Goldstein et al., 2006). Mature SREBP2 binds to the sterol regulatory element (SRE) in
the promoter regions of the SREBP2 target genes including the genes encoding the
enzymes involved in cholesterol biosynthesis pathway (Figure 2) (Shimano and Sato,
2017). Previous studies reported that SREBP2 binds weakly to the promoters,
suggesting the requirement of coactivators for enhancing gene expression (Guan et al.,
1997; Zerenturk et al., 2012). Several coactivators, such as nuclear transcription factor
Y (NF-Y), specificity protein 1 (SP1), and CREB-binding protein (CBP) are known to
interact with SREBP2 in hepatocytes and adipocytes (Dooley et al., 1998;
Giandomenico et al., 2003; Inoue et al., 1998; Wang et al., 2008). In addition to the
cholesterol level, excessive cholesterol-derived oxysterols, including 22-, 24-, 25-, and
27-hydroxycholesterol are detected by Insulin-induced gene proteins (INSIGs) including
two isoforms, INSIG1 and INSIG2 to stabilize SREBP2-SCAP complex in the ER
membrane and decrease transcriptional activity of SREBP2 as negative feedback
(Radhakrishnan et al., 2008).
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1.3 Cholesterol biosynthesis pathway.

Mevalonate Pathway

Acetoacetyl-CoA
Hmgcs1
HMG-CoA
Hmgcr
Mevalonate
Mvk
Mevalonate-5-P
Pmvk
Non-sterol
Mevalonate-5-PP
Mvd
Isoprenoids Pathway
Isopentenyl-5-PP Coenzyme Q Dolichol
Idi1
Geranyl-PP
Fdps
Farnesyl-PP
Geranylgeranyl-PP
Fdft1
De novo Cholesterol
Squalene
Pathway
Sqle
2,3-Oxidosqualene
Bloch
Kandutsch-Russell
Lss
Lanosterol
Dhcr24
Cyp51
Cyp51
Tm7sf2
Tm7sf2
Msmo1
Nsdhl
Msmo1
Hsd17b7
Nsdhl
Hsd17b7
Ebp
Ebp
Sc5d
Sc5d
Dhcr7
Desmosterol
7-dehydrocholesterol
Dhcr24
Dhcr7
Cholesterol

Figure 3. Cholesterol biosynthesis pathway.
Cholesterol biosynthesis pathway is a series of enzymatic reactions consist of
mevalonate pathway, non-sterol isoprenoids pathway, and de novo cholesterol
pathway labeled in blue.

Cholesterol is synthesized de novo from acetyl-coenzyme A (CoA) via a series of
enzymatic reactions (Figure 3). Two acetyl-CoA molecules form acetoacetyl-CoA via
thiolase and proceed to mevalonate pathway, which is different from fatty acid synthesis
branched from acetyl-CoA to malonyl-CoA (Nohturfft and Zhang, 2009). The ratelimiting step of cholesterol biosynthesis is the conversion of 3-hydroxy-3-methylglutaryl

5

(HMG)-CoA to mevalonate catalyzed by HMG-CoA reductase (HMGCR). ER-localized
HMGCR is regulated by post-translational negative feedback in addition to SREBP2mediated HMGCR gene activation at the transcriptional level (Luo et al., 2019). Notably,
INSIGs mediate ubiquitylation and degradation of HMGCR by directly sensing mostly
oxysterols rather than cholesterol (DeBose-Boyd, 2008). Farnesyl-pyrophophate (PP) in
mevalonate pathway is converted to squalene to proceed to de novo cholesterol
biosynthesis (Figure 3). As a branch point, Farnesyl-PP can be converted to many
nonsterol isoprenoids derivatives, which are important metabolites for cancer cell
survival and growth (Figure 3) (Goldstein and Brown, 1990; Mullen et al., 2016). Postlanosterol steps are branched into two parallel pathways, the Bloch and KandutschRussell (K-R) pathways (Figure 3) (Bloch, 1965; Kandutsch and Russell, 1960).
Interestingly, recent study demonstrated that these pathways occurred depending on
the tissue-specific intermediate flux (Mitsche et al., 2015). Whereas Bloch pathway
occurs in testes and adrenal gland, modified Kandutsch-Russell pathway takes place in
brain, skin, preputial glands (Mitsche et al., 2015). Lastly, the final product of the
pathway, cholesterol can be oxidized to different forms of oxysterols through both
enzymatic and non-enzymatic steps, which can activate LXR to eliminate excessive
cellular cholesterol (Chen et al., 2007a). Particularly, neuron-specific cholesterol 24hydroxylase (CYP46) is required to convert cholesterol to 24S-hydroxycholesterol (24OHC) to prevent excessive accumulation of cholesterol as blood-brain barrier blocks the
exit of cholesterol-rich lipoproteins (Martín et al., 2014).
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1.4 Eye lens structure and cataracts.
Anterior (Cornea)
Cornea

Lens

Retina

LEC

500 µm

LFC

Posterior (Retina)

Figure 4. Anatomical view of the eye lens.
Eye lens lies between cornea and cornea, and eye lens is consisting of two cell
types, lens epithelial cells (LECs) and lens fiber cells (LFCs).

The eye lens lies between cornea and retina (Figure 4) and is composed of two
types of cells, lens epithelial cells (LECs) and lens fiber cells (LFCs). LFCs are
differentiated from LECs at the transitional zone with substantial upregulation of the
major soluble lens proteins called crystallins at the expression level and migrate toward
the core of the lens where LFCs further mature. During maturation, LFCs gradually
undergo programmed organelle degradation and reach terminal differentiation in the
lens core to achieve lens transparency (Michael and Bron, 2011; Toyama and Hetzer,
2013; Yanshole et al., 2013). Maintaining the transparency of eye lens is essential to
properly reflect light onto the retina for efficient visual processing.
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Crystallins are expressed as three isoforms, α-, β-, and γ-crystallins, which
consist 90% of the total proteins in eye lens cells (Bloemendal, 1977; Graw, 2009). High
solubility of crystallins is critical for maintaining the transparency of the eye lens to
properly reflect light onto the retina (Andley, 2007). Cataract is an impairment of vision
caused by opaque lens due to accumulation of large aggregates, which is the leading
cause of blindness responsible for 33.4% of vision loss (10.8 millions of overall 32.4
million blind individuals) worldwide (Khairallah et al., 2015). The major proteins
susceptible to aggregation in cataract are crystallins (Moreau and King, 2012).
Particularly, α-crystallins, as members of small heat-shock proteins, function as
chaperones for β- and γ-crystallins to maintain their proper folding (Horwitz, 2003). In
humans and mice, mutations of α-, β-, and γ-crystallins cause congenital cataract
(Andley, 2007). In addition, aging-related cataract is often associated with abnormal
modifications of crystallins due to UV radiation or reactive oxygen species
(Santhoshkumar et al., 2014; Yanshole et al., 2013).

1.5 Cellular protein homeostasis and diseases.
Protein aggregation refers to abnormal association of misfolded proteins. Cells
prevent excessive accumulation of protein aggregation by molecular chaperons and
proteolytic degradation (Figure 5) (Muchowski and Wacker, 2005). Failure in controlling
protein aggregation is associated with human disorders such as neurodegenerative
diseases, cataract, cancer, and type II diabetes (Gonzalez-Teuber et al., 2019; Lim and
Yue, 2015; Moreau and King, 2012; Muchowski and Wacker, 2005; Mukherjee et al.,
2015). Notably, the intrinsic ability to prevent abnormal protein aggregation differs
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among the cell types. For example, disease-associated proteins are more susceptible to
formation of toxic aggregates in neural cells. Neurodegenerative diseases such as
Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) are
often associated with dysfunction of cellular strategies to prevent toxic protein
aggregation from neural cells (Lim and Yue, 2015). Additionally, aberrant folding of the
crystallins leads to pathogenic protein aggregates, eventually manifesting as cataracts
(Moreau and King, 2012). Notably, eye lens proteins including structural proteins and
metabolic enzymes are long-lived, therefore, it is critical for the protein homeostasis
machinery to maintain the protein quality control, particularly in aging as new proteins
are not made to compensate (Liu et al., 2019). Yet, it is still unclear the mechanisms
through which the cell types prone to aggregation such as neural cells and eye lens
cells are particularly vulnerable to protein homeostasis. Therefore, mechanistic
understanding of protein homeostasis will contribute to developing better therapeutic
targets for NDs and cataracts, which are two of the leading medical challenges of the
aging society.
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Figure 5. Protein homeostasis.
Synthesized proteins are folded into three-dimensional functional conformation.
Molecular chaperones facilitate the refolding of misfolded proteins while excess
stress of misfolded proteins can be coped with unfolded protein response,
chaperone-mediated autophagy, and macroautophagy.
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1.6 High demand for cholesterol biosynthesis in eye lens.
Eye lens tissue is avascular, which limits entry of blood cholesterol and minimize the
potential impact of cholesterol uptake originated from other tissues to the lens cells
(Cenedella, 1996; Cenedella et al., 2003; Hartman et al., 1996). Importantly, lipid
composition analysis revealed that eye lens cell membrane contains a larger portion of
cholesterol than do other cell types, strongly implicating a high demand for cholesterol
in the lens (Figure 6a) (Borchman and Yappert, 2010). Unusually abundant cholesterol
in lens membrane is critical for a-crystallin binding to the lens membrane for its
chaperone activity to prevent abnormal crystallin aggregation, which is linked with the
onset of cataracts (TANG et al., 1998). In human cataracts, cataractous lens is known
to contain much lower cholesterol/phospholipid than the normal lens based on the total
lipid profiling study from the 61-70-year-old human donors (Figure 6b) (Jacob et al.,
2001).
a

Typical Membrane
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Lens Membrane
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(mol)
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Figure 6. High demand for cholesterol in eye lens.
a Cholesterol/phospholipid ratio is 2-4-fold higher in lens membrane than the typical
membrane in other tissue types.
b Lower cholesterol content in cataractous lens compared to the healthy lens.
Values taken from Robert F. Jacob, Richard J. Cenedella, and R. Preston Mason,
“Evidence for distinct cholesterol domains in fiber cell membrane from cataractous
human lenses” JBC 2001 276, 13573-13578.
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1.7 Cholesterol deficiency in cataract pathophysiology.
Importance of cholesterol biosynthesis in prevention of cataractogenesis is
implicated in various human syndromes and pharmacological treatments (Cenedella,
1996; Cenedella et al., 2003; Hartman et al., 1996). Various genetic syndromes that
manifest as cataracts are caused by mutations of cholesterol biosynthesis genes
(Barnes and Quinlan, 2016; Cenedella, 1996; Porter and Herman, 2011b). For instance,
it has been reported that missense mutations of lanosterol synthase (LSS), a cyclization
enzyme in cholesterol biosynthesis, caused cataracts in a pedigree analysis of
consanguineous family of Caucasian descent (Zhao et al., 2015). Also, about 20% of
the patients with Smith-Lemli-Opitz syndrome (SLOS), who are deficient in 7dehydrocholesterol reductase (DHCR7), have cataracts (Cotlier and Rice, 1971; Kelley
and Hennekam, 2000). It has also been reported that 30% of the patients with
mevalonic aciduria due to mevalonate kinase (MVK) deficiency presented with
cataracts(Hübner et al., 1993). Additionally, lathosterolosis and microcephaly,
congenital cataract, and psoriasiform dermatitis (MCCPD), caused by deficiency in
either sterol-C5-desaturase (SC5D) or methylsterol monoxygenase 1 (MSMO1), is
known to display cataracts as one of the clinical features (He et al., 2011; Krakowiak et
al., 2003). Lastly, 33.7% of the patients who received treatment with statins, an
inhibitors of HMGCR that suppresses cholesterol biosynthesis, had cataracts as a side
effect (Leuschen et al., 2013; Saint-Gerons et al., 2019). Similar to human patients,
multiple animal models with defects in cholesterol biosynthesis genes such as Srebf2,
Lss, and squalene synthase (Fdft1) have displayed cataractogenic phenotypes (Merath
et al., 2011; Mori et al., 2006).
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1.8 Cholesterol metabolism in brain development.
Brain is the most cholesterol-rich organ, which accounts for 23% of the total
cholesterol in the body even though brain represents only 2% of the total body weight
(Dietschy and Turley, 2004a). Cellular cholesterol homeostasis is maintained by two
sources, biosynthesis and uptake (Ikonen, 2008). Brain depends extensively on de novo
cholesterol biosynthesis as the blood brain barrier (BBB) blocks the uptake of
cholesterol from circulation (Liu et al., 2010; Martín et al., 2014). Glial cells such as
oligodendrocytes and astrocytes are the major cholesterol-producing cell types in the
brain (Martín et al., 2014). 70-80% of brain cholesterol resides in myelin, a compact
multilayer membrane structure wrapped around the nerve axons critical for rapid
saltatory nerve conduction, which is generated by oligodendrocytes in the central
nervous system (CNS) (Figure 7). Myelin is a lipid rich material, and cholesterol
accounts for the highest molar percentage (~52%) among all myelin lipids (Chrast et al.,
2011b). Another glial cell type, astrocyte also provides cholesterol for synaptogenesis
and synaptic transmission (Bercury and Macklin, 2015; Camargo et al., 2009).
Oligodendrocytes and astrocytes majorly depend on biosynthesis of their own, while
neurons take up extracellular cholesterol generated mainly by astrocytes (Martín et al.,
2014; Pfrieger and Ungerer, 2011).
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Nerve axon

Figure 7. Schematic description of the formation of myelin by
oligodendrocytes.
Figure reprinted/modified from Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai,
Sharon R. Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan,
Chythra R. Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind U.K. Rao,
Feng Zhou, Hongwu Zheng, Matthew N. Rasband, Yiwen Chen, Fei Lan, Amy B.
Heimberger, Benjamin M. Segal, and Jian Hu, “Mature myelin maintenance requires
Qki to coactivate PPARβ-RXRα–mediated lipid metabolism.” J Clin Invest.
2020;130(5):2220-2236.
Permission to use this figure was acquired from the journal.
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Cholesterol supply is required differentially at different stages of life depending
on the brain functions. For example, neurons maintain consistent turnover of cholesterol
due to high metabolic rate throughout the life time (Pfrieger and Ungerer, 2011).
Conversely, oligodendrocytes are required to produce large amount of cholesterol in the
critical developmental stage of adolescence, where myelin biogenesis progresses
rapidly to encircle neurons in human and mouse model (Makinodan et al., 2012; Martín
et al., 2014; Whitaker et al., 2016). Studies showed that cholesterol biosynthesis rate is
highest in the postnatal 2-3 weeks in mice (Dietschy and Turley, 2004b), and then it
drops down significantly in adult and remains at a low level for the rest of life (Martín et
al., 2014; Quan et al., 2003). Consistently, sterol regulatory element-binding protein 2
(SREBP2), the major transcription factor of cholesterol biosynthesis displays high
expression in early time point in the peripheral nerve system (PNS) (Salles et al., 2003;
Verheijen et al., 2003). Besides, surface area of myelin membrane is estimated to be
increased by 6500 folds from immature to fully myelinated oligodendrocytes during the
first 2 weeks after birth in rats (Chrast et al., 2011a; Kraus and Michalak, 2011;
Webster, 1971). These lines of evidence suggest a critical role of cholesterol
biosynthesis in oligodendrocytes for myelin biogenesis in a time-sensitive manner.
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1.9 Dysregulation of brain cholesterol metabolism in neurological diseases.
Importance of cholesterol biosynthesis in myelination is implicated in various
neurological disorders. Hereditary diseases such as Smith-Lemli-Optiz syndromes,
desmosterolosis, and lathosterolosis are caused by deficiency of cholesterol
biosynthesis genes encoding DHCR7, 24-Dehydrocholesterol reductase (DHCR24),
SC5D, respectively (Kraus and Michalak, 2011; Porter and Herman, 2011b). SLOS
patients present cognitive defects and delayed motor and language development with
the feature of hypomyelination (Porter and Herman, 2011b; Ryan et al., 1998). Patients
with desmosterolosis show defects in the corpus callosum, thinning of white matter, and
seizures (Zerenturk et al., 2013). One of the major neurodevelopmental disorders,
schizophrenia is initiated usually in late adolescence or early adulthood when
maturation of the brain such as myelin biogenesis occur (Le Hellard et al., 2010; Steen
et al., 2017). White matter abnormalities are often displayed in schizophrenic patients in
association with reduced lipid metabolism (Steen et al., 2017). Among the 108
schizophrenia-associated genomic loci, it is notable that one is located on chromosome
22q13.2, which includes SREBF2, the gene encoding SREBP2 (Steen et al., 2017).
Antipsychotic drugs are known to increase SREBP2 activity, resulting in upregulation of
expression of genes involved in cholesterol biosynthesis such as HMGCR, HMGCS1,
MVK, LSS, and CYP51 (Fernø et al., 2005; Le Hellard et al., 2010), suggesting a
potential role of SREBP2-mediated cholesterol biosynthesis in the pathogenesis of
schizophrenia. In addition to the mutations on cholesterol biosynthesis genes that can
cause hereditary neurological diseases with manifestations of myelination defects,
pharmacological inhibition of cholesterol biosynthesis has also been shown to cause
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myelination defects. For instance, inhibitors of HMGCR, a rate-limiting enzyme in
cholesterol biosynthesis, have been shown to cause myelin defects in human (Miron et
al., 2009). Besides the neurological diseases with myelination defects, reduction of
cholesterol biosynthesis is also associated with neurogenerative diseases such as AD,
HD, PD, and autism spectrum disorders, whose myelin involvement has been
documented but less understood (Leoni and Caccia, 2014; Mohamed et al., 2018;
Segatto et al., 2019; Tsunemi et al., 2012; Xiang et al., 2011). Taken together,
cholesterol biosynthesis plays a pivotal role in brain function particularly myelination,
and dysregulated cholesterol metabolism can cause various neurological diseases
depending on the natures of the mutations/defects in the molecular pathway regulating
cholesterol metabolism.

1.10 Cellular and molecular functions of Quaking and diseases.
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Figure 8. Schematic diagram of Quaking isoforms, QKI-5, QKI-6, and QKI-7.
Three QKI isoforms have a common domain, STAR, which has the RNA-binding KH
domain while the C-terminus varies among three isoforms. QKI-5 has a nuclear
localization signal (NLS) (Wu et al., 1999) underlined.
Figure modified from Ryota Yamagishi, Takeshi Tsusaka, Hiroko Mitsunaga,
Takaharu Maehata, and Shin-ichi Hoshino, “The STAR protein QKI-7 recruits PAPD4
to regulate post-transcriptional polyadenylation of target mRNAs.” Nucleic Acids Res.
2016 Apr 7;44(6):2475-90.
Permission to use this figure was acquired from the journal.
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Quaking (QKI) is a member of the signal transduction and activation of RNA
(STAR) family of proteins (Vernet and Artzt, 1997). Three isoforms of QKI, QKI-5, QKI6, and QKI-7, are identified in human and mice (Figure 8). All isoforms share an
heterogeneous nuclear ribonucleoprotein (hnRNP K) homology (KH) domain containing
a specific sequence called the QKI RNA recognition element (QRE) (YUAAY) that has
the capacity to directly binds to RNA (Figure 8) (Galarneau and Richard, 2005; Teplova
et al., 2013). KH domain is adjacent to QUA1 domain at N-terminus and QUA2 domain
at C-terminus, and QUA1 domain is known to mediate homo- and heterodimerization of
QKI proteins for the QKI-RNA complex (Figure 8) (Teplova et al., 2013). QKI was
initially identified in Quaking viable (Qkv) mice bearing a spontanueous mutation
(Sidman et al., 1964a). Qkv mice show rapid tremor or “quaking” in the hidlimbs during
the develoment starting from postanatal day 11 and convulsive tonic-clonic seizures in
adulthood (Hogan, 1977). Qkv mice have been invetigated as a hypomyelination model
to study the function of QKI proteins since the reduced expression of QKI-6 and QKI-7
in Qkv mice lead to hypomyelination of the central nervous system (CNS) (Hogan,
1977), whereas Qk-null mice are embryonic-lethal with the defects in embryonic blood
vessel formation between embryonic day 9.5 and 10.5 (Li et al., 2003). QKI is invovled
in RNA metabolism including the stability, export, and alternative splicing of mRNA
regulating the myelin development (Chénard and Richard, 2008; Darbelli and Richard,
2016b). In addition to the myelin development, QKI functions in other developmental
processes such as monocyte differentiation and muscle differentiation (Li et al., 2003).
Using the cell type-specific conditional Qk deletion in the mouse model, previous
studies demonstrated that QKI functions as a tumor suppressor by regulating the
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endolysosomal pathway in neural stem cells (NSCs) and glioma stem cells (Shingu et
al., 2017) and an important regulator of mature myelin maintenance (Zhou et al., 2020).
QKI is also linked with the human diseases such as myelin disorders including Multiple
sclerosis, intellectual disabilities including Schizophrenia, 6q terminal deletion
syndrome, and cancer (Chénard and Richard, 2008; Darbelli and Richard, 2016b).

1.11 Gap of knowledge in tissue-specific cholesterol metabolism and genetic
association of Quaking in human cataracts.
A number of proteins are suggested to regulate the processing and
transcriptional activity of SREBP2 in the liver, such as SREBP cleavage-activating
protein (SCAP), progestin and adipoQ receptors 3 (PAQR3), CREB-binding protein
(CBP), hepatocyte nuclear factor-4 (HNF-4), and small heterodimer partner (SHP)
(Brown et al., 2018; Kim et al., 2015; Misawa et al., 2003; Oliner et al., 1996; Xu et al.,
2015). Although SREBP2 is ubiquitously expressed, SREBP2-mediated cholesterol
biosynthesis seems to depend on different regulators in different tissues. For example,
glycerol kinase 5 (GK5), a skin-specific kinase, regulates SREBP2 processing and
controls cholesterol homeostasis in sebocytes, terminally differentiated epithelial cells in
sebaceous glands that are required for normal hair follicle differentiation and cycling
(Zhang et al., 2017). Hence, different tissues are impacted by dysregulated cholesterol
biosynthesis to different extents. For instance, hypercholesterolemia often leads to
cardiovascular diseases in humans (Galarneau and Richard, 2005), whereas insufficient
cholesterol levels caused by various hereditary mutations of cholesterol biosynthesis
genes preferentially lead to cataracts in the eye lens (Cenedella, 1996). Consistently,
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lipid composition analysis revealed that eye lens cells contain a larger portion of
cholesterol than do other cell types, strongly implicating a high demand for cholesterol
in the lens (Borchman and Yappert, 2010). Therefore, studying cholesterol biosynthesis
in the eye lens may identify novel transcriptional regulators of SREBP2 and provide
insight into tissue-specific cholesterol homeostasis.
Despite genetic and pharmacological studies supporting the essential role of
cholesterol biosynthesis in regulating crystallin folding and lens transparency,
understanding the molecular mechanisms underpinning the transcriptional regulation of
cholesterol biosynthesis genes in the eye lens is rather limited. 6q deletion syndrome
displays cataracts as one of the clinical features (Engwerda et al., 2018; Group, 2018).
Although multiple genes reside in the 6q terminal deletions, breakpoint of a single gene,
Quaking (QKI), has been shown to cause a clinical phenotype highly similar to the
common 6q deletion syndrome phenotypes, suggesting that QKI loss plays a
pathogenic role in 6q deletion syndrome (Backx et al., 2010). Because deletion of QKI is
linked with 6q deletion syndrome in humans, in the present thesis project (Chapter 3),
we sought to determine whether and how QKI loss causes cataractogenesis. Using a
recently generated conditional Qk knockout (KO) mouse model, we showed that Qk
deficiency in the lens epithelium led to cataracts with 100% penetrance. The cataracts
formed in Qk-deficient mice were caused by a reduced cholesterol level, which could be
rescued by administering sterol eye drops to the mice. Mechanistically, we identified Qki
as a novel regulator of Srebp2-mediated transcription of cholesterol biosynthesis genes.
In addition, we showed for the first time that Qki directly interacts with DNA to regulate
transcription.
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1.12 Quaking in CNS myelination.
Mammalian Quaking (Qk) undergoes alternative splicing to express the RNAbinding proteins Qki-5, Qki-6, and Qki-7 (Darbelli and Richard, 2016a). Various studies
have extensively demonstrated that Qki regulates the RNA processing of the genes
encoding myelin basic protein (MBP), myelin-associated glycoprotein (MAG), p27kip1,
and neurofascin 155 in oligodendrocytes (Darbelli et al., 2016; Larocque et al., 2005;
Larocque et al., 2002a; Li et al., 2000; Zhao et al., 2010). The quaking viable (qkv)
mouse is a spontaneous recessive mutant with an approximate 1-Mbp deletion in the
upstream of Qk locus, leading to diminished expression of Qki in oligodendrocytes
(Ebersole et al., 1996; Hardy et al., 1996). Qkv homozygotes suffer from tremor and
early death due to severe hypomyelination in the CNS (Sidman et al., 1964b). Previous
studies showed that qkv mice exhibited reduced myelin lipid content, including
cholesterol (Baumann et al., 1968; Singh et al., 1971), and this phenomenon was
thought to be secondary to impaired differentiation and maturation of oligodendrocytes
(Chen et al., 2007b; Darbelli et al., 2016; Larocque et al., 2005). However, similar
numbers of oligodendrocytes in some regions of the CNS in qkv mice and control mice
and even hyperplasia in these regions in the former mice were observed (Doukhanine
et al., 2010; Hardy et al., 1996; Myers et al., 2016). These contradictory data suggested
that Qki might regulate myelination in the CNS through mechanisms besides controlling
oligodendrocyte differentiation and that reduced myelin lipid in qkv mice could be a
direct consequence of Qk loss rather than secondary to impaired oligodendrocyte
differentiation. Interestingly, our recent study demonstrated that Qki is not required for
mature oligodendrocyte survival in adult mice, and that Qki-5 forms a complex with
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peroxisome proliferator-activated receptor beta (PPARb)-retinoid X receptor alpha
(RXRa) to transcriptionally control fatty acid metabolism, which is essential for mature
myelin maintenance (Zhou et al., 2020). Although previous studies have shown the
defect in cholesterol metabolism is highly associated with the neurological disorders
including hereditary diseases and neurogenerative diseases, the mechanisms
underpinning how oligodendrocytes regulate cholesterol biosynthesis in myelin
development still remains unclear. We therefore hypothesized that Qki might also
regulate lipid metabolism, such as cholesterol biosynthesis, during developmental
myelination and further investigated the role of Qki in cholesterol metabolism in
myelination in the present thesis project (Chapter 4).
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Chapter 2: Materials and methods
2.1 Mice models.
Nestin-CreERT2 mice (C57BL/6) were gifts from R. Kageyama (Kyoto University,
Kyoto, Japan) (Imayoshi et al., 2008). Plp-CreERT2 mice (C57BL/6)(Doerflinger et al.,
2003), Rosa26-CreERT2 mice (C57BL/6) (Ventura et al., 2007) and mTmG mice
(C57BL/6) (Muzumdar et al., 2007) were from Jackson Laboratories (Bar Harbor, ME).
Conditional Qk knockout mice (QkL/L) with two loxP sequences flanking the exon 2 of Qk
gene were generated by our lab as previously described (Shingu et al., 2017). QkL/L
mice were crossed with Nestin-CreERT2 transgenic mice, Plp-CreERT2 transgenic mice,
or R26-CreERT2 mice wherein the expression of tamoxifen-inducible Cre was under the
control of the Nestin promoter, Plp promoter, or Gt(ROSA)26Sor promoter. Mice were
maintained at MD Anderson’s animal facility under pathogen-free conditions, maintained
under a 12-hour light-dark schedule, allowed free access to water and food, and
monitored for signs of illness every other day. All mouse experiments were conducted in
accordance with protocols approved by the Institutional Animal Care and Use
Committee of The University of Texas MD Anderson Cancer Center.
Nestin-CreERT2;QkL/L mice were injected subcutaneously with 20 µL of tamoxifen
(10 mg/mL) (Sigma-Aldrich) dissolved in corn oil for two consecutive days at the age of
P7 and P8 to induce the deletion of Qk. Littermates (Nestin-CreERT2;Qk+/+, NestinCreERT2; QkL/+, or QkL/L mice) of the same age and genetic background were injected
concomitantly with tamoxifen and used as controls. Beginning at P4, Plp-CreERT2;QkL/L,
Plp-CreERT2;QkL/+ mice, Plp-CreERT2;WT mice, and QkL/L mice were injected
subcutaneously with 10 µL of tamoxifen (10 mg/mL) for two consecutive days. After
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tamoxifen injection, the experimental mice were monitored daily, and their neurological
impairments were recorded for further plotting of a quaking phenotype-free survival
curve. When the Qk-iCKO mice reached the clinical endpoint, they had severe
paralysis, significant weight loss, and hunched posture and were near death. Thus, they
were euthanized for humanistic care.

2.2 Primary cells.
For NSC isolation, the whole brains of the Nestin-CreERT2;QkL/L mice at P1
were dissected, sliced into small pieces, and dissociated enzymatically using Neural
Tissue Dissociation Kits, according to the manufacturer’s instructions (Miltenyi Biotec).
The single-cell suspension of NSCs was then maintained in NeuroCult Basal Medium
(Stemcell Technologies) containing NeuroCult Proliferation Supplement (Stemcell
Technologies), 20 ng/mL EGF (ProteinTech), 10 ng/mL bFGF (ProteinTech), 50
units/mL penicillin G (Thermo Fisher Scientific), and 50 μg/mL streptomycin (Thermo
Fisher Scientific). For gene deletion of Qk, the NSCs were treated with 100 nM 4hydroxytamoxifen (Sigma-Aldrich) two times.
For NLPC differentiation, NSCs were seeded onto the culture dishes precoated
with 2 ug/ml fibronectin (R&D Systmes) in PBS overnight in the NSC medium
described above. After two days, NSPC differentiation was induced in DMEM/F12
(Thermo Fisher Scientific, 11320033) supplemented with 0.05 % bovine serum
albumin (Sigma-Aldrich), 1% nonessential amino acids (Thermo Fisher Scientific), 1´
N-2 (Thermo Fisher Scientific), 1´ B-27 (Thermo Fisher Scientific), 50 units/mL
penicillin G, and 50 μg/mL streptomycin with treatment of 100 ng/mL Noggin
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(PeproTech) for 6 days (Step 1) and 100 ng/ml bFGF (ProteinTech), 20 ng/ml BMP4
(PeproTech), 20 ng/ml BMP7 (PeproTech) for 12 days (Step 2)(Yang et al., 2010). All
cell culture was performed under 5% CO2 atmospheric oxygen, at 37°C in a humidified
incubator.
To induce in vitro oligodendrocyte differentiation, NSCs were seeded onto
culture dishes precoated with 20 μg /mL poly-L-ornithine (Sigma-Aldrich) and 10 μg
/mL laminin (Thermo Fisher Scientific) at 2.5 × 104 cells/cm2 and cultured in the NSC
medium described above. Two days later, the medium was changed to Neurobasal
Medium (Thermo Fisher Scientific) supplemented with B-27 (Thermo Fisher
Scientific), 2 mM GlutaMAX-I (Thermo Fisher Scientific), 30 ng/mL 3,3',5-triiodo-Lthyronine (Sigma-Aldrich), 50 U/mL penicillin G, and 50 μg /mL streptomycin. The
cells were cultured in differentiation medium for three days, and fresh medium was
replaced every other day.

2.3 Cell lines.
HLE-B3 cells were obtained from ATCC (Cat# CRL-11421) and cultured in
Eagle’s minimum essential medium (ATCC) containing 20% fetal bovine serum
(HyClone), 50 units/mL penicillin G, and 50 μg/mL streptomycin. Lipid depletion in
HLE-B3 cells was induced with the treatment of 5% lipoprotein depleted fetal bovine
serum (Kalen Biomedical LLC), 10 μM compactin (Sigma-Aldrich), and 50 μM
mevalonate (Sigma-Aldrich)(Xu et al., 2015). 100 μM MG-132 (Sigma-Aldrich) was
treated in HLE-B3 to increase nuclear stabilization of mature SREBP2 (Sundqvist and
Ericsson, 2003). All cell culture was performed under 5% CO2 atmospheric oxygen, at
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37°C in a humidified incubator.

2.4 Rotarod behavioral analysis.
The tamoxifen-injected mice were trained for five trials at a constant 5 rpm using
a rotarod apparatus (Harvard Bioscience) and then tested in a 120-second trial at a
constant 5 rpm. The latency of mice of falling off the rotarod was recorded. If a mouse
stayed on the rotarod for more than 120 seconds, it was recorded as 120 seconds.
Three trials were tested for each mouse at intervals of at least 30 minutes. Statistical
analysis was performed using the mean latency of mice falling off the rotarod of three
trials.

2.5 Tissue preparation and immunofluorescence.
Mice were euthanized by CO2 inhalation followed by cervical dislocation. Ocular
tissues, brains, and optic nerves were immediately dissected, fixed in formalin and
embedded in paraffin. For frozen sections, dissected ocular tissues were fixed in 4%
paraformaldehyde (PFA), dehydrated in 30% sucrose in PBS, and embedded in optimal
cutting temperature compound (OCT). The prepared tissue sections were boiled in
citrate buffer (Poly Scientific R&D Corp.) for heat-induced antigen retrieval followed by
blocking with 10% horse serum for 1 hour at room temperature. The following primary
antibodies were used for staining overnight at 4°C: anti-Ubiquitin (MBL, MK-11-3), anti–
Qki-5 (immunizing rabbit with a short synthetic peptide
[CGAVATKVRRHDMRVHPYQRIVTADRAATGN], Genscript), anti-GFP (Abcam,
ab13970), anti-p62 (CST, 5114), anti-Nestin (BD Biosciences, 556309), anti-GFAP (BD
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Biosciences, 556330), anti-Hmgcs1 (Abcam, ab155787), anti-MBP (SMI-94R) and anti–
β-Amyloid (SIG-39220) were from BioLegend; anti-PLP (ab105784), anti-Iba1
(ab107159) were from Abcam; anti-MAG (#9043), anti-GFP (#2555), and anti-Pdgfra
(#3174) were from Cell Signaling Technology; anti-Aspa (ABN1698), anti-Olig2
(AB9610), and anti-NeuN (MAB377) antibody were from Merck Millipore; anti-Gstpi
(311) was from MBL International; anti-Qki (SAB5201536) and anti-Srebp2
(HPA031962) were from Sigma-Aldrich; and anti-Gfap (556330) was from BD
Biosciences. The sections were incubated with appropriate Alexa Fluor dye-conjugated
secondary antibodies (Thermo Fisher Scientific) for one hour at room temperature.
FluoroMyelin (Thermo Fisher Scientific) was stained directly onto rehydrated slides for
20 minutes at room temperature according to the manufacturer’s instructions. The
sections were mounted using a VECTASHIELD an antifade mounting medium with
DAPI. For immunofluorescence of NLPCs, cells on fibronectin-coated coverslips were
fixed with 4% PFA and treated with 0.1% Triton X-100. After blocking with 1% BSA for 1
hour, the cells were incubated with the following primary antibodies for overnight at 4°C:
anti-Pax6 (Abcam, ab5790), anti-aB-crystallin (Abcam, ab13496), anti–Qki-5
(immunizing rabbit with a short synthetic peptide
[CGAVATKVRRHDMRVHPYQRIVTADRAATGN], Genscript)
The samples were then incubated with the corresponding Alexa Fluor conjugated
secondary antibodies (Thermo Fisher Scientific) for 1 hour at room temperature and
mounted using a VECTASHIELD with DAPI (Vector Laboratories). Fillipin staining was
performed on the frozen tissues using cell-based cholesterol assay kit (Abcam,
ab133116) based on the manufacturer’s instructions, and TO-PRO3 (Thermo Fisher
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Scientific) was used for nuclear counterstaining. Most immunofluorescence images
were captured with Leica DMi8 microscope. The confocal images were captured with
Nikon A1R confocal microscope.

2.6 Silver staining.
The lens tissues of control and Nestin-CreERT2;QkL/L mice were homogenized in
radioimmunoprecipitation (RIPA) lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM sodium
chloride, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate,
supplemented with freshly added protease inhibitor cocktail). After centrifugation at
13,000 g at 4°C for 10 minutes, the supernatant was collected and quantified using a
DC protein assay (Bio-Rad). 3-5 µg of protein lysates was separated by 4-12% gradient
NuPAGE gels (Invitrogen) and visualized by Pierce™ Silver Staining Kit (Thermo Fisher
Scientific).

2.7 Mass spectrometry.
Aggregates from the lenses of Nestin-CreERT2;QkL/L mice were dissected and
solubilized with 8 M urea followed by visualization of proteins using Coomassie blue
staining and analysis by Taplin Biological Mass Spectrometry Facility (Harvard Medical
School).

2.8 Congo Red staining.
Formalin-fixed paraffin sections of ocular tissues were rehydrated, washed, and
incubated in Congo Red solution (0.5% Congo Red (Fisher Scientific) in 50% alcohol)
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for 20 min. The tissue sections were then rinsed and transferred to alkaline alcohol
solution (1X sodium hydroxide, 50% alcohol) briefly and rinsed. The sections were then
counterstained with hematoxylin for 30 sec, rinsed, and dehydrated (Westermark et al.,
1999).

2.9 Electron microscopy.
Beginning at P7, Nestin-CreERT2;QkL/L mice (n = 3) and control mice (n = 3)
were injected with 20 µL of tamoxifen (10 mg/mL) on two consecutive days. Also,
beginning at P4, Plp-CreERT2;QkL/L mice (n = 3) and control mice (n = 5) were injected
with 10 µL of tamoxifen (10 mg/mL) on two consecutive days. Two weeks later, these
experimental mice were transcardially perfused with 2% paraformaldehyde. Their optic
nerves were then postfixed in a cold PBS solution containing 3% glutaraldehyde and
2% paraformaldehyde at 4°C and processed at the MD Anderson High Resolution
Electron Microscopy Facility. In brief, these fixed optic nerves were washed in 0.1 M
sodium cacodylate buffer, treated with 0.1% Millipore-filtered cacodylate-buffered
tannic acid, postfixed with 1% buffered osmium tetroxide for 30 minutes, and stained
en bloc with 1% Millipore-filtered uranyl acetate. The samples were dehydrated in
increasing concentrations of ethanol and then infiltrated with and embedded in LX-112
medium. The samples were polymerized in a 60°C oven for about three days.
Ultrathin sections of the samples were cut using a Leica Ultracut microtome, stained
with uranyl acetate and lead citrate in a Leica EM stainer, and examined using a JEM
1010 transmission electron microscope (JEOL USA) at an accelerating voltage of 80
kV. Digital images of the sections were captured using an AMT imaging system
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(Advanced Microscopy Techniques). ImageJ software (National Institutes of Health)
was used to measure the axonal calibers and diameters of myelinated fibers; the
percentage of myelinated axons, g-ratio, axonal diameter, and density of axon in these
optic nerves were quantified on the basis of these measurements. Lenses from control
and Nestin-CreERT2;QkL/L at the age of P30 were immediately dissected after
euthanasia described above and processed as shown above.

2.10 Lentivirus production and infection of cells.
The coding DNA sequence region of Srebf2 was amplified by PCR from pLKOpuro Flag-Srebp2 (addgene #32018)(Peterson et al., 2011) and engineered to a
pcDNA vector containing 2X Flag to generate an insert of Srebp2 with 2X Flag at the
N terminus (2X Flag-Srebp2). pLKO-puro Flag-Srebp2 containing 1X Flag at the N
terminus was cut with SalI and NotI to remove the Srebp2, and 2X Flag-Srebp2 from
pcDNA was fused with the cut vector to generate Srebp2 expressing vector with 3X
Flag at the N terminus using In-Fusion cloning kit (Takara Bio), and the coding DNA
sequence region of wild-type with a hemagglutinin (HA) tag at the C terminal was first
cloned into pENTR TOPO vector (Thermo Fisher Scientific) and recombined to the
lentiviral vector pInducer20 (Meerbrey et al., 2011) using Gateway LR clonase II
enzyme mix (Thermo Fisher Scientific) according to the manufacturer’s instructions..
The lentiviruses packaged in HEK293T cells were infected to HLE-B3 cells and NSCs.
The cells were then treated with puromycin (InvivoGene) for selection of Flag-Srebp2+
cells and G418 (Life Technologies) for Qki-5–HA+ infected cells. The viable cells were
used for further experiments. Doxycycline treatment was performed to induce the
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expression of Qki-5–HA.
Targeted gene deletion of QKI in HLE-B3 cells was conducted by
CRISPR/Cas9 system using plentiCRISPRv2 plasmid (Sanjana et al., 2014; Shalem
et al., 2014). After lentiviral infection, QKI-target HLE-B3 cells were enriched by
puromycin (InvivoGene) selection.

2.11 Immunoblotting and co-immunoprecipitation (Co-IP).
Lens tissue lysates were prepared as described above. Protein lysates of HLEB3 cells and NLPCs were also prepared from the RIPA-soluble fraction and measured
using a DC protein assay (Bio-Rad). 40-100 µg of proteins was separated on 4-12%
gradient NuPAGE gels (Invitrogen) and transferred to a nitrocellulose membrane and
probed with anti-ubiquitin (MBL, MK-11-3), anti-p62 (CST, 5114), anti-Hsp90 (Abcam,
ab59459), anti-Hmgcs1 (Abcam, ab155787), anti-Hmgcr (Abcam, ab174830), anti-Lss
(Abcam, ab80364), anti-Fdps (Abcam, ab189874), and anti–Qki-5 (immunizing rabbit
with a short synthetic peptide [CGAVATKVRRHDMRVHPYQRIVTADRAATGN],
Genscript), anti–aB-crystallin (Abcam, ab13496), anti–aA-crystallin (Abcam, ab5595),
anti–b-crystallin (Santa Cruz Technology, sc-22745), anti–b-actin (Sigma-Aldrich,
A5441,) overnight at 4°C followed by incubation with the corresponding horseradish
peroxidase (HRP)-conjugated secondary antibodies and detection using a SuperSignal
enhanced chemiluminescence system (Thermo Fisher Scientific). For co-IP, HLE-B3
cells, NLPCs, and differentiated oligodendrocytes were washed twice with the cold PBS
and lysed in hypotonic lysis buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl2, and 10 mM
KCl, supplemented with freshly added protease inhibitors and DTT) for 10 minutes. The
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swollen cells were disrupted by a dounce homogenizer on ice followed by centrifugation
at 13,000g at 4°C for 15 minutes. The pellet (nuclei) was resuspended in low salt buffer
(20 mM HEPES [pH 7.9], 1.5 mM MgCl2, 20 mM KCl, 0.2 mM EDTA, and 25% glycerol,
supplemented with freshly added protease inhibitors and DTT) followed by
centrifugation at 13,000g at 4°C for 10 minutes. The pellet was fixed by 1%
formaldehyde in NP-40 buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA,
and 0.05% NP-40, supplemented with freshly added protease inhibitors) for 10 minutes
followed by quenching with 0.125 M glycine and washing with cold PBS. The
crosslinked pellet was then sonicated using a Bioruptor Pico sonication device
(Diagenode) for 60 cycles (30 seconds on, 30 seconds off) on high power setting. After
centrifugation at 13,000 g at 4°C for 10 minutes to remove insoluble debris, the
supernatant (nuclear fraction) was incubated with antibodies against Qki-5 (immunizing
rabbit with a short synthetic peptide [CGAVATKVRRHDMRVHPYQRIVTADRAATGN],
Genscript), Srebp2 (10007663, Cayman Chemical), or normal rabbit immunoglobulin
(CST, 2729) G at 4°C overnight followed by further incubation in the presence of
magnetic recombinant protein G coated-beads (Thermo Fisher Scientific) for another 2
hours at 4°C. Alternatively, co-IP was performed as described above except using antiFlag M2 magnetic beads (Sigma-Aldrich) for 4 hours, and co-IP using denatured antiFLAG M2 magnetic beads which were boiled at 95°C for 30 minutes was served as a
control. Bound beads were then washed 3 times in cold NP-40 buffer by inverting the
tubes, boiled in sample buffer at 95°C for 20 minutes, and subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting with anti–
QKI-5, anti-SREBP2, anti-Flag (Sigma-Aldrich, 1804), and anti-HA (Abcam, ab18181).
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2.12 Subcellular fractionation.
HLE-B3 cells were cultured in lipid depletion condition described above, collected
and washed in PBS, and resuspended in lysis buffer containing 10 mM HEPES [pH
7.4], 10 mM KCl, 0.05% NP-40, protease inhibitor cocktail, phosphatase inhibitor, and
dithiothreitol). Protein lysates were incubated for 20 min on ice and centrifuged at
14,000 rpm at 4°C for 10 min. The supernatants containing the cytoplasmic proteins
were separated, and the cell pellets were washed, resuspended in low salt buffer (10
mM Tris-HCl [pH 7.4], 0.2 mM MgCl2, 1% Triton X-100 and incubated for 15 min on ice.
After centrifugation at 14,000 rpm at 4°C for 10 min, the supernatants containing
nuclear soluble proteins were separated. The cell pellets were then resuspended in 0.2
N HCl and incubated for 20 min on ice followed by 10 min of centrifugation at 14,000
rpm at 4°C. The Supernatant containing chromatin proteins were then neutralized with
the equal volume of 1M Tris-HCl [pH 8.0]. Each fraction was quantified and proceeded
to immunoblotting assay with the following primary antibodies: anti–QKI-5 (immunizing
rabbit with a short synthetic peptide [CGAVATKVRRHDMRVHPYQRIVTADRAATGN],
Genscript), anti-SREBP2 (Abcam, ab30682), anti-GAPDH (Santa Cruz Biotechnology,
SC-32233), anti-SP1 (Abcam, ab13370), and anti-Histone H3 (Abcam, ab5176) (Toiber
et al., 2013).

2.13 Cholesterol measurement.
The lens (at P19), whole brain (at P19), and corpus callosum (at P21) tissues of
control and Nestin-CreERT2;QkL/L mice at P19 were homogenized in the lipid extraction
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buffer (chloroform : isopropanol : NP-40 = 7 : 11 : 0.1) (200 μl of the lipid extraction
buffer per 10mg of tissue). After centrifugation at 13,000 g at 4°C for 10 minutes, the
supernatant was collected and air-dried to remove the organic solvent. Dried lipid was
used to measure cholesterol levels by Total Cholesterol Assay Kits (Cell Biolabs)
according to the manufacturer’s instructions. For plasma cholesterol measurement,
blood was collected retro-orbitally from control and Nestin-CreERT2;QkL/L mice at P19,
immediately followed by treatment of 0.5 M EDTA as an anticoagulant. Then, the blood
samples are centrifuged at 2,000 g at 4°C for 10 minutes, and the top layer was used
with 1:50 dilution for cholesterol measurement as shown above.

2.14 Lanosterol treatment.
2 µl of lanosterol eye drop (Lanomax, Ventura Laboratories Brea California
92821 USA) was directly applied to the eyes of control and Nestin-CreERT2;QkL/L mice
twice a day for 7 days starting from the age of P14. This study was approved by MD
Anderson’s animal facility. The dissected lenses at P21 were immediately imaged by
Leica DFC450 C microscope camera, and aggregation index was quantified using
Image J.

2.15 Reverse transcriptase quantitative PCR (RT-qPCR).
Total RNA was isolated using a RNeasy Mini Kit (Qiagen) as per the
manufacturer’s instructions. 2 µg of RNA was reverse transcribed to cDNA by
SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher Scientific). Real-time
RT-qPCR was performed using the iTaq Universal SYBR Green Supermix (Bio-Rad)
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with a 7500 Fast Real-Time PCR system (Applied Biosystems). The quantitative
mRNA level of cholesterol biosynthesis genes was assessed according to the ΔΔCT
method using Actb (mouse corpus callosum and eye lens tissues) and GAPDH
(NLPCs and HLE-B3 cells) as reference genes. List of oligonucleotide primer pairs
used in RT-qPCR is provided in Table 1.

2.16 RNA-sequencing and pathway enrichment analysis.
Total RNA was isolated from freshly dissected lenses from control (n=3) and
Nestin-CreERT2;QkL/L (n=3) mice at P17-19 and freshly collected brains from control
mice ( n= 2) and Plp-CreERT2;QkL/L mice (n = 2) at P30 using a RNeasy Mini Kit with
the treatment of DNase (Qiagen). RNA sequencing was conducted by the Illumina
HiSeq/MiSeq sequencing service at the MD Anderson Sequencing and Microarray
Facility. The stranded paired-end RNA sequencing analysis procedure was referenced
to Pertea’s protocol(Pertea et al., 2016). In brief, STAR (2.6.1b) program (Dobin et al.,
2013) was used to align pair-end RNA sequence data against the mouse reference
genome (mm10) and the human reference genome (hg19) version
(GRCh37.primary_assembly.genome) with STAR-2.6.1b with parameters -outSAMunmapped Within --outFilterType BySJout --twopassMode Basic -outSAMtype BAM SortedByCoordinate. After applying the HTSeq (0.11.0)(Anders et
al., 2015) to extract the raw count tables based on the aligned bam files, DESeq2
(Love et al., 2014) was used to perform normalization and differential gene expression
analysis. Differentially expressed genes (p-value < 0.05) were used for analysis of
canonical cellular pathways and upstream transcription regulators altered upon Qki
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depletion by Ingenuity pathway analysis (IPA) (Qiagen Inc.).

2.17 Chromatin immunoprecipitation-sequencing (ChIP-seq) and ChIP-qPCR.
The ChIP assays were performed as described previously (Lan et al., 2007). In
brief, NLPCs, HLE-B3 cells, and adherent differentiated oligodendrocytes were
crosslinked by 1% formaldehyde for 10 minutes and quenched by 0.125M glycine.
Then the crosslinked cells were suspended in ChIP lysis buffer (50 mM Tris-HCl [pH
7.4], 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.1% sodium
deoxycholate, with freshly added protease inhibitors) and sonicated to 200 - 300bp.
The sheared chromatin was diluted in ChIP dilution buffer (50 mM Tris-HCl [pH 7.4],
100 mM NaCl, 2 mM EDTA, 1% Triton X-100, and 0.1% sodium deoxycholate, with
freshly added protease inhibitors) at a ratio of 1:1, and then incubated with anti–Qki-5
(immunizing rabbit with a short synthetic peptide
[CGAVATKVRRHDMRVHPYQRIVTADRAATGN], Genscript), anti-Srebp2 (10007663,
Cayman Chemical), or anti-Pol II (Abcam, ab817) antibodies overnight at 4°C. After
incubation with prewashed magnetic recombinant protein G coated-beads (Thermo
Fisher Scientific) for 2 hours, the protein-DNA complexes were washed three times
with high-salt buffer (50 mM HEPES [pH 7.5], 500 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 0.1% sodium deoxycholate, and 0.1% SDS with freshly added protease
inhibitors), twice with low-salt buffer (10 mM Tris-HCl [pH 8.0], 250 mM LiCl, 1 mM
EDTA, 0.5% NP-40, and 0.5% sodium deoxycholate, with freshly added protease
inhibitors), and once with TE buffer (10 mM Tris-HCl [pH 8.0] and 1 mM EDTA).
Elution and reverse crosslinking were carried out in the elution buffer (50 mM Tris-HCl
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[pH 8.0], 10 mM EDTA, and 1% SDS) at 65°C for 4 hours. After digestion with RNase
A (Thermo Fisher Scientific) and proteinase K (Promega) for 1 hour at 55°C, DNA
samples were purified using a PCR purification kit (Qiagen). Library preparation was
performed under the instructions of the KAPA Hyper Prep Kit (Kapa Biosystems) and
sequenced by Illumina HiSeqX Ten or NovaSeq 6000 (Jiangxi Haplox Clinical Lab
Cen, Ltd). The FASTQ data were trimmed by Trim Galore (v0.4.4_dev) and mapped
to the mouse genome (mm10 version) or human genome (hg19 version) using Bowtie
(v1.2.2) (Langmead et al., 2009), then peaks were identified by macs2 (v2.1.2)(Feng
et al., 2012) with the parameters ‘macs2 callpeak -f BAM -g mm/hs -q 0.05 -t
ChIP.bam -n NAME -c INPUT.bam’Homer (v4.10.1)(Heinz et al., 2010) with the
following steps: makeTagDirectory and findPeaks Sample_tag -style factor -size auto minDist default -i Input_tag -fdr 0.001. Signalplots and Heatmaps were generated with
ngsplot (Shen et al., 2014). ChIP-seq between WT and KO were normalized by total
reads. IPA was used to analyze canonical cellular pathways enriched in genes whose
promoters were co-occupied by Qki-5, Srebp2, and Pol II and in the overlapping gene
cluster of Qki-5-bound genes in ChIP-seq and significantly downregulated genes in
QkL/L NLPCs and QKI KO HLE-B3 cells relative to WT according to RNA-seq. Motifs
enriched in QKI-5 peaks in NLPCs and HLE-B3 cells were identified by
HOMER(v4.10.1) with the following parameters: findMotifsGenome.pl peaklist.bed
mm10 –size given –len 6,8,10,12,14 –mis 2(Heinz et al., 2010). ChIP-qPCR was
performed on a 7500 Fast Real-Time PCR system (Applied Biosystems) using iTaq
Universal SYBR Green Supermix (Bio-Rad). List of oligonucleotide primer pairs used
in ChIP-qPCR can be found in Table 1.
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2.18 Protein expression and purification.
The full length Qki-5 and STAR domain were cloned into an in-house modiﬁed
version of pET-32a vector (Novagen, USA)(Xie et al., 2018). A Thioredoxin (Trx)-His6
tag and a PreScission protease cleavage site are present at the N-terminus of the
multiple cloning sites. The resulting proteins contained a Trx-His6 tag on the N-termini of
both full length Qki-5 and STAR domain. The recombinant proteins were expressed in
BL21 (DE3) Codon Plus Escherichia coli cells at 16 ℃ for 16–18 hours. The cells were
then lysed by an AH-1500 high pressure homogenizer (ATS Engineering Limited,
China). The Trx-His6-tagged protein complex was puriﬁed by Ni-NTA afﬁnity
chromatography (Qiagen, USA) followed by size-exclusion chromatography on a
HiLoad 26/600 Superdex 200 (GE Healthcare, USA) in 50 mM Tris, pH 7.5, and 150
mM NaCl. Finally, protein was collected and concentrated for MST experiment.

2.19 Microscale thermophoresis.
MST experiments were performed on a Monolith NT.115 (NanoTemper,
Germany) with a blue filter. Purified proteins were labeled by Att488-NHS, and the
labeled proteins were separated from the free Atto488-NHS using a gravity column (PD
MiniTrap G-25, GE Healthcare). 40 nM Atto488-labeled proteins (2X of the final reaction
concentration) were prepared in PBS with 0.1% Tween-20, and oligonucleotides (QREs
and QDEs) were dissolved and 2-fold serially diluted in PBS into 16 different
concentration. 10 µl of oligonucleotides of each concentration was thoroughly mixed
with 10 µl of 40 nM labeled proteins, and the mixture was incubated at room
temperature for 10 min. Approximately 10 µl of the mixtures were then loaded into
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standard/premium treated capillaries. Measurement were performed at 25°C using 60%
MST power. Each experiment was repeated three times. Data analyses were performed
using the NanoTemper analysis software.

2.20 Statistical analysis.
Statistical analysis was performed using GraphPad Prism 8 software. The
sample size was based on experimental feasibility, sample availability, and the number
of necessary to obtain definitive results. The number of animals in each experiment is
described in the corresponded Figure legends. Numerical results are presented as
mean with error bars representing standard deviation (SD) except for Fig. 3f with
standard error of the mean (SEM). For comparisons between the two groups, a twotailed unpaired t-test was used except for Fig. 28c with a two-tailed paired t-test. To
compare three or more groups, one-way analysis of variance (ANOVA) with Tukey’s
multiple comparisons test was conducted. Animal survival durations were analyzed
using the log-rank test. Data distribution was assumed to be normal but has not been
formally tested. All values of p < 0.05 were considered to be statistically significant.
There were no randomization or blinding events during the experiments.

2.21 Data availability.
The RNA-and ChIP-seq data described herein have been deposited in the
National Center for Biotechnology Information Gene Expression Omnibus and are
accessible at GSE145475
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145475), GSE144757
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(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144757), GSE145116
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145116; token:
yjwtqumcnzsjreh), GSE145117
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145117; token:
irineqsmplsvjcl), GSE144756
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144756; token:
szcbyeukfdqlrsz), and GSE126577.
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Table 1. Primers.
Primer name
Sequence
Mouse RT-qPCR primer set
mHmgcs1-Forward
TGGAAGCCTTTGGGGACG
mHmgcs1-Reverse
GGTGAGTACTGTGCCAGGAC

Source

mHmgcr-Forward
mHmgcr-Reverse

CCAAGAGAGAAAAGTTGAGG
TTGCACCTTTCTCTGCATTC

This study

mPmvk-Forward
mPmvk-Reverse

AGGAGTATGCTCGGGAGCATG
TGTGTCACTCACCAGCCAGATAG

This study

mMvd-Forward
mMvd-Reverse

CAGCCAATGGAGACAAGTTCC
GTCCTGGTCCGACCTGAGTG

This study

mIdi1-Forward
mIdi1-Reverse

ATTACCTTTCCAGGTTGTTTCACC
TTTAGATCAACCTCTTCCAAGG

This study

mFdps-Forward
mFdps-Reverse

TCCAGGTCCAGGACGACTACCTTG
CCCATAATTCTCCTCTAAGATCTGG

This study

mFdft1-Forward
mFdft1-Reverse

GTGCTATTCCACAGGTAATG
GATCCGGTGATAAATCTCTTC

This study

mLss-Forward
mLss-Reverse

GGCTCCTGGGAGGGCTCCTG
CTGCACAAGCAGCCCCATCTTGG

This study

mCyp51-Forward
mCyp51-Reverse

ACTTACGACCAGTTGAAGGATCTG
CCTGCCACCGTCTGAGGGGTC

This study

mTm7sf2-Forward
mTm7sf2-Reverse

CTCATCTGCCTCCTTAAGGTTATTGG
GGGATGGTCTCAAGACCAGCCAC

This study

mMsmo1-Forward
mMsmo1-Reverse

ACGAGTTTCAGGCTCCATTTGG
CATAACCGCTGTGCACATCG

This study

mNsdhl-Forward
mNsdhl-Reverse

CAGGAGAGAGCAGTACTGGATG
CAGGTTTTCCCCATTTCCAATC

This study

mHsd17b7-Forward
mHsd17b7-Reverse

GAATTTCAACCAGAAGGGTCTG
ACAAAAAAGCGAAGGAGCCAC

This study

mSc5d-Forward
mSc5d-Reverse

ACTTTCCAAATGGCTGGATTCATC
TATGTATGCGCTTGTAGACCAG

This study
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This study

mActb-Forward
mActb-Reverse

CCACCATGTACCCAGGCATT
CCGATCCACACAGAGTACTT

mGapdh-Forward
TCACCACCATGGAGAAGGC
mGapdh-Reverse
GCTAAGCAGTTGGTGGTGCA
Human RT-qPCR primer set
hHMGCS1-Forward
hHMGCS1-Reverse
hHMGCR-Forward
hHMGCR-Reverse
hIDI1-Forward
hIDI1-Reverse

GGGCAGGGCATTATTAGGCTAT
TTAGGTTGTCAGCCTCTATGTTGAA
CCCCTCTCCAGGTGTTCACA
AATTGAGGTAGGTTTCATAGAGATGCT
TTTCCAGGTTGTTTTACGAATACG
TCCTCAAGCTCGGCTGGAT

hFDFT1-Forward
hFDFT1-Reverse

TCAGACCAGTCGCAGTTTCG
CTGCGTTGCGCATTTCC

hSQLE-Forward
hSQLE-Reverse

CGTGCTCCTCTTGGTACCTCAT
CGGTCAAGGCGGAGATTATC

hCYP51-Forward
hCYP51-Reverse

TGCAGCCTGGCTCTTACCA
AGCTCTGTCCCTGCGTCTGA

hMSMO1-Forward
hMSMO1-Reverse

GAAAAGCCGGCACCAAGA
TCAAAGAGAGAATCAGCTCAAACTG

hGAPDH-Forward
GGATTTGGTCGTATTGGG
hGAPDH-Reverse
GGAAGATGGTGATGGGATT
Mouse ChIP-qPCR primer set
mC-Hmgcs1-Forward
GGTCGGTGGCTATAAAGCTG
mC-Hmgcs1-Reverse
CGGGACACTCACCCAAAG
mC-Hmgcr-Forward
mC-Hmgcr-Reverse

GCTCGGAGACCAATAGGA
CCGCCAATAAGGAAGGAT
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This study
(Giulietti et al.,
2001)

(Moon et al.,
2019)
(Moon et al.,
2019)
(Moon et al.,
2019)
(Moon et al.,
2019)
(Moon et al.,
2019)
(Moon et al.,
2019)
(Moon et al.,
2019)
(Xiang et al.,
2012)

This study
(Jeon et al.,
2008)

mC-Mvk-Forward
mC-Mvk-Reverse

AGCACGTCATCGGTGTGAT
TGGGAACTTCAAGCAAGCC

(Kim et al., 2015)

mC-non-target-Forward
ATGCCTAACTTCCAGTTCCAGG
mC-non-target-Reverse
AGCTTAGAGCAGAAAGCTGGT
Human ChIP-qPCR primer set
hC-HMGCR_Forward
CTTATTGGTCGAAGGCTCGT
hC-HMGCR_Reverse
CTCACTAGAGGCCACCGAAC

This study

hC-MVD_Forward
hC-MVD_Reverse

CACGCGCTACCACAGGATT
CGTCCATTGGCTGAGAGGTA

This study

hC-FDPS_Forward
hC-FDPS_Reverse

GCAGGATCGCGTTATCTGTC
GCTCTGTGGGTCGAGTAGTT

This study

hC-CYP51_Forward
hC-CYP51_Reverse

AGGTGATCTCGGCCTACATC
TTATTTGGGGCTGTCGGAGT

This study

hC-non-target-Forward
hC-non-target-Reverse

TGCCCAGCCTCAGTTTCTTA
GCAACCAAACCATGAGCTGA

This study
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This study

Chapter 3: Qki-activated cholesterol biosynthesis in prevention of cataracts in
eye lens
3.1 Deletion of Qk in eye lens cells leads to cataracts.

Nestin
Exon1

CreERT2 under
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✕
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loxP
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Exon1

Exon3

Qk-iCKO

Figure 9. Schematic diagram of the generation of Qk-Nestin-iCKO mice.
To investigate the mechanism underpinning Qki’s regulation of protein
homeostasis in vivo, we chose the Nestin-CreERT2; QkL/L mouse model (hereafter
denoted as “Qk-iCKO”) (Shingu et al., 2017) (Figure 9), as Nestin is a specific marker of
ectodermal lineage, that of lens epithelial cells and NSCs (Figure 10a) (Corsten and
Shah, 2008; Cvekl and Ashery-Padan, 2014; Ogino et al., 2012). We confirmed that
lens epithelial cells express ectodermal markers such as Nestin and GFAP using
immunofluorescent staining (Figure 10b) (Hatfield et al., 1984; Song et al., 2009).

44

Figure 10. Eye lens cells in ectodermal lineage.
a Schematic of the ectodermal lineage during early development. Blue arrow
indicates eye lens cell lineage differentiated from the ectoderm origin.
b Representative immunofluorescent stains of lens cells (black square in the
schematic of the eye lens structure) in paraffin-embedded sections of ocular tissue
for Nestin (green) and GFAP (red) (scale bar: 200 µm) at P30. DAPI (blue): nuclei.
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To determine whether this model has deletion of Qk in lens cell lineages
specifically and efficiently, we crossed Qk-iCKO mice with the Rosa26-loxP-mTRedSTOP-loxP-mGFP reporter line (Muzumdar et al., 2007; Shingu et al., 2017), which
enabled us to trace Qki-depleted cells according to the expression of green fluorescent
protein (GFP). First, we found that Qki isoforms, Qki-5 and Qki-6 are specifically
expressed in the lens cells and predominantly localized to the nucleus (Figure 11a, b).
In the Qk-iCKO mice injected with tamoxifen (tam) at postnatal day 7 (P7), Qki-5
expression was nearly 100% depleted in all GFP+ lens cells at P19 (Figure 11a, b). Of
note, another isoform, Qki-6 was highly localized to the nucleus similar to Qki-5, but the
expression of Qki-6 was only 30% decreased in GFP+ lens cells of Qk-iCKO mice at
P19 (Figure 12a, b), potentially due to the relatively higher stability of Qki-6 compared to
Qki-5, suggesting that Qki-5 is the major Qki isoform required for the phenotypic
alteration in eye lens from the Qk-iCKO mice.
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Figure 11. Abolishment of Qki-5 expression in eye lens cells from Qk-iCKO
mice.
a Representative immunofluorescent stains of lens cells in paraffin-embedded
sections of ocular tissue from control (Ctrl) and Qk-iCKO mice for GFP (green) and
Qki-5 (red) (scale bar: 50 µm) at P19. DAPI (blue): nuclei. Schematic at the far right
depicting the morphological impairment of eye lens structure upon Qki loss in QkiCKO mice compared to the control mice. b Quantification of GFP+Qki5+ cells among
all GFP+ cells in the eye lens tissue represented in a. n = 3 mice/group.

Figure 12. Moderate decrease of Qki-6 expression in eye lens cells in Qk-iCKO
mice.
a Representative immunofluorescent stains of lens cells in paraffin-embedded
sections of ocular tissue from control and Qk-iCKO mice for GFP (green) and Qki-6
(red) (scale bar: 50 µm) at P19. DAPI (blue): nuclei. b Quantification of GFP+Qki6+
cells among all GFP+ cells in the eye lens tissue represented in a. n = 3 mice/group.
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Additionally, we demonstrated that GFP is localized to the membrane shown by
co-staining with the lens-specific membrane protein called aquaporin 0 (AQP0) in
control mice consistent with the previous mTmG reporter study (Muzumdar et al., 2007)
(Figure 13a). Upon Qki loss, plasma membrane structure of lens fiber cells was largely
affected with mislocalization of membrane proteins such as GFP and AQP0 to the
cytoplasmic compartment (Figure 13a). Importantly, the lens fiber cells failed to
elongate and migrate toward the center of the body and show aberrant directionality
(Figure 11a and Figure 13b). Tightly packed lens fiber cells surrounded by a wellaligned lens membrane structure are critical for chaperone activity of a-crystallin for
proper folding of soluble crystallins, ultimately for the lens transparency (TANG et al.,
1998). Indeed, all Qk-iCKO mice receiving P7 tam injections exhibited cloudy eye
lenses starting at P19, which progressed to massive aggregates in the lenses at P30
while the control mice (including Nestin-CreERT2; Qk+/+, Nestin-CreERT2; QkL/+, and
QkL/L) displayed transparent and healthy lenses (Figure 14a).
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Figure 13. Disintegration of the lens cells membrane structure in Qk-iCKO
mice.
a Representative immunofluorescent stains of lens cells in paraffin-embedded
sections of ocular tissue from control and Qk-iCKO mice for GFP (green) and AQP0
(red) (scale bar: 50 µm) at P19. DAPI (blue): nuclei. b Representative nuclear fast
red stains of paraffin-embedded ocular tissue section from control and Qk-iCKO mice
(scale bar: 200 µm) at P30.
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Figure 14. Cataract formation in the eye lens of Qk-iCKO mice.
a Representative images of eyes and eye lenses isolated from control and Qk-iCKO
mice at early (P19) and late (P30) time points. Scale bar: 0.5 mm. b RIPA-soluble
fractions of protein lysates from the isolated lenses of Control and Qk-iCKO mice at
early (P19) and late (P30) time points visualized using silver staining.
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Because cataracts are known to be initiated from soluble, but covalent multimers
of crystallins in human eye lens (Srivastava et al., 2004; Su et al., 2011), we first asked
if the lens proteins display soluble multimeric conformation upon Qk deletion. We
showed that loss of Qk in lens cells led to significant increase in higher molecular
weights in RIPA buffer-soluble fractions of total proteins compared to controls in a timedependent manner, suggesting that the initial protein aggregates upon Qk deletion are
soluble in RIPA buffer (Figure 14b). Furthermore, we used intracellular protein
aggregation markers such as ubiquitin and p62 to show that the soluble protein
aggregates in Qki-depleted lenses are intracellular, which is consistent with the previous
studies suggesting that crystallin aggregates are progressed from the intracellular
aggregates during cataract formation (Hu et al., 2020; Zhao et al., 2015). Indeed, we
observed that Qk-deficient lens cells displayed massive accumulation of ubiquitin
(green) while the neighboring Qki+ cells (red) rarely showed the accumulation at P17
(Figure 15). Similarly, p62 also accumulated significantly in Qk-deficient lens cells,
which were marked by GFP expression at P19 (Figure 16). Consistently,
immunoblotting also showed that Qk-deficient lens cells were progressively enriched in
proteostatic stress markers such as heat shock protein 90 (hsp90) and p62 (Figure 17)
(Kuusisto et al., 2001).
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Figure 15. Ubiquitin accumulation in the lens cells of Qk-iCKO mice.

Qk-iCKO

Ctrl

Representative immunofluorescent stains of lens cells in paraffin-embedded sections
of eyes obtained from control and Qk-iCKO mice for ubiquitin (green) and Qki-5 (red)
at early time points P17. DAPI (blue): nuclei. Scale bar: 100 µm.
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Figure 16. Accumulation of p62 in the lens cells of Qk-iCKO mice.
Representative immunofluorescent stains of lens cells in paraffin-embedded sections
of eyes obtained from control and Qk-iCKO mice for GFP (green) and p62 (red) at
early time points P19. DAPI (blue): nuclei. Scale bar: 100 µm.
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Figure 17. Upregulation of proteostatic markers in the lens cells of Qk-iCKO
mice.
Immunoblots of lenses isolated from control and Qk-iCKO mice at P19 and P30 for
detection of the proteostatic stress markers, Hsp90 and p62. b actin and Ponceau S:
loading control.
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Ultimately, we found that Qki depletion-induced protein aggregates in the lenses
at the later time point (after 1 month) were RIPA buffer-insoluble and only dissolved in
urea (Figure 18) as suggested in human cataract lens (Su et al., 2011). To further test if
the protein aggregates in Qk-deficient lenses recapitulate crystallin aggregates in
human cataract lens (Moreau and King, 2012), we dissolved the aggregates isolated
from the Qki-depleted lens tissue of the later time point using a strong denaturant (8 M
urea) (Figure 18). Mass spectrometric analysis demonstrated that the vast majority of
the urea-denatured protein aggregates in Qk-deficient lenses belonged to the family of
crystallins, including various isoforms of a-, b-, and g-crystallins (Figure 18), which are
the major components of human and mouse cataracts, suggesting that these
aggregates are bona fide cataracts in Qk-deficient lenses. We also confirmed that
mRNA and protein levels of crystallin isoforms were not significantly changed upon Qki
depletion (Figure 19), suggesting that it is not the alteration of crystallin expression per
se that caused abnormal protein aggregation. We further characterized the protein
aggregates induced by Qk deletion as forms of amyloid fibrils using Congo Red staining
(Figure 20a); this is the most common form of crystallin aggregation, resulting in
cataracts (Meehan et al., 2004). In addition, transmission electron microscopy
confirmed that the protein aggregates in Qk-deficient lenses displayed amyloid-like
fibrils (Figure 20b) (Makley et al., 2015). Taken together, these data suggested that Qki
is required for maintaining proper protein folding in lens cells, which is essential for the
transparency of the lens.
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Figure 18. Enrichment of abnormal crystallin aggregation in Qki-depleted lens.
Aggregates extracted from Qk-iCKO lenses (red circle) dissolved in 8 M urea and
visualized using Coomassie blue staining. The strong Coomassie blue-stained band
(red square) was excised and subjected to mass spectrometric (MS) analysis. The
most enriched proteins according to MS analysis were ranked as shown in the table.
loading control.
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Figure 19. Expression level of crystallin isoforms in lens tissue is not altered
upon Qki loss.
a Raw read counts in RNA-seq data for crystallin isoforms in lenses isolated from
control and Qk-iCKO mice at P17-19. ns = not significant (p ≥ 0.05; t-test). The
results are presented as means with SD. b Peptide numbers (#) for crystallin
isoforms in lenses isolated from control and Qk-iCKO mice at P19 according to mass
spectrometry.
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Figure 20. Characterization of Qk-iCKO mice as a cataract model with the
observation of amyloid-like fibrils.
a-b Representative images of (a) Congo Red-stained (scale bar: 200 µm) and (b)
transmission electron microscopy-analyzed (scale bar: 250 nm) control and Qk-iCKO
lenses at P30.
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3.2 Qki is a novel regulator of the cholesterol biosynthesis pathway in eye lens.
To identify the mechanisms by which Qki regulates protein homeostasis in lens
cells, we performed transcriptomic profiling of lens cells isolated from control and QkiCKO mice. We selected the time point (P17-19) when cataract phenotype is apparent
in Qk-deficient lens cells and secondary effects of Qki loss on the transcriptome can be
minimized. Cholesterol biosynthesis was the most enriched downregulated pathway
upon Qk deletion as determined using Ingenuity Pathway Analysis (IPA) (Figure 21a).
Notably, transcriptomic profiling data demonstrated that 14 of total 19 enzymes involved
in the steps in cholesterol biosynthesis decreased at the mRNA level upon Qki loss
(Figure 21b, c).

a
0

-log(p-value)
2 4 6 8 10

Superpathway of Cholesterol Biosynthesis
RAN Signaling
Sertoli Cell-Sertoli Cell Junction Signaling
Cholesterol Biosynthesis I
Cholesterol Biosynthesis II
Cholesterol Biosynthesis III
Zymosterol Biosynthesis
Gap Junction Signaling
Germ Cell-Sertoli Cell Junction Signaling
EIF2 Signaling
VEGF Signaling
Regulation of eIF4 and p70S6K Signaling
Geranylgeranyldiphosphate Biosynthesis I
Amyloid Processing
Epithelial Adherens Junction Signaling
Mevalonate Pathway I
Threshold

b

Ctrl Qk-iCKO
1 2 3 11 2 3

Fdps
Fdps
Hsd17b7
Hsd17b7
Lss
Lss
Nsdhl
Nsdhl
Tm7sf2
Tm7sf2
Hmgcs1
Hmgcs1
Cyp51
Cyp51
Fdft1
Fdft1
Mvd
Mvd
Msmo1
Msmo1
Hmgcr
Hmgcr
Pmvk
Pmvk
Sc5d
Sc5d
Idi1
Idi1
Mvk
Mvk
Sqle
Sqle
Dhcr24
Dhcr24
Dhcr7
Dhcr7
Ebp
Ebp

c

Acetoacetyl-CoA
Hmgcs1
HMG-CoA
Hmgcr
Mevalonate
Mvk
Mevalonate-5-P
Pmvk
Mevalonate-5-PP
Mvd
Isopentenyl-5-PP
Idi1
Geranyl-PP
Fdps
Farnesyl-PP
Fdft1
Squalene
Sqle
2,3-Oxidosqualene
Lss
Lanosterol

1.5
0

-1.5
Z score

Bloch

Msmo1
Nsdhl

Cyp51
Tm7sf2
Hsd17b7
Ebp
Sc5d
Dhcr7
Desmosterol
Dhcr24

Kandutsch-Russell

Dhcr24
Cyp51 Tm7sf2
Nsdhl Msmo1
Hsd17b7
Ebp
Sc5d
7-dehydrocholesterol

Cholesterol

Dhcr7

Figure 21. Downregulated cholesterol biosynthesis in Qki-depleted lens
a IPA of the genes with a significant reduction of mRNA expression in isolated QkiCKO mouse lenses compared to the control mouse lenses at P17-19 according to
RNA-seq (p < 0.05). The top enriched downregulated canonical cellular pathways are
ranked according to p-value. Cellular pathways involved in cholesterol biosynthesis
are labeled in red. b Heat map showing the relative expression value (Z score) of all
19 genes involved in cholesterol biosynthesis in control (n = 3) and Qk-iCKO (n = 3)
lenses according to RNA-seq data ranked by fold change. c Cholesterol biosynthesis
pathway with the genes encoding the enzymes involved in each step of the pathway.
Red labeled indicate the cholesterol biosynthesis genes downregulated shown in b.
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We confirmed that Qki loss significantly decreased the expression of 14 genes
involved in cholesterol biosynthesis as demonstrated by reverse transcriptionquantitative polymerase chain reaction (RT-qPCR) (Figure 22a). Consistently, protein
expression levels of cholesterol biosynthesis enzymes such as hydroxymethylglutarylCoA synthase (Hmgcs1), Hmgcr, Lss, and farnesyl diphosphate synthase (Fdps) were
also greatly reduced (Figure 22b).

Figure 22. Reduced expression of enzymes involved in cholesterol
biosynthesis in the eye lens from Qk-iCKO mice compared to the control mice.
a Results of RT-qPCR analysis of cholesterol biosynthesis genes in isolated control
and Qk-iCKO lenses at P17-19. **p < 0.01; ***p < 0.001; ****p < 0.0001 (t-test). The
results are presented as means with standard deviation (SD). b-c Immunoblots and
quantification of enzymes involved in cholesterol biosynthesis (Hmgcs1, Hmgcr, and
Fdps) and Qki-5 in isolated control and Qk-iCKO lenses at P19. b actin: loading
control.
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In accord with the in vivo findings in our mouse model, downregulation of the
cholesterol biosynthesis pathway was also evident in human lens epithelial cell line
(HLE-B3) cells in which QKI was deleted using the CRISPR-Cas9 system (Figure 23ac). RNA sequencing (RNA-seq) also demonstrated reduced expressions of cholesterol
biosynthesis genes in QKI-deleted HLE-B3 cells.

Figure 23. Reduced expression of enzymes involved in cholesterol
biosynthesis in HLE-B3 lens cells with Qki depletion compared to the wild type
(WT).
a qPCR analysis of cholesterol biosynthesis genes in WT and QKI KO HLE-B3 cells
(n = 3). ***p < 0.001; ****p < 0.0001 (t-test). The results are presented as means with
SD. b-c Immunoblots and quantification of WT and QKI KO HLE-B3 cells for
detection of HMGCS1, FDPS, and QKI-5. GAPDH: loading control.
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Because HLE-B3 is an immortalized cell line, we utilized the NSC-derived lens
progenitor-like cells (NLPCs) from Qk-iCKO mice to better recapitulate our in vivo
finding for the further molecular studies. Pax6high NSCs differentiated into Pax6intermediate
aB-crystallinhigh NLPCs when we induced with stepwise growth factor-based treatment
(first step: Noggin; second step: BMP4, BMP7, and bFGF) for induction of lens cell
lineage (Figure 24a) (Yang et al., 2010). Qki expression was completely abolished in
NSCs and NLPCs by treatment with 4-hydroxytamoxifen (Figure 24b, c).
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Figure 24. Generation of in vitro eye lens model for studying the function of Qki
at the molecular level.
a Schematic of the differentiation of NSCs to NLPCs (left). Bright-field images and
immunostains for Pax6 (green) and aB-crystallin (red) in NSCs and NLPCs (right).
DAPI (blue): nuclei. Scale bar: 50 µm. b Immunofluorescent staining of WT and Qkidepleted (Qk-/-) NSCs for Qki-5. DAPI (blue): nuclei. Scale bar: 50 µm. c
Immunoblots of Qki-5 for validation of effective Qk deletion in NLPCs. GAPDH:
loading control.
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Consistent with the observation in mouse eye lens tissue and HLE-B3 cells,
cholesterol biosynthesis was also one of the most downregulated pathways in NLPCs
upon Qk deletion (Figure 25a). The majority of the cholesterol biosynthesis genes (16 of
19) were downregulated at the mRNA level in Qki-depleted NLPCs compared to wildtype (WT), which was in line with the RNA-seq data in HLE-B3 cells (Figure 25b).
Consistently, RT-qPCR validated the reduced mRNA expression of cholesterol
biosynthesis genes enriched in RNA-seq in NLPCs (Figure 25c).
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Figure 25. Downregulated cholesterol biosynthesis pathway in in vitro eye lens
model.
a The top enriched downregulated canonical cellular pathways in Qk-/- NLPCs
compared to WT NLPCs according to RNA-seq (IPA; p < 0.05) are ranked according
to p-value. Cellular pathways involved in cholesterol biosynthesis are labeled in red.
b Heat map of the relative average expression value (Z score) of all 19 genes
involved in cholesterol biosynthesis according to RNA-seq data in WT (n = 3) and Qk/(n = 3) of NLPCs and WT (n=3) and QKI KO (n=3) HLE-B3 cells. c Results of RTqPCR analysis of cholesterol biosynthesis genes in WT and Qk-/- NLPCs. *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001 (t-test). The results are presented as means
with SD.
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We next asked whether downregulation of cholesterol biosynthesis genes
induced by Qk deficiency results in a decreased cholesterol level. We found that the
cellular cholesterol level as visualized using filipin staining was reduced upon Qk
deletion from lens cells at P19 (Figure 26a, b). Consistently, the total free cholesterol
level was markedly lower in lenses isolated from Qk-iCKO mice than in those from the
control mice at P19 (Figure 26c). To note, we did not observe the systemic alteration of
cholesterol level in brain and plasma at P19 (Figure 27a, b), suggesting the lensspecific role of Qki in regulating cholesterol level.
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Figure 26. Reduction of cellular cholesterol level in Qki-depleted lenses
compared to the control lenses.
a Filipin (blue) staining of lens cells from frozen sections of the eyes of Ctrl and QkiCKO mice at P19. TO-PRO3 (magenta): nuclei. Scale bar: 10 µm. b Quantification
of filipin intensity (A.U.) in the regions between the white dotted lines in a in control
and Qki-depleted lenses. ****p < 0.0001 (t-test). The results are presented as means
with SD (number of cells counted = 10). c Quantification of total free cholesterol
levels (µg/mg tissue) in lenses isolated from control and Qk-iCKO mice at P19. **p <
0.01 (t-test). The results are presented as means with SD (n = 5).
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Figure 27. No alteration of systemic cholesterol level in Qk-iCKO mice
compared to the control mice.
a-b Quantification of total cholesterol levels in (a) whole brain and (b) blood (plasma)
from the control and Qk-iCKO mice at P19. ns = not significant (p ≥ 0.05; t-test). The
results are presented as means with SD. (a) Ctrl: n = 5, Qk-iCKO: n = 4 (b) Ctrl: n =
12, Qk-iCKO: n = 9.
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Recent studies have reported the potential role of sterol molecules in alleviating
cataract formation (Makley et al., 2015; Zhao et al., 2015). To determine whether
replenishment of sterols leads to alleviation of cataract formation induced by Qk
deletion, we applied lanosterol drops to the eyes of Qk-iCKO mice for 1 week (from P14
to P21), during which the cataract phenotype developed rapidly (Figure 28a) (Hu et al.,
2020; Shen et al., 2018; Zhao et al., 2015). We found that lanosterol significantly
reduced the opacity and improved the transparency of Qk-deficient lenses (Figure 28b,
c), suggesting that regulation of sterol levels by Qki is required for maintaining the
transparency of the lens. Taken together, these data suggested that Qki is a novel
regulator of cholesterol biosynthesis in eye lens cells and that cataracts induced by Qki
depletion were caused by insufficient cholesterol biosynthesis.
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Figure 28. Sterol supply alleviates the cataract phenotype in the lenses of QkiCKO mice.
a Timeline and schematic of lanosterol-based treatment in mice. b Representative
images of lenses isolated from Ctrl and Qk-iCKO mice given either mock (control) or
lanosterol-based treatment for 1 week. Scale bar: 0.5 mm. c Quantification of the
area of protein aggregates from isolated Ctrl and Qk-iCKO lenses after mock and
lanosterol-based treatment. Aggregation index = C / average of the area of
aggregates in Ctrl lenses with the mock treatment. C = area of aggregates. **p <
0.01; ns = not significant (p ≥ 0.05; t-test). The results are presented as means with
standard error of the mean (SEM) (n = 6).
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3.3 QKI-5 cooperates with SREBP2 to regulate transcription of cholesterol
biosynthesis genes.
To decipher the mechanism by which Qki regulates cholesterol biosynthesis at
the molecular level, we focused on studying the molecular function of Qki-5 among the
Qki isoforms in cholesterol biosynthesis as Qki-5 is the major isoform that showed
nearly 100% depletion in expression at P19, the time point cholesterol biosynthesis
pathway is downregulated and cataract phenotype is observed in the eye lens from the
Qk-iCKO mice. We found that the nuclear localized splicing isoform of QKI, QKI-5 was
most abundant in chromatin fractions compared to the nuclear soluble fraction in HLEB3 cells (Figure 29a), and our lab recently showed that Qki-5 functions as a
transcriptional co-activator of peroxisome proliferator-activated receptor beta (PPARb)retinoid X receptor alpha (RXRa) complex (Zhou et al., 2020), suggesting that QKI-5
might also regulate the expression of genes involved in cholesterol biosynthesis.
Besides, Srebp2, the major transcription factor of cholesterol biosynthesis genes was
one of the top upstream transcription regulators of differentially expressed genes in the
lenses from control and Qk-iCKO mice, including all of the cholesterol biosynthesis
genes regulated by Qki, according to IPA (Figure 29b).
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Figure 29. QKI-5 is abundantly associated with chromatin in the lens cells, and
Srebp2 is one of the major upstream regulators responsible for the altered
cellular pathways found in Qki-depleted lens compared to the control lens.
a Immunoblots of QKI-5 in subcellular fractions of WT and QKI KO HLE-B3 cells.
GAPDH: cytosol; SP1: nuclei; Histone H3: chromatin. b The top enriched upstream
transcription regulators of the genes expressed at lower levels in Qk-iCKO mice than
in Ctrl mice in RNA-seq data (p < 0.05) ranked according to p-value.
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In addition, it has been shown that mutations of SREBP2 target genes in human
and Srebf2 (the gene encoding Srebp2) mutations in mouse led to cataract formation
(Kelley and Hennekam, 2000; Merath et al., 2011; Mori et al., 2006; Zhao et al., 2015),
recapitulating the phenotype of Qk-iCKO mice. Therefore, we next sought to determine
whether QKI-5 regulates expression of the genes involved in cholesterol biosynthesis by
modulating SREBP2-mediated cholesterol biosynthesis. We first reasoned that QKI-5
and the mature form of SREBP2, which is localized to the nucleus to activate
transcription, might form a complex on chromatin. Under cholesterol withdrawal, when
SREBP2 activity is transcriptionally robust to drive de novo cholesterol biosynthesis, we
found that QKI-5 interacted with mature SREBP2 as demonstrated in HLE-B3 cells via
co-immunoprecipitation (co-IP) (Figure 30a, b). Consistently, Qki-5 and Srebp2 also
formed a complex in NLPCs (Figure 30c, d).

Figure 30. QKI-5 interacts with SREBP2 in the same molecular complex.
a-b Co-IP of HLE-B3 cells overexpressing QKI-5–HA and Flag-SREBP2 with (a)
anti–QKI-5 antibody blotting with anti-Flag and –QKI-5 antibodies and (b) antiSREBP2 antibody blotting with anti-HA and -SREBP2 antibodies. c-d Co-IP of
NLPCs overexpressing Flag-Srebp2 with (c) anti–Qki-5 antibody blotting with antiFlag and –Qki-5 antibodies and (d) anti-Srebp2 antibody blotting with anti–Qki-5 and
-Srebp2 antibodies.
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We further asked whether the complex of Qki-5 and Srebp2 regulates
transcription in lens cells. To answer this question, we performed chromatin IP followed
by high-throughput DNA sequencing (ChIP-seq) with NLPCs to determine whether Qki5 and Srebp2 co-localize to promoter regions genome-wide. We found that 40.36% of
Qki-5 peaks, 64.53% of Srebp2 peaks, and 46.12% of RNA polymerase II (Pol II) peaks
in NLPCs were in the promoter regions, whereas promoter regions accounted for only
4.41% of the reference genome (Figure 31a), demonstrating that Qki-5 preferentially
interacts with gene promoters as do Srebp2 and Pol II. We also showed that in HLE-B3
cells, QKI-5 (23.20%) and SREBP2 (22.60%) binding events were highly enriched in the
promoter regions, whereas total promoter regions only account for 1.80% of the entire
genome (data not shown). Furthermore, we found that the QKI-5, SREBP2, and POL II
peaks were greatly enriched and correlated with at transcription start sites (TSSs) in
both NLPCs and HLE-B3 cells (Figure 31b, c). These data suggest the cooperation
between QKI-5 and SREBP2 in regulation of transcription.
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Figure 31. Co-localization of Qki-5, Srebp2, and Pol II at promoters genomewide.
a Genomic annotation of genome or Qki-5–, Srebp2-, and Pol II-binding sites from
ChIP-seq in NLPCs. Promoters are confined to the regions of ±2 kb from the TSS. b
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Reinforcing the notion that Qki-5 is involved in the regulation of transcription of
Srebp2 targets, we found that 9,032 promoters were co-occupied by Qki-5, Srebp2, and
Pol II, which accounted for 91.84% of the total promoters occupied by Srebp2 (n =
9,834) in NLPCs (Figure 32a). Similarly, SREBP2 highly co-occupied the promoter
regions with QKI-5 in HLE-B3 cells, as 76.77% of the SREBP2 binding promoters (152
of 198) were co-bound by QKI-5 and POL II (data not shown). Additionally, the known
DNA binding motif of SREBP2 was enriched in the QKI-5 binding peaks in both NLPCs
and HLE-B3 cells (Figure 32b), indicating a high likelihood of transcriptional regulation
of QKI-5 in the SREBP2 target genes. Taken together, these data suggested that QKI-5
regulates SREBP2-mediated transcription in eye lens cells.
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Figure 32. Qki-5 cooperates with Srebp2 to regulate transcription of cholesterol
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To further identify Srebp2-bound genes whose transcription is specifically
regulated by Qki-5, we performed cellular pathway enrichment analysis of the
overlapping promoter-bound peaks (n = 9,032) in Qki-5, Srebp2, and Pol II ChIP-seq
data in NLPCs (Figure 32a). We found that cholesterol biosynthesis was the most
enriched pathway determined by IPA (Figure 32c) and that 12 of the 19 cholesterol
biosynthesis enzymes were enriched as Qki-5/Srebp2/Pol II targets (Figure 32d).
Additionally, we showed that Qki-5, Srebp2, and Pol II were co-localized to the promoter
regions of all 19 cholesterol biosynthesis genes, visualized as individual tracks in ChIPseq data (Figure 33). These data suggested that the Qki-5/Srebp2/Pol II complex
predominantly occupies cholesterol biosynthesis genes.

Figure 33. Co-occupancy of Qki-5, Srebp2, and Pol II at the promoter regions of
cholesterol biosynthesis genes.
UCSC Genome Browser snapshot of the promoter regions of cholesterol
biosynthesis genes encoding the cholesterol biosynthesis enzymes labeled in blue in
Fig. 32d, which are co-bound by Qki-5, Srebp2, and Pol II.
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To further validate direct target genes of Qki-5, we clustered the genes (n = 301)
whose promoters are occupied by Qki-5 and expressions are significantly
downregulated in both Qk-iCKO lenses and Qk-deficient NLPCs according to RNA-seq
data (Figure 34a). We found that the cholesterol biosynthesis pathway was the most
enriched pathway determined by IPA (Figure 34b), suggesting that transcription of
cholesterol biosynthesis genes is directly regulated by Qki-5 in lens cells. Of note is that
10,329 genes bound by Qki-5 were not downregulated, suggesting the existence of
additional transcriptional mechanisms of tissue-specific Qki-5–mediated gene
expressions (data not shown). Because QKI-5 also interacts with promoters of other
genes in addition to SREBP2 target genes, we asked whether QKI-5 has a stronger
feature of co-occupancy with SREBP2 than with other transcription factors in lens cells.
To that end, we stratified the Qki-5 ChIP-seq read densities (RPM) based on whether
they overlapped with Srebp2 ChIP-seq peak densities (RPM) in NLPCs (Figure 34c).
We found that the Qki-5 ChIP-seq RPM on the promoter regions of Qki-5+Srebp2+–
bound genes (n = 9,047) were considerably higher than those on the promoter regions
of Qki-5+Srebp2-–bound genes (n = 1,583) (Figure 34c), a phenomenon also observed
in HLE-B3 cells (data not shown). Taken together, these data suggest that QKI-5
preferentially binds to SREBP2-associated promoters over other promoters.
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3.4 QKI transcriptionally enhances cholesterol biosynthesis by facilitating
SREBP2/POL II recruitment.
Based on the fact that QKI-5 and SREBP2 formed a complex and co-occupied
the promoters of the genes involved in the cholesterol biosynthesis pathway, which was
reflected by the downregulation of genes during cholesterol biosynthesis upon QKI
depletion, we sought to test the hypothesis that QKI regulates transcription of
cholesterol biosynthesis by enhancing the recruitment of SREBP2 to the promoter
regions of cholesterol biosynthesis genes. Indeed, we found that the association of
mature SREBP2 with chromatin was reduced in QKI-deficient HLE-B3 cells (Figure
35a). Also, consistent with previous studies, we observed two different sizes of mature
SREBP2 (Kamisuki et al., 2009; Moon et al., 2019; Sakai et al., 1996; Seo et al., 2011;
Suzuki et al., 2010), and the lower molecular weight of these two sizes of mature
SREBP2 was highly associated with chromatin. We found that upon QKI depletion, the
chromatin-associated SREBP2 form was significantly decreased at the protein level in
HLE-B3 cells, suggesting that QKI helps recruit SREBP2 to promoters or stabilize it on
promoters. Supporting this notion, SREBP2 ChIP-seq data demonstrated that
occupancy by SREBP2 in the promoter regions of SREBP2-bound genes decreased in
NLPCs and HLE-B3 cells upon QKI depletion (Figure 35b, c). Consistently, POL II
occupancy in the promoter regions of SREBP2-bound genes also decreased due to QKI
depletion in both NLPCs and HLE-B3 cells (Figure 35d, e), implying that recruitment of
the transcription complex SREBP2/POL II was reduced by QKI depletion genome-wide.
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Figure 35. Reduced occupancies of SREBP2 and Pol II at promoters.
a Immunoblots for detection of SREBP2 (mature) in subcellular fractions of HLE-B3
cells. GAPDH: cytosol; SP1: nuclei; Histone H3: chromatin. b-c Signal plots showing
RPM for SREBP2 in (b) NLPCs and (c) HLE-B3 cells ±2.5 kb from the TSS of
SREBP2-bound peaks in WT and QKI KO cells. d-e Signal plots showing the read
counts per million mapped reads for POL II in (d) NLPCs and (e) HLE-B3 cells ±2.5
kb from the TSS of POL II-bound peaks in WT and QKI KO cells.
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Consistent with our finding that cholesterol biosynthesis was one of the most
enriched cellular pathways directly regulated by Qki-5, the bindings of both Srebp2 and
Pol II to the cholesterol biosynthesis genes were significantly decreased upon Qki
depletion in NLPCs (Figure 36a-c). ChIP-qPCR also confirmed the reduced Srebp2 and
Pol II recruitment to the promoter regions of Hmgcs1, Hmgcr, and Mvk upon Qki
depletion in NLPCs (Figure 36d, e). We further revealed that the reductions of Srebp2
and Pol II binding on the promoters of the genes highly bound by Srebp2 were
significantly correlated with the downregulations of gene expressions upon Qki
depletion, and mevalonate diphosphate decarboxylase (Mvd), Hmgcs1, methylsterol
monooxygenase 1 (Msmo1), Sc5d, Fdps, Hmgcr, Mvk, and phosphomevalonate kinase
(Pmvk) involved in cholesterol biosynthesis all fell into this gene cluster as shown in
Figure 36f, suggesting that Qki-5 is essential for transcriptional enhancement of these
cholesterol biosynthesis genes.
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Figure 36. Qki-5 transcriptionally enhances cholesterol biosynthesis by
facilitating Srebp2/Pol II recruitment in NLPCs.
a-b RPM value of all the 19 cholesterol biosynthesis genes in (a) Srebp2 ChIP-seq
and (b) Pol II ChIP-seq in WT and Qk-/- NSPCs. c Representative UCSC Genome
Browser snapshot of the promoter regions of cholesterol biosynthesis genes from
ChIP-seq of NLPCs. d-e Srebp2 and Pol II ChIP-qPCR analysis of the promoter
regions of Hmgcs1, Hmgcr, and Mvk in WT and Qk-/- NLPCs. **p < 0.01; ***p < 0.001;
****p < 0.0001; ns = not significant (p ≥ 0.05; t-test). The results are presented as
means with SD. f Heat map of normalized fold change of RPM in WT NLPCs over
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fold change in RNA-seq of NLPCs. Arrows indicate cholesterol biosynthesis genes.
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Consistently, cholesterol biosynthesis genes, including FDPS, squalene
epoxidase (SQLE), LSS, MVD, MVK, cytochrome P450 family 51 (CYP51), HMGCS1,
HMGCR, MSMO1, and hydroxysteroid 17-beta dehydrogenase 7 (HSD17B7), were
among the 152 genes (Figure 37) whose SREBP2 and POL II peaks were reduced
most dramatically upon QKI loss in HLE-B3 cells (Figure 37 and Figure 38a-c). Lastly,
ChIP-qPCR confirmed the reductions of SREBP2 and POL II on the promoter regions of
HMGCR, MVD, FDPS, and CYP51 upon QKI depletion in HLE-B3 cells (Figure 38d, e).
Taken together, these data suggested that QKI-5 facilitates formation of SREBP2mediated transcriptional complexes in the cholesterol biosynthesis gene promoters and
enhances the transcription of these genes.
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Figure 37. Enrichment of cholesterol biosynthesis genes in the gene cluster
with the decrease in occupancy of SREBP2 and POL II upon QKI loss in HLEB3 cells.
Heat map of normalized RPM (RPM/average of RPMWT and RPMQKI KO) in WT and
QKI KO HLE-B3 cells in SREBP2 and POL II ChIP-seq data ranked by QKI-5 ChIPseq read densities (RPM). Arrows indicate cholesterol biosynthesis genes.

80

MSMO1

SQLE

CYP51

MVK
40

0
40

0
40

0
40

0
40

0
100

0
200

0
100

0
50

0
100

0
200

0
100

0
50

0
100

0
100

0
100

0
100

0
100

0
100

0
100

0

0

0

Input %

0.0

***

0.05
*

ns

PS
YP
on 51
-ta
rg
et
N

FD

C

H

M

G
C

R

0.00

PS
YP
on 51
-ta
rg
et

POL II

**

0.10

ns

FD

RPKM

**

0.2

C

*

SREBP2

0.4

R

*

****

****

N

10
20
30
40

RPKM

RPKM
2
4
6
8

*
*

*
*
*

*

VD

*

0.15

0.6

M

*

WT
QKI KO

****

0.8

IDI1

POL II

WT
QKI KO

Input %

MVK
PMVK
IDI1
FDFT1
LSS
TM7SF2
NSHDL
HSD17B7
EBP
SC5D
DHCR7
DHCR24

e

SREBP2

G
C

*

*

10
20
30

*

d

HMGCS1
HMGCR
MVK
PMVK
MVD
IDI1
FDPS
FDFT1
SQLE
LSS
Cyp51
TM7SF2
MSMO1
NSDHL
HSD17B7
EBP
SC5D
DHCR7
DHCR24

W
T
Q
KI
KO

W
T
Q
KI
KO

c

HMGCS1
HMGCR
MVK
PMVK
MVD
IDI1
FDPS
FDFT1
SQLE
LSS
Cyp51
TM7SF2
MSMO1
NSDHL
HSD17B7
EBP
SC5D
DHCR7
DHCR24

M

0

H

0
100

W
T
Q
KI
KO

WT

KO

WT

40

KO

Input

HMGCS1
40

WT

SREBP2

FDPS

40

KO

ChIP-seq

POL II

b

MVD

VD

HMGCR

5kb

M

a

Figure 38. Reduced occupancy of SREBP and Pol II on the promoter regions of
cholesterol biosynthesis genes upon QKI loss in HLE-B3 cells.
a UCSC Genome Browser snapshot of the promoter regions of cholesterol
biosynthesis genes from ChIP-seq of WT and QKI KO HLE-B3 cells. b-c Heat maps
comparing the RPM (±0.5 kb from the TSS) in the promoter regions of cholesterol
biosynthesis genes in WT and QKI KO HLE-B3 cells in SREBP2 and POL II ChIPseq data. Genes with asterisk (*) in SREBP2 ChIP-seq were shown as a separate
heat map. d-e ChIP-qPCR analysis of the promoter regions of HMGCR, MVD, FDPS,
and CYP51 in WT and QKI KO HLE-B3 cells. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001; ns = not significant (p ≥ 0.05; t-test). The results are presented as
means with SD.
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3.5 Qki interacts with single-stranded DNA.
The major functional domain of Qki is the STAR (signal transduction activator of
RNA metabolism) domain, which includes QUA1, K homology (KH), and QUA2
components, and it has been shown that the KH domain binds to both RNA and singlestranded DNA (ssDNA) (Pal and Levy, 2019; Teplova et al., 2013). For instance, both
heterogeneous nuclear ribonucleoprotein K (hnRNP K) and far upstream elementbinding protein 1 (FUBP1) are known to bind to ssDNA and RNA through the KH
domain (Braddock et al., 2002a; Braddock et al., 2002b). Accordingly, we hypothesized
that QKI can also bind to ssDNA to regulate SREBP2-dependent transcription. To
determine whether QKI binds to DNA, we purified recombinant full-length Qki-5 protein
from Escherichia coli and tested whether they interact with DNA and RNA in vitro
(Figure 39).

Figure 39. Purification of recombinant Qki-5 protein.
Schematic of full-length Qki-5 and Coomassie blue-stained gels of purified Qki-5
proteins in the stepwise fractionation procedure using Ni-NTA and a HiLoad 26/600
Superdex 200 column.
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Using microscale thermophoresis (MST) assay, we confirmed that purified fulllength of Qki-5 bind to the known RNA sequence that contain the QKI RNA recognition
element (QRE) YUAAY (Figure 40) (Galarneau and Richard, 2005; Teplova et al.,
2013). Previous studies showed that mutations of UAA can dramatically disrupt QKI-
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RNA interaction(Galarneau and Richard, 2005; Sharma et al., 2019).
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Figure 40. Validation of Qki-5 binding to QRE using MST assay.
Schematic of the MST assay of bacterially expressed recombinant Qki-5 and QRE.
The titration curve for the MST assay for fluorescently labeled Trx–His6–Qki-5 (fulllength) and QRE1 (CUUCUUAAUAUAACUGCCUUAAACUUUAAU) is shown at
right.
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1.0E-03

We reasoned that if QKI interacts with ssDNA, it may recognize a similar
sequence containing TAA. Because SREBP2 binding motif was enriched in QKI-5
binding peaks both in HLE-B3 and NLPCs (Figure 32b), we then designed ssDNA
oligos originated in the promoter regions of SREBP2 target genes and proximally
downstream of the sterol regulatory elements (SREs)(Sharpe and Brown, 2013; Vallett
et al., 1996). These ssDNA oligos were denoted as QKI DNA recognition elements
(QDEs), which contain both TAA and SREs (Figure 41a, b) (Galarneau and Richard,
2005; Teplova et al., 2013). We found that Qki-5 interacted with QDE sequences
derived from the cholesterol biosynthesis genes, such as squalene epoxidase (QDE1),
MVK (QDE2), HMGCR (QDE3), Hmgcs1 (QDE4), and FDPS (QDE5), in the MST assay
(Figure 41b, c). Mutation of a core binding motif (TAA -> GCG) in QDE1-5 led to
significant reduction of the binding affinity with Qki-5, suggesting a motif-favorable
feature in binding of Qki-5 to DNA. Taken together, these data suggested that other
than interacting with RNAs, Qki also enhances Srebp2-mediated transcription
potentially by interacting with ssDNAs at promoters.
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Figure 41. Qki-5 interacts with ssDNA.
a Schematic of designing the QDEs proximally downstream of SREs in the promoter
regions of cholesterol biosynthesis genes in the MST assay performed to examine
the interaction with Qki-5. b The ssDNA oligos (QDE and QDE-m [mutant]) tested in
the MST assay and the Kd value of each oligo in the assay. c Titration curves for the
MST assay showing the Kd values for fluorescently labeled Trx-His6-Qki-5 (fulllength) and QDE/QDE-m. e Schematic diagram depicting proposed mechanisms by
which Qki-5 cooperates with Srebp2 to enhance transcription of cholesterol
biosynthesis, which maintains proper sterol levels to ensure protein homeostasis in
eye lens cells and prevent cataracts.
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Chapter 4: Qki regulates myelinogenesis through Srebp2-dependent cholesterol
biosynthesis
4.1 Deletion of Qk in mouse NSCs leads to hypomyelination in the CNS.
We asked whether the hypomyelination induced by knockout of Qk is due to
impaired oligodendrocyte differentiation or defective myelinogenesis. Unlike the Olig2Cre and Pdgfra-CreERT2 alleles, the Nestin-CreERT2 allele, in which expression of
tamoxifen-inducible Cre is under the control of the Nestin promoter, enabled us to
investigate whether knockout of Qk affects differentiation of the entire oligodendrocyte
lineage, including the step from neural stem cells (NSCs) to oligodendrocyte progenitor
cells (OPCs). We crossed mice bearing the Qk-loxP allele with mice bearing the NestinCreERT2 allele and Qk was specifically deleted in NSCs by injecting tamoxifen into
C57BL/6J Nestin-CreERT2;QkL/L pups at postnatal day 7 (P7; in all subsequent
experiments using this cohort)—the time point when oligodendrocyte differentiation and
myelinogenesis start (Figure 9) (Armati and Mathey, 2010). About 12 days after
tamoxifen injection, Nestin-CreERT2;QkL/L mice (hereafter denoted as “Qk-Nestin-iCKO
mice”) began to exhibit visible tremors and ataxia accompanied by a significant
reduction in coordinate movement as measured using the rotarod test and a marked
growth retardation (Figure 42a-c). Neurological deficits in Qk-Nestin-iCKO mice
progressed quite rapidly, and the mice eventually displayed hunched posture, paralysis,
and hyperpnea, with a median survival duration of 13 days after tamoxifen injection
(Figure 42d). In contrast, Nestin-CreERT2;wild-type (WT), Nestin-CreERT2;QkL/+, and
QkL/L littermates, which were also injected with tamoxifen in the same manner, were
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phenotypically normal. Thus, these littermates were used as control mice in the
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Figure 42. Deletion of Qk in mouse NSCs leads to severe hind limb paralysis
and motor deficits.
a Representative images of severe hind limb paralysis in Qk-Nestin-iCKO mice two
weeks after tamoxifen injection. Ctrl, control. b Latency of mice falling off the rotarod
at a constant speed (5 rpm). n = 6 mice in the Qk-Nestin-iCKO group; n = 9 mice in
the control group. c Body weights of Qk-Nestin-iCKO mice (n = 29) and control mice
(n = 22) 12 days after tamoxifen injection. d Kaplan-Meier curves of and log-rank test
results for overall survival in Qk-Nestin-iCKO mice (n = 157) and control mice (n =
153).
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Two weeks after tamoxifen injection (in all subsequent experiments unless
specified otherwise), Qk-Nestin-iCKO mice had severe hypomyelination as evidenced
by a substantial reduction in the levels of expression of MBP, proteolipid protein (PLP),
and MAG (23.7%, 28.2%, and 16.6% of those in control mice, respectively) and a
marked increase in the frequency (4.1-fold greater than that in control mice) of Iba1+
microglial infiltration in the corpus callosum tissues (Figure 43). To further determine the
effect of Qki on myelin formation, we crossed mice bearing the mTmG allele (Muzumdar
et al., 2007) with Qk-Nestin-iCKO mice or control mice. The mTmG reporter, in which
expression of cell membrane-localized tdTomato (mT) is replaced by cell membranelocalized EGFP (mG) in Cre recombinase-expressing cells, enabled us to trace newly
formed myelin (after tamoxifen injection) according to the membrane-bound GFP
signals. The percentage of the GFP+ area in the corpus callosum tissues in Qk-NestiniCKO;mTmG mice markedly decreased relative to that in control Nestin-CreERT2;mTmG
mice (10.6% vs. 68.7%) (Figure 43).
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Figure 43. Deletion of Qk in mouse NSCs leads to reduction of myelin proteins
in the corpus callosum of the CNS.
Representative images of and quantification of immunofluorescent staining of MBP,
PLP, MAG, GFP, and Iba1 in the corpus callosum tissues in Qk-Nestin-iCKO mice (n
= 3) and control mice (n = 4) two weeks after tamoxifen injection. Scale bars, 50 µm.
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In line with these findings, ultrastructural analyses of myelin sheaths in the optic nerves
using transmission electron microscopy revealed that only 23.3% of the axons were
myelinated in Qk-Nestin-iCKO mice, whereas compact myelin formed in 79.0% of the
axons in control mice (Figure 44a). The myelin sheaths wrapping the sparse axons in
Qk-Nestin-iCKO mice were considerably thinner than those in control mice and failed to
form the compact myelin structure (g-ratio, 0.94 versus 0.78; P < 0.0001) (Figure 44a).
Despite severely compromised axonal ensheathment, the axonal diameter and density
of axon in Qk-Nestin-iCKO mice were comparable with those in control mice (data not
shown), and no evidence of axonal damage was detected in Qk-Nestin-iCKO mice via
immunofluorescent staining of amyloid precursor protein (Figure 44b). Taken together,
these data demonstrated that depletion of Qki in mouse NSCs results in severe
neurological deficits due to hypomyelination in the CNS.
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Figure 44. Deletion of Qk in mouse NSCs leads to hypomyelination in the CNS.
a Representative electron micrographs of the optic nerves in Qk-Nestin-iCKO mice
and control mice with quantification of the percentage of myelinated axons and gratios two weeks after tamoxifen injection (n = 3 mice/group). Scale bars, 500 nm. b
Representative images and quantification of immunofluorescent staining of amyloid
precursor protein (App) in the corpus callosum tissues in Qk-Nestin-iCKO mice (n =
3) and control mice (n = 4) two weeks after tamoxifen injection. Scale bars, 50 µm.
Data are shown as mean ± s.d. and were analyzed using Student's t test. ***P <
0.001; ****P < 0.0001; ns, not significant.
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4.2 Qki loss in NSCs does not impair formation of OPCs or Aspa+Gstpi+
myelinating oligodendrocytes.
Next, we sought to determine whether the hypomyelination observed in QkNestin-iCKO mice was caused by a defect in the generation of OPCs from NSCs,
impaired maturation from OPCs to oligodendrocytes, or a failure of myelinogenesis.
Excluding the first possibility, we found that the number of Pdgfra+ OPCs in the
developing cortex tissues in Qk-Nestin-iCKO mice was slightly higher than that in
control mice (data no shown), probably due to a compensatory increase in the
proliferation of OPCs in response to hypomyelination. Notably, 92.6% of Pdgfra+ OPCs
in Qk-Nestin-iCKO mice lacked expression of Qki, indicating that Qki does not affect the
generation or survival of OPCs. Excluding the second possibility above,
immunofluorescent staining of Aspa and Gstpi, two well-established markers of mature
oligodendrocytes, revealed that the numbers of Aspa+ and Gstpi+ mature
oligodendrocytes in the corpus callosum tissues in Qk-Nestin-iCKO mice were
comparable to those in control mice (data now shown). Also, co-immunofluorescent
staining of Aspa and Gstpi demonstrated that they represent the same mature
oligodendrocyte population (Figure 45a). Of note, the majority of these Aspa+ and Gstpi+
oligodendrocytes in Qk-Nestin-iCKO mice lacked expression of Qki (data not shown),
indicating that OPCs without expression of Qki are still capable of differentiating into
Aspa+Gstpi+ mature oligodendrocytes.
Analyses of the previous transcriptomic studies (Marques et al., 2016; Zhang et
al., 2014) revealed that the mRNA level of Aspa in myelinating oligodendrocytes was
much higher than that in newly formed oligodendrocytes and OPCs (Figure 45b, c). In

92

agreement with this, immunofluorescent staining of Aspa in the corpus callosum tissue
in mice at P21 revealed expression of Aspa in myelin sheaths in addition to the cell
bodies of oligodendrocytes (Figure 45d). Coupled with the observation that Aspa and
Gstpi positivities represented the same mature oligodendrocyte population (Figure 45a),
these data demonstrated that Aspa+Gstpi+ mature oligodendrocytes represent a subset
of myelin-forming oligodendrocytes. Taken together, these data suggested that NSCs
without expression of Qki are still capable of generating OPCs and subsequently
differentiating into Aspa+Gstpi+ myelinating oligodendrocytes.
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Figure 45. Qki Loss in NSCs does not impair formation of OPCs or Aspa+Gstpi+
myelinating oligodendrocytes.
a Representative images of immunofluorescent staining of Gstpi and Aspa in the
corpus callosum tissues in WT mice at three weeks of age (n = 4 mice/group). Scale
bars, 50 µm. The Venn diagram depicts the overlap of Aspa+ and Gstpi+
oligodendrocytes. b-c RNA-seq expression data for Aspa transcripts from the
databases of Gonçalo Castelo-Branco’s laboratory (b) and Ben A. Barres’s and
Jiaqian Wu’s laboratory (c). VLMC, vascular and leptomeningeal cells; COP,
differentiation-committed oligodendrocyte precursors; NFOL, newly formed
oligodendrocytes; MFOL, myelin-forming oligodendrocytes; MOL, mature
oligodendrocytes. d Representative images of immunofluorescent staining of Aspa in
the corpus callosum regions in WT mice at three weeks of age. Scale bars, 50 µm.
Data are shown as mean ± s.d. and were analyzed using one-way ANOVA with
Tukey’s multiple comparisons test. **P < 0.01; ****P < 0.0001; ns, not significant.
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4.3 Qki loss leads to defective myelin membrane assembly.
The unexpected finding that Qk-Nestin-iCKO mice did not have reduced numbers
of Aspa+Gstpi+ mature myelin-forming oligodendrocytes yet exhibited severe myelin
defects (Figure 43 and Figure 44) suggested that Qki loss impairs myelinating ability of
Aspa+Gstpi+ oligodendrocytes without affecting the differentiation and survival of these
cells. Consistent with previous studies demonstrating that Qki regulates the RNA
homeostasis of myelin proteins, including MBP (Darbelli et al., 2016; Larocque et al.,
2005; Larocque et al., 2002a; Li et al., 2000; Zhao et al., 2010), we found that
expression of MBP in the corpus callosum tissues was greatly reduced upon Qki
depletion (Figure 43 and Figure 46a). In addition, unlike the homogeneous MBP
staining in control mice, an uneven and patchy MBP staining pattern was detected in
Qk-Nestin-iCKO mice (Figure 46a), implicating that MBP was not properly assembled in
myelin sheaths other than a reduction in its expression. We also found that whereas
MBP and PLP co-localized very well in the corpus callosum tissues in control mice, the
MBP and PLP co-localization rate markedly decreased in Qk-Nestin-iCKO mice (45.7%
vs. 88.5%) (Figure 46b). Similarly, the MBP and MAG co-localization rate in Qk-NestiniCKO mice was substantially lower than that in control mice (26.9% vs. 75.1%) (Figure
46c). Previous studies demonstrated that the proper interaction of myelin proteins such
as PLP, MBP, and MAG with myelin lipids is required for formation of raft-like domains
on myelin membrane, which is essential for myelin membrane assembly (Aggarwal et
al., 2011; Ozgen et al., 2016; Saher et al., 2005; Simons et al., 2000). To determine
whether defective myelin assembly in Qk-Nestin-iCKO mice was the result of abnormal
myelin lipid component(s), we measured the myelin lipid level in the corpus callosum
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tissues via staining with FluoroMyelin, a lipophilic dye with high selectivity for myelin
lipids (Monsma and Brown, 2012). The percentage of the FluoroMyelin+ area was
88.7% in control mice but only 6.6% in Qk-Nestin-iCKO mice (Figure 46d). More
importantly, although the levels of both PLP and FluoroMyelin in Qk-Nestin-iCKO mice
were lower than those in control mice, the ratio of FluoroMyelin to PLP in Qk-NestiniCKO mice was only about one fourth of that in control mice (Figure 46e), suggesting
that the levels of myelin lipids were more profoundly reduced than were the levels of
myelin proteins upon Qki depletion (Figure 43 and Figure 46d). Taken together, these
data suggested that the myelin lipid components are disrupted by Qki loss in
oligodendrocytes, which may consequently lead to defective assembly of myelin
proteins with myelin lipids and inability to form compact myelin.
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Figure 46. Qki loss leads to defective myelin membrane assembly.
a Representative images of immunofluorescent staining of MBP in the corpus
callosum tissues in Qk-Nestin-iCKO mice and control mice two weeks after
tamoxifen injection. b-c Representative images of and quantification of the colocalization rates of immunofluorescent staining of (b) MBP-PLP and (c) MBP-MAG
in the corpus callosum tissues in Qk-Nestin-iCKO mice and control mice two weeks
after tamoxifen injection. d Representative images of and quantification of staining of
FluoroMyelin in the corpus callosum tissues in Qk-Nestin-iCKO mice and control
mice two weeks after tamoxifen injection. e Quantification of the relative ratio of
FluoroMyelin to PLP in the corpus callosum tissues in Qk-Nestin-iCKO mice (n = 3)
and control mice (n = 4) two weeks after tamoxifen injection. Scale bars, 50 µm. Data
are shown as mean ± s.d. and were analyzed using Student's t test. The r values in
the scatter plots (b and c) were calculated using Pearson’s correlation. ****P <
0.0001.
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4.4 Qk deletion in OPCs leads to defective myelinogenesis without impairing
differentiation of Aspa+ myelinating oligodendrocytes.
Nestin is expressed in NSCs, which can differentiate into neurons, astrocytes,
and oligodendrocytes, so deletion of Qk in Qk-Nestin-iCKO mice potentially also affects
neurons and astrocytes besides oligodendrocytes. Immunofluorescent staining of NeuN
(a marker of neurons) and GFAP (a marker of astrocytes) revealed comparable
numbers of neurons and astrocytes in the brains in Qk-Nestin-iCKO mice and control
mice (data not shown), indicating that Qki loss in NSCs has minimal effect on the
neuron and astrocyte populations in the brain, and hypomyelination induced by Qki loss
is not secondary to defects in neurons or astrocytes.
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Figure 47. Schema of the generation of Qk-Plp-iCKO mice.

To further confirm that dysmyelination in Qk-Nestin-iCKO mice was
oligodendroglial lineage cell-autonomous, mice bearing the Qk-loxP allele were bred
with mice bearing the Plp1-CreERT2 allele, in which expression of tamoxifen-inducible
Cre is under the control of the Plp1 promoter (Figure 47). Because the activity of the
Plp1 promoter in the CNS of early neonatal mice is restricted to a subset of OPCs
poised to differentiate into myelinating oligodendrocytes (Guo et al., 2009), tamoxifen
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administration in Plp1-CreERT2;QkL/L pups at P4 (hereafter denoted as “Qk-Plp-iCKO
mice”) enabled us to delete Qk in this subset of OPCs (Figure 47). All Qk-Plp-iCKO
mice began to experience tremors and ataxia about 11 days after tamoxifen injection,
and they gradually displayed reduced coordinate movement, marked growth retardation,
hunched posture, and paralysis before dying about 18 days after tamoxifen injection
(data not shown), whereas the control mice (including Plp1-CreERT2;Qk+/+, Plp1CreERT2;QkL/+, and QkL/L littermates) did not exhibit neurological symptoms after
tamoxifen injection at P4.
Similar to that observed in Qk-Nestin-iCKO mice, expression of MBP in the
corpus callosum tissues in Qk-Plp-iCKO mice two weeks after tamoxifen injection (in all
subsequent experiments unless specified otherwise) was significantly lower than the
robust expression in control mice (data not shown). In addition, the percentage of the
GFP+ area in the corpus callosum tissues in Qk-Plp-iCKO;mTmG mice markedly
decreased relative to that in control Plp-CreERT2;mTmG mice (5.0% vs. 20.5%) (data
not shown), confirming a hypomyelinating phenotype in Qk-Plp-iCKO mice. Taken
together, these data demonstrated that the hypomyelination induced by Qki depletion in
OPCs is attributable to defective myelinogenesis.
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4.5 Qki regulates transcription of the genes involved in myelin cholesterol
biosynthesis.
b
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Figure 48. Qki regulates transcription of the genes involved in myelin
cholesterol biosynthesis.
a Bar graph showing the five canonical pathways most affected by Qki on the basis
of differentially expressed genes in Qk-Plp-iCKO mice and control mice (n = 2
mice/group). Blue and red indicate pathways whose activity decreased or increased,
respectively, in Qk-Plp-iCKO mice. b Overlapping canonical pathway networks for
the top 20 canonical pathways with a minimum of three common molecules in
different pathways. GGPP, geranylgeranyl diphosphate. c Bar graph showing the 10
upstream regulators most enriched in Qk-Plp-iCKO mice. d Schema of the
cholesterol biosynthesis pathway. e Quantification of expression of representative
enzymes involved in cholesterol biosynthesis in the corpus callosum tissues in QkNestin-iCKO mice and control mice two weeks after tamoxifen injection according to
real-time qPCR (n = 4 mice/group).

To investigate the underlying mechanisms by which Qki regulates
myelinogenesis, transcriptomic profiling (RNA sequencing [RNA-seq]) of the brains in
Qk-Plp-iCKO mice and control littermates was performed. Overall, expression of 673
and 692 genes in Qk-Plp-iCKO mice was significantly lower and higher than those in
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control mice, respectively (fold change > 1.2; P < 0.05). Ingenuity Pathway Analysis
(IPA) revealed that the canonical pathways affected most by Qki depletion were
cholesterol biosynthesis, mevalonate pathway, zymosterol biosynthesis, and
geranylgeranyl diphosphate biosynthesis (Figure 48a, b), which are all associated with
de novo cholesterol biosynthesis pathway. Consistently, IPA-based upstream regulator
analysis revealed that Qki loss led to inactivation of Srebp2 and Srebp cleavageactivating protein (Scap) as well as activation of insulin-induced gene 1 protein (Insig1),
which inhibits Srebp2 function by interacting with Scap to retard the Scap/Srebp
complex in the endoplasmic reticulum (Figure 48c). Hence, transcription of multiple
Srebp2 target genes encoding the enzymes involved in cholesterol biosynthesis,
including hydroxymethylglutaryl-CoA synthase 1 (Hmgcs1), 3-hydroxy-3-methylglutarylCoA reductase (Hmgcr), farnesyl diphosphate synthase (Fdps), and lanosterol synthase
(Lss), was strongly diminished by Qki depletion (Figure 48d). In agreement with the
observation in Qk-Plp-iCKO mice, quantitative real-time PCR (qPCR) analysis
confirmed reduced transcription of these genes involved in cholesterol biosynthesis in
Qk-Nestin-iCKO mice (Figure 48e). Verifying reduced expression of enzymes involved
in cholesterol biosynthesis upon Qki loss, we found that the levels of Hmgcs1 and Fdps
proteins, which were measured using immunofluorescent staining in Aspa+Qkioligodendrocytes in the corpus callosum tissues in Qk-Nestin-iCKO mice, were only
11.2% and 12.7% of those in Aspa+Qki+ oligodendrocytes in control mice, respectively
(data not shown). The lower expression of Hmgcs1, Hmgcs2, Hmgcr, Fdps, and Lss in
Qk-Nestin-iCKO mice than in control mice at the protein level was further confirmed via
immunoblotting (data not shown).
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Figure 49. Reduction of cholesterol level in the corpus callosum of the CNS
from Qk-Nestin-iCKO mice compared to the control mice.
Quantification of the cholesterol levels in the corpus callosum tissues in Qk-NestiniCKO mice (n = 6) and control mice (n = 5) two weeks after tamoxifen injection.
Data are shown as mean ± s.d. and were analyzed using Student's t test. *P< 0.05;
**P < 0.01; ***P < 0.001; ****P < 0.0001.

As a consequence of reduced expression of enzymes involved in cholesterol
biosynthesis, Qk-Nestin-iCKO mice exhibited dramatically lower concentrations of both
free cholesterol and cholesteryl ester in the corpus callosum tissues than did control
mice (Figure 49). Taken together, these data suggested that Qki regulates transcription
of enzymes involved in cholesterol biosynthesis in oligodendrocytes and controls
synthesis of this rate-limiting building block of myelinogenesis during development.
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4.6 Qki-5 cooperates with Srebp2 to regulate cholesterol biosynthesis.
Srebp2 is the major transcription factor that regulates expression of the genes
involved in cholesterol biosynthesis and import (Horton et al., 2002b). Besides lower
global expression of the genes involved in cholesterol biosynthesis in Qki-depleted
oligodendrocytes than in control oligodendrocytes, we found that Srebp2 and its
regulatory partners (Scap and Insig1) were the upstream regulators of these
differentially expressed genes (Figure 48c). Immunofluorescent staining revealed that
expression of Srebp2 in Aspa+ oligodendrocytes was similar in Qk-Nestin-iCKO mice
and control mice (data not shown), indicating that transcriptional activity but not
expression of Srebp2 may be suppressed by Qki loss in oligodendrocytes. On the basis
of our previous observation that the nuclear-localized Qki isoform, Qki-5 was
predominantly localized to chromatin and functions as a co-activator of PPARb-RXRa
complex to transcriptionally regulate fatty acid metabolism in oligodendrocytes in adult
mouse brain, which is essential for the maintenance of mature myelin homeostasis
(Zhou et al., 2020), we hypothesized that Qki-5 regulates transcription of the genes
involved in cholesterol biosynthesis by interacting with Srebp2 during myelin
development of young mice when cholesterol biosynthesis is highly active. Accordingly,
reciprocal co-immunoprecipitation (co-IP) assays performed using oligodendrocytes that
differentiated from NSCs revealed a robust interaction between Qki-5 and Srebp2
(Figure 50a-c).
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Figure 50. Molecular interaction between Qki-5 and Srebp2 in the
oligodendrocytes.
a Results of co-IP using an anti–Qki-5 antibody with differentiated oligodendrocytes
followed by detection of Srebp2 via immunoblotting. b Results of co-IP using an antiSrebp2 antibody with differentiated oligodendrocytes followed by detection of Qki-5
via immunoblotting. c Results of co-IP using an anti-Flag antibody with differentiated
oligodendrocytes having ectopic expression of Flag-Srebp2 followed by detection of
Qki-5 via immunoblotting.
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To determine whether the molecular interaction between Qki-5 and Srebp2 in
oligodendrocytes impacts transcriptional control of the genes involved in cholesterol
biosynthesis, we performed chromatin IP (ChIP) combined with high-throughput DNA
sequencing (ChIP-seq) using differentiated oligodendrocytes with antibodies against
Qki-5 and Srebp2. We identified 17,709 peaks for Qki-5 ChIP-seq and 957 peaks for
Srebp2 ChIP-seq. Genomic distribution analyses revealed that 50.11% and 82.27% of
Qki-5– and Srebp2-binding events were enriched in the promoter regions, respectively
(Figure 51a). Notably, the promoter/transcriptional start site (TSS)-binding occupancies
of Qki-5 and Srebp2 strongly correlated with each other (Figure 51b, c).
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a Global distribution of the ChIP-seq events of Qki-5, Srebp2, and Pol II in
differentiated oligodendrocytes. UTR, untranslated region. b-c ChIP-seq density heat
maps (b) and average genome-wide occupancies (c) of Qki-5, Srebp2, and Pol II in
differentiated oligodendrocytes. Regions within 2.5 kb of the TSS are included. All
events are rank-ordered from high to low Qki-5 occupancy.
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Specifically, 88.73% of total Srebp2-binding events (811 of 914) in the promoter
regions overlapped with Qki-5–binding events (Figure 52a). Furthermore, ChIP-seq
analysis of RNA polymerase II (Pol II), an indicator of transcriptionally active sites,
revealed that 99.75% of the overlapping binding events between Qki-5 and Srebp2 (809
of 811) were co-occupied by Pol II (Figure 52a), suggesting that the Qki-5 and Srebp2
form a complex that regulates transcription.
Canonical pathway analysis of genes bound by Qki-5, Srebp2, and Pol II (n =
809) (Figure 52a) revealed that the cholesterol biosynthesis pathway was the most
enriched cellular pathway potentially regulated by transcriptional collaboration between
Qki-5 and Srebp2 (Figure 52b). The promoter regions of the genes involved in
cholesterol biosynthesis, such as Hmgcs1, Hmgcr, Fdps, cytochrome P450, family 51
(Cyp51), and methylsterol monoxygenase 1 (Msmo1), were co-occupied by Qki-5,
Srebp2, and Pol II (Figure 52c). Consistently, ChIP-qPCR confirmed that Qki-5, Srebp2,
and Pol II were highly enriched in the promoter regions of Hmgcs1 and Hmgcr (Figure
52d). Taken together, these data suggested that transcriptional cooperation between
Qki-5 and Srebp2 regulates cholesterol biosynthesis.
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Figure 52. Colocalization of Qki-5 with Srebp2 and Pol II on the promoter
regions of the genes involved in cholesterol biosynthesis.
a Venn diagram of the overlap of Qki-5–, Srebp2-, and Pol II-binding events in the
promoter regions in differentiated oligodendrocytes. Promoters are defined as TSS ±
2 kb. b Canonical pathway analysis of Qki-5–, Srebp2–, and Pol II–co-occupied
genes in differentiated oligodendrocytes. Cellular pathways involved in cholesterol
biosynthesis are labeled in dark pink. c Representative ChIP-seq binding events of
Qki-5, Srebp2, and Pol II in the promoter regions of the genes involved in cholesterol
biosynthesis. d ChIP-qPCR results showing the recruitment of Qki-5, Srebp2, and
Pol II to the promoter regions of Hmgcs1 and Hmgcr in differentiated
oligodendrocytes. Data are shown as mean ± s.d. and were analyzed using
Student’s t test. ****P < 0.0001; ns, not significant.
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Because Qki-5 binds to a large number of the promoter regions genome-wide,
we further sought to identify the specific cellular pathways in oligodendrocytes directly
regulated by Qki at transcriptional level during myelin formation. Canonical pathway
analysis of 194 overlapping genes among 5,885 Qki-5–bound genes in Qki-5 ChIP-seq
of freshly isolated mouse oligodendrocytes (Zhou et al., 2020) and 673 significantly
downregulated genes in Qk-Plp-iCKO mice revealed that cholesterol biosynthesis was
the most enriched pathway (Figure 53a, b). This was also consistent for the overlapping
genes among Qki-5–bound genes in differentiated oligodendrocytes and the
significantly downregulated genes in Qk-Plp-iCKO mice (Figure 54a, b). This analysis
suggested that the Qki-5/Srebp2 complex predominantly regulates expression of the
genes involved in cholesterol biosynthesis.
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Figure 53. Genes involved in cholesterol biosynthesis as a direct target of Qki5 in the isolated oligodendrocytes.
a Venn diagram of the overlap of Qki-5–bound genes in Qki-5 ChIP-seq from freshly
isolated mouse oligodendrocytes and the genes with markedly lower expression in
Qk-Plp-iCKO mice than in control mice. DE, differentially expressed. b Canonical
pathway analysis of the 194 overlapping genes shown in a. Cellular pathways
involved in cholesterol biosynthesis are labeled in magenta.
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To determine how Qki-5 transcriptionally enhances Srebp2-mediated cholesterol
biosynthesis, we performed ChIP-seq with WT and Qki-depleted differentiated
oligodendrocytes using antibodies against Qki-5, Srebp2, and Pol II. Because Srebp2bound genes were mostly involved in cholesterol biosynthesis (Figure 55), to further
examine the molecular alteration upon Qki depletion, we focused on the gene clusters
bound by Srebp2, which were strongly co-occupied by Qki-5, Srebp2, and Pol II in their
promoter regions (Figure 56a). Notably, occupancies of Srebp2 (725 of 914) and Pol II
(894 of 914) in the promoter regions were strikingly reduced upon Qki depletion (Figure
56b, c).
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Figure 55. Enrichment of cholesterol biosynthesis pathway in the Srebp2bound genes in differentiated oligodendrocytes.
Canonical pathway analysis of Srebp2-bound genes in differentiated
oligodendrocytes. Cellular pathways involved in cholesterol biosynthesis are labeled
in blue.
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Particularly, the promoter occupancy of Srebp2 on all 17 target genes enriched in
cholesterol biosynthesis according to IPA analysis (Figure 55) such as Msmo1,
Hmgcs1, Cyp51, isopentenyl-diphosphate delta isomerase 1 (Idi1), squalene epoxidase
(Sqle), and Hmgcr, was globally reduced upon Qki depletion (Figure 57a, b). ChIPqPCR further confirmed reduced recruitment of Srebp2 to the promoter regions of
Hmgcs1 and Hmgcr upon Qki depletion (Figure 57c). Taken together, these data
suggested that Qki-5 transcriptionally activates Srebp2-mediated cholesterol
biosynthesis in oligodendrocytes, which is essential for proper myelin formation during
brain development.
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Chapter 5: Discussion for Chapter 3 (Eye lens story)
5.1 Importance of understanding the molecular mechanism of cholesterol
biosynthesis regulation in eye lens cells.
Whereas the importance of de novo cholesterol production in eye lens cells is
evident in cataracts associated with human hereditary diseases and genetic mouse
models with mutations of cholesterol biosynthesis genes (Kelley and Hennekam, 2000;
Mori et al., 2006; Zhao et al., 2015), how cholesterol biosynthesis is regulated
mechanistically in lens cells remained unclear. A low level of intracellular cholesterol
triggers translocation of endoplasmic reticulum-embedded SREBP2 to the Golgi
apparatus, where SREBP2 is cleaved to a mature form, which is then transported to the
nucleus for transcriptional activation of cholesterol biosynthesis genes (Goldstein et al.,
2006). Multiple studies have shown that mature SREBP2 interacts with ubiquitous
transcription factors such as Sp1 and NF-Y as well as co-activators such as CREBbinding protein to synergistically activate transcription of cholesterol biosynthesis genes
(Sato, 2009). However, studies of the regulation of SREBP2 in a tissue-specific manner
are lacking. Our study demonstrated that genetic deletion of Qk leads to a
cataractagenic phenotype in the mouse eye lens due to downregulation of the
cholesterol biosynthesis pathway. Moreover, we elucidated the mechanisms by which
Srebp2-mediated cholesterol biosynthesis is transcriptionally enhanced by Qki to meet
the high demand for cholesterol for maintenance of lens transparency. Therefore, we
propose that Qki functions as a novel transcriptional regulator of Srebp2-mediated
cholesterol biosynthesis to prevent abnormal protein aggregation in the lens (Figure 58).
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5.2 The role of cholesterol in stabilizing the molecular chaperon, a-crystallin for
lens transparency.
Previous studies suggested that sterols are required for the proper function of
membrane-embedded a-crystallins, which serve as chaperones to facilitate the folding
of lens proteins, including b- and g-crystallins (Bloemendal et al., 2004; Haslbeck et al.,
2005; Makley et al., 2015). Another potential role of cholesterol in protein homeostasis
is to function as an important component of the cell membrane for proper protein
trafficking and degradation (Ikonen, 2018). Previously, we showed that Qki is an
important regulator of endolysosome formation in NSCs (Shingu et al., 2017), so it is
likely that regulation of cholesterol levels by Qki in the eye lens may also contribute to
proper trafficking and function of lens proteins for maintaining protein solubility in the
lens.

5.3 DNA binding of Qki in transcriptional regulatory network.
As a KH domain-containing protein, Qki has been shown to bind to RNA.
However, other KH domain-containing proteins, such as hnRNP K and FUBP1, interact
with both RNA and DNA (Braddock et al., 2002a). Here, we demonstrated that, like
other KH domain-containing proteins, Qki-5 can bind to ssDNA (QDE) similar to the
RNA-binding motif (QRE) of Qki, which is in close proximity to SREs on the promoters
of cholesterol biosynthesis genes (Galarneau and Richard, 2005; Teplova et al., 2013).
Notably, motif analysis on the top peaks of Qki-5 ChIP-seq data by HOMER identified a
few known transcription factor-binding motifs (e.g., SREBP2, CAAT box-binding
transcription factor/nuclear factor-1 (CTF/NF1), Activating transcription factor (ATF4),

118

nuclear factor erythroid 2 related factor-1 (NRF1), SRY-related HMG-box 10 (SOX10),
PPAR). Therefore, we postulate that the binding of Qki-5 to chromatin is co-determined
by its interactions with both DNA and other transcriptional factors/co-factors, although
we cannot exclude the possibility of Qki interacting with chromatin through RNA. In
addition, Qki-5 seemingly shares the feature of various DNA-binding proteins that
exhibit weakly conserved sequence specificity, such as the chromatin modifiers Chd1
and CHD8 (Ryan et al., 2011; Zhao et al., 2018). Notably, more than one quarter of the
Qki-5–bound peaks (28.87% in NLPCs and 32.30% in HLE-B3 cells) fell into intergenic
regions in Qki-5 ChIP-seq data (Figure 31a). Therefore, Qki-5 potentially activates
transcription by stabilizing the transcriptional complex and regulating dynamics of the
chromatin structure by interacting with both promoter and cis-regulatory element such
as enhancers (Klemm et al., 2019; MacQuarrie et al., 2011). It is noteworthy to further
investigate the spatial distribution of Qki-5 and other key factors in transcriptional
regulatory networks and how they coordinate to initiate transcription.

5.4 Gene expression of cholesterol biosynthesis regulated by Qki.
Recent studies suggested that HNRNP K, a well-established KH-domain
containing RNA/DNA binding protein, played an important role in maintaining epidermal
progenitor function through both transcriptional and post-transcriptional regulations
(Barboro et al., 2014; Li et al., 2019). Similarly, although we showed that Qki-5
regulates the expressions of cholesterol biosynthesis genes mainly through
transcriptional activation, we cannot exclude the possibility that Qki-5 also regulates
some of these genes post-transcriptionally as Qki is known to regulate mRNA
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metabolism including mRNA splicing, stability, export, and translation (Darbelli and
Richard, 2016b; Larocque et al., 2002b). In addition to Qki-5, the other two splicing
isoforms of Qki, Qki-6 and Qki-7 can potentially contribute to the downregulation of
cholesterol biosynthesis genes as our Qk deletion targeted depletion of all three
isoforms. Interestingly, Hmgcs1 and Sc5d are the putative mRNA targets regulated by
Qki (Galarneau and Richard, 2005). Therefore, Qki may regulate the cholesterol
biosynthesis pathway in eye lens cells through both transcriptional and
posttranscriptional regulations.

5.5 Protein homeostasis in eye lens cells regulated by Qki.
We showed that Qki-5 and Srebp2 bound to the non-canonical genes in addition
to the cholesterol biosynthesis genes with ChIP-seq data in lens cells, which suggests
that Qki-5 may cooperate with Srebp2 in regulating alternative cellular pathways that
control protein homeostasis in eye lens cells. Notably, the protein ubiquitination
pathway, which is known to regulate protein homeostasis (Muchowski and Wacker,
2005), was one of the pathways most enriched in both Qki-5/Srebp2–binding events
and downregulated genes in RNA-seq (Figure 32c and Figure 34b) in lens cells. Most
abundant gene cluster in ubiquitin-proteosome system decreased upon Qki loss
belongs to the major part of 26S proteasome subunits in the proteasomal degradation
process (Livneh et al., 2016), suggesting the entire proteasomal degradation process is
compromised with Qki depletion, leading to the accumulation of undegraded polyubiquitinated proteins (Figure 15). As impairment of proteasomal degradation is
associated with protein aggregation diseases including neurodegenerative diseases
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(NDs) as well as cataracts (Lu et al., 2014; Rao et al., 2015; Thibaudeau et al., 2018),
the potential role of Qki in proteasome regulation is of interest for future investigation.
Conversely, in oligodendrocytes (Chatper 4) the protein ubiquitination pathway was
enriched by Qki-5 ChIP-seq but not by Srebp2 ChIP-seq or RNA-seq, suggesting
tissue-specific regulation of Qki-5 in gene expression depending on the tissue functions.
Of note, lens cells display broad spectrum of Srebp2-bound genes (Figure 32a)
compared to oligodendrocytes, in which Srebp2 preferentially binds to cholesterol
biosynthesis genes (Chapter 4). This discrepancy can be explained by the previous
studies reporting that Srebp2 is localized to the promoters of noncanonical target genes
in a tissue-specific manner (Jeon et al., 2008; Seo et al., 2011; Shao and Espenshade,
2012).

5.6 Different background of Qk-iCKO mice between eye lens and myelin studies.
In the myelin study of Qki (Chapter 4), the median survival duration in Qk-iCKO
mice was 13 days after tam injection due to severe dysmyelination, and the Qk-iCKO
cohort in the eye lens study of Qki (Chapter 3) had a 75.86% median survival rate over
the postnatal 1 month of age, which allowed us to study the progression of the cataract
phenotype to the late time point (P30). We believe that the difference in the survival
times between these two cohorts of Qk-iCKO was due to the background of the mice. In
the myelin study (Chapter 4), the mice were on a pure C57BL/6J background, whereas
the mice in the eye lens study (Chapter 3) were on a mixed C57BL/6J and FVB
background. Oligodendrocyte progenitor cells (OPCs) have been shown to repopulate
as a third wave of cortically arising OPCs from NSCs initiating at birth and reaching the
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maximum number around 2-4 weeks after birth (van Tilborg et al., 2018a). However, the
exact time point of this wave of OPC generation can be greatly influenced by the mouse
background (van Tilborg et al., 2018a), resulting in highly variable Qk deletion in OPCs
with P7 injection of tam in Qk-iCKO cohorts of different backgrounds.

5.7 Implication of our study in human diseases.
As a universal regulator of cholesterol biosynthesis in many tissues, SREBP2 may
not be a feasible therapeutic target to modulate tissue-specific cholesterol levels.
Therefore, the newly established molecular mechanism of cholesterol biosynthesis
regulation by Qki that we describe herein provides specificity in targeting cholesterol
biosynthesis in a tissue-specific manner. Surgical removal of the opaque lens with
intraocular lens implantation is a common treatment for cataracts (Brian and Taylor, 2001).
Notably, cataract surgery has the potential risks of retinal detachment, iris prolapse, and
even blindness (Daien et al., 2015; Reddy et al., 2016). Therefore, our finding opens new
possibilities for noninvasive treatment of cataracts to provide alternative therapeutic
options. Furthermore, because a-crystallins belong to a family of heat shock proteins
known to function as chaperones for coping with aggregation-prone proteins involved in
neurodegenerative diseases such as tau and a-synuclein (Liu et al., 2018; Mok et al.,
2018; Webster et al., 2019), understanding the role of cholesterol in protein homeostasis
in the eye lens will potentially facilitate understanding of protein homeostasis in the brain.
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Chapter 6: Discussion for Chapter 4 (Myelin story)
6.1 Regulation of cholesterol biosynthesis in myelin development.
Timely onset of oligodendrocyte myelination is essential for brain development
(Armati and Mathey, 2010). Cholesterol is an important functional component of myelin
formation, and deficiency in cholesterol biosynthesis is associated with various
hypomyelinating diseases reported in human genetic studies (Nwokoro et al., 2001;
Porter and Herman, 2011a). Brain cholesterol production mainly depends on de novo
synthesis to fulfill the high demand for cholesterol due to the restriction of cholesterol
entry into the brain by the blood-brain barrier. However, how cholesterol biosynthesis is
regulated in oligodendrocytes, the primary myelinating cells in the CNS, is not clear.
The present study revealed that Qki functions as a novel transcriptional co-activator of
Srebp2 in oligodendrocytes to ensure supply of cholesterol for proper developmental
myelination in a timely manner.

6.2 Identification of a subpopulation of oligodendrocytes required for cholesterol
production during myelin development.
Previous studies showed that cholesterol biosynthesis is highly active during the
early stage of brain development (Dietschy and Turley, 2004a). However, the cell types
primarily responsible for cholesterol biosynthesis in myelin formation were not clear. In
the present study, we observed that Aspa and Gstpi were co-expressed with Srebp2,
Fdps, and Hmgcs1 in oligodendrocytes, suggesting that Aspa+Gstpi+ cells represent a
subset of myelinating oligodendrocytes with highly active cholesterol biosynthesis (data
not shown). Aspa has been shown to be more abundantly expressed in myelinating
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oligodendrocytes than in premyelinating oligodendrocytes (Marques et al., 2016; Zhang
et al., 2014). Additionally, Canavan disease caused by Aspa deficiency is accompanied
by myelin deficiency with reduced level of myelin lipids, including cholesterol, as Aspa
enzymatically produces acetate as a source of acetyl-CoA, a precursor for synthesis of
cholesterol (Madhavarao et al., 2005). These lines of evidence, in combination with our
observations, suggest that Aspa+Gstpi+ cells represent a subset of myelinating
oligodendrocytes. In addition to oligodendrocytes, previous studies reported that
cholesterol generated by astrocytes also contributes to myelination (Camargo et al.,
2017). However, the uptake of cholesterol from astrocytes was not sufficient to
compensate for the reduced cholesterol synthesis in oligodendrocytes with deletion of
Scap (Camargo et al., 2017), Fdft1 (Saher et al., 2005), or Qk (current study), indicating
that oligodendrocytes are the major cell types producing cholesterol for myelination
during early development.
Previous studies showed that qkv mice had reduced myelin lipid content,
including cholesterol (Baumann et al., 1968; Singh et al., 1971). This phenomenon was
previously thought to be the secondary effect to loss of mature oligodendrocytes in qkv
mice during development. However, in the present study, we uncovered a previously
uncharacterized function of Qki in controlling transcription of the genes involved in
cholesterol biosynthesis without affecting the differentiation of Aspa+Gstpi+ myelinating
oligodendrocytes. Further studies are needed to elucidate how Aspa+Gstpi+
oligodendrocytes specifically regulate cholesterol biosynthesis and how other cell types,
including astrocytes, contribute to oligodendroglial myelination.
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6.3 Different functions of Qki isoforms during oligodendrocyte differentiation and
myelinogenesis.
During the characterization of oligodendroglial lineage cell populations, we
observed that the differentiation of Aspa+Gstpi+ myelinating oligodendrocytes was not
impaired upon Qki depletion, but their cholesterol biosynthesis was severely defective.
Previous studies showed that all three isoforms of Qki are essential for the
differentiation and maturation of oligodendrocytes (Chen et al., 2007b; Darbelli et al.,
2016; Larocque et al., 2005). Specifically, the number of Olig2+ oligodendroglial lineage
cells in QKIFL/FL;Olig2–Cre mice was about 50% lower than that in control mice (Darbelli et
al., 2016). Therefore, we also checked whether oligodendroglial lineage cell populations
other than Aspa+Gstpi+ myelinating oligodendrocytes were affected by Qki loss in our
Qk-Nestin-iCKO mice. Of note, the number of Olig2+ (marker of oligodendroglial
lineage) cells in the corpus callosum tissues in Qk-Nestin-iCKO mice was 50.9% lower
than that in control mice (data not shown), suggesting that Qki loss partially blocks
OPCs differentiation into Olig2+Aspa-Gstpi- oligodendroglial lineage cells, whose
function is unclear. Collectively, we found that Qki plays variable roles in the
differentiation of different subpopulations of oligodendrocyte lineage cells, leading to an
intriguing question what determines the specific roles of Qki during oligodendrocyte
differentiation and myelinogenesis, which needs to be further investigated.
Mammalian Quaking (Qk) undergoes alternative splicing to express the RNAbinding proteins Qki-5, Qki-6, and Qki-7 (Darbelli and Richard, 2016a). In the current
study, we showed that Qki-5 is required for transcriptional activation of Srebp2mediated cholesterol biosynthesis in oligodendrocytes. Notably, we observed that
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expression of myelin proteins such as MBP, PLP, and MAG was greatly reduced upon
Qki depletion (Figure 43). Although we did not find these proteins to be direct
transcriptional targets of Qki-5 and Srebp2, the stability and nuclear export of MBP
mRNA may be regulated by Qki-6 and Qki-7 as shown in qkv mice, where expression of
Qki-6 and Qki-7 is predominantly depleted (Larocque et al., 2002a; Li et al., 2000).
Another nonmutually exclusive explanation of decreased expression of MBP is that the
reduction in cholesterol level induced by Qki depletion potentially leads to
destabilization of myelin because protein:lipid ratio is crucial for proper integration of
proteins and lipids in myelin membrane (Aggarwal et al., 2011; Ozgen et al., 2016;
Saher et al., 2005; Simons et al., 2000), which is shown by the defect in colocalization
of different myelin proteins (Figure 46b). Although we showed that Qki-5
transcriptionally regulates cholesterol biosynthesis, it is still unclear if Qki-6 and Qki-7
also play a role in the enhancement of cholesterol biosynthesis pathway by regulating
mRNA of cholesterol biosynthesis-related genes as we observed more significant
decrease of these genes at the protein level compared to the mRNA level (Figure 48e).
Therefore, further investigation is needed to determine the specific roles of different Qki
isoforms during oligodendrocyte differentiation and myelinogenesis in early brain
developmental stages.

6.4 Qki as a transcriptional co-activator of Srebp2 in cholesterol biosynthesis.
Previous studies showed that cholesterol biosynthesis in oligodendrocytes and
Schwann cells could be regulated by transcriptional regulators such as Tcf7l2, Chd8,
and Maf (Kim et al., 2018; Zhao et al., 2016; Zhao et al., 2018). However, how Srebp2,
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the master transcription factor in cholesterol biosynthesis, is regulated in
oligodendrocytes is unclear. In the present study, we demonstrated that Qki-5 functions
as a co-activator of Srebp2 to enhance transcription of the genes involved in cholesterol
biosynthesis in myelinating oligodendrocytes and that depletion of Qki leads to reduced
promoter occupancy of Srebp2 and Pol II and decreased transcription of the genes
involved in cholesterol biosynthesis (Figure 56 and Figure 57). Further studies are
needed to determine how Qki enhances transcriptional activity of Srebp2.

6.5 Oligodendroglial lineage cell populations targeted in our mouse model.
Notably, we observed that Qki was deleted in nearly all Pdgfra+ OPCs (92.6%) in
Qk-Nestin-iCKO mice (data not shown), which led to the question of how most of the
OPCs were targeted under the control of Nestin-Cre after birth. Cortically derived OPCs
are considered to make up about 80% of all OPCs in the cortex, which are called lateborn OPCs because they arise as a third wave of OPCs initiating at birth and reaching
maximum in number 2-4 weeks after birth in mice (van Tilborg et al., 2018b). This
population of OPCs is known to replace the OPCs originating at embryonic stages in the
forebrain (Bergles and Richardson, 2015), suggesting an active generation of OPCs
from NSCs during the first month after birth, potentially leading to highly efficient Qki
depletion in NSC-derived Pdgfra+ OPCs in our study. On the basis of these findings, it is
not difficult to understand that although Qki was efficiently depleted in OPCs of Qk-PlpiCKO mice at P4 and P5, an active generation of WT OPCs from WT NSCs diluted the
OPC pool, leading to Qki depletion in only a subset of OPCs in Qk-Plp-iCKO mice at
P18 (data not shown). Thus, although both Qk-Nestin-iCKO mice and Qk-Plp-iCKO
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mice showed demyelinating phenotype, Qk-Nestin-iCKO mice exhibited a more severe
phenotype than did Qk-Plp-iCKO mice.

6.6 Clinical implications of our study.
Effort has been made to treat hypomyelinating disorders such as SLOS,
Pelizaeus-Merzbacher disease, and Charcot-Marie-Tooth disease type 1A with dietary
supplementation of lipids, including cholesterol (Fledrich et al., 2018; Saher et al., 2012;
Tierney et al., 2010). However, challenges still remain, as cholesterol rarely crosses the
blood-brain barrier, and long-term benefits of cholesterol supplementation have not
been clearly examined (Tierney et al., 2010). Whether dietary supplementation of
cholesterol can rescue hypomyelination in Qk-iCKO mice would be interesting to know.
Of note, we previously demonstrated that Qki plays an important role in intracellular
vesicle trafficking in NSCs (Shingu et al., 2017). If the same function of Qki exists in
oligodendrocytes, cholesterol transport and uptake would be impaired due to defective
intracellular vesicle trafficking in Qki-depleted oligodendrocytes, which may lead to
inefficiencies in high-cholesterol diet-based therapy. The present findings will potentially
provide understanding of brain-specific cholesterol biosynthesis and shed light on
mechanism-based therapeutics for enhancing oligodendrocyte myelination. As QKI is
one of the genes most associated with various neurological diseases (Darbelli and
Richard, 2016a), understanding the mechanisms underpinning Qki/Srebp2-mediated
cholesterol biosynthesis and myelination will help identify tissue-specific therapeutic
opportunities for neurological diseases associated with myelin defects (Nwokoro et al.,
2001; Porter and Herman, 2011a).

128

References
Aggarwal, S., Yurlova, L., and Simons, M. (2011). Central nervous system myelin: structure,
synthesis and assembly. Trends Cell Biol 21, 585-593.
Anders, S., Pyl, P.T., and Huber, W. (2015). HTSeq—a Python framework to work with highthroughput sequencing data. Bioinformatics 31, 166-169.
Andley, U.P. (2007). Crystallins in the eye: function and pathology. Progress in retinal and eye
research 26, 78-98.
Armati, P.J., and Mathey, E.K. (2010). The biology of oligodendrocytes (Cambridge ; New York:
Cambridge University Press).
Backx, L., Fryns, J.P., Marcelis, C., Devriendt, K., Vermeesch, J., and Van Esch, H. (2010).
Haploinsufficiency of the gene Quaking (QKI) is associated with the 6q terminal deletion
syndrome. American Journal of Medical Genetics Part A 152, 319-326.
Barboro, P., Ferrari, N., and Balbi, C. (2014). Emerging roles of heterogeneous nuclear
ribonucleoprotein K (hnRNP K) in cancer progression. Cancer letters 352, 152-159.
Barnes, S., and Quinlan, R.A. (2016). Small molecules, both dietary and endogenous, influence
the onset of lens cataracts. Experimental eye research.
Baumann, N.A., Jacque, C.M., Pollet, S.A., and Harpin, M.L. (1968). Fatty acid and lipid
composition of the brain of a myelin deficient mutant, the "quaking" mouse. Eur J Biochem 4,
340-344.
Bercury, K.K., and Macklin, W.B. (2015). Dynamics and mechanisms of CNS myelination.
Developmental cell 32, 447-458.

129

Bergles, D.E., and Richardson, W.D. (2015). Oligodendrocyte Development and Plasticity. Cold
Spring Harb Perspect Biol 8, a020453.
Bloch, K. (1965). The biological synthesis of cholesterol.
Bloemendal, H. (1977). The vertebrate eye lens. Science 197, 127-138.
Bloemendal, H., de Jong, W., Jaenicke, R., Lubsen, N.H., Slingsby, C., and Tardieu, A. (2004).
Ageing and vision: structure, stability and function of lens crystallins. Progress in biophysics and
molecular biology 86, 407-485.
Borchman, D., and Yappert, M.C. (2010). Lipids and the ocular lens. Journal of lipid research 51,
2473-2488.
Braddock, D.T., Baber, J.L., Levens, D., and Clore, G.M. (2002a). Molecular basis of sequencespecific single-stranded DNA recognition by KH domains: solution structure of a complex
between hnRNP K KH3 and single-stranded DNA. The EMBO journal 21, 3476-3485.
Braddock, D.T., Louis, J.M., Baber, J.L., Levens, D., and Clore, G.M. (2002b). Structure and
dynamics of KH domains from FBP bound to single-stranded DNA. Nature 415, 1051.
Brian, G., and Taylor, H. (2001). Cataract blindness: challenges for the 21st century. Bulletin of
the World Health Organization 79, 249-256.
Brown, M.S., Radhakrishnan, A., and Goldstein, J.L. (2018). Retrospective on cholesterol
homeostasis: the central role of scap. Annual review of biochemistry 87, 783-807.
Camargo, N., Goudriaan, A., van Deijk, A.F., Otte, W.M., Brouwers, J.F., Lodder, H., Gutmann,
D.H., Nave, K.A., Dijkhuizen, R.M., Mansvelder, H.D., et al. (2017). Oligodendroglial myelination
requires astrocyte-derived lipids. PLoS Biol 15, e1002605.

130

Camargo, N., Smit, A.B., and Verheijen, M.H. (2009). SREBPs: SREBP function in glia–neuron
interactions. The FEBS journal 276, 628-636.
Cenedella, R.J. (1996). Cholesterol and cataracts. Survey of ophthalmology 40, 320-337.
Cenedella, R.J., Kuszak, J.R., Al-Ghoul, K.J., Qin, S., and Sexton, P.S. (2003). Discordant
expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb Thom
rats. Journal of lipid research 44, 198-211.
Chen, W., Chen, G., Head, D.L., Mangelsdorf, D.J., and Russell, D.W. (2007a). Enzymatic
reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell
metabolism 5, 73-79.
Chen, Y., Tian, D., Ku, L., Osterhout, D.J., and Feng, Y. (2007b). The selective RNA-binding
protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation.
J Biol Chem 282, 23553-23560.
Chénard, C.A., and Richard, S. (2008). New implications for the QUAKING RNA binding protein in
human disease. Journal of neuroscience research 86, 233-242.
Chrast, R., Saher, G., Nave, K.-A., and Verheijen, M.H. (2011a). Lipid metabolism in myelinating
glial cells: lessons from human inherited disorders and mouse models. Journal of lipid research
52, 419-434.
Chrast, R., Saher, G., Nave, K.A., and Verheijen, M.H. (2011b). Lipid metabolism in myelinating
glial cells: lessons from human inherited disorders and mouse models. J Lipid Res 52, 419-434.
Corsten, M.F., and Shah, K. (2008). Therapeutic stem-cells for cancer treatment: hopes and
hurdles in tactical warfare. The lancet oncology 9, 376-384.

131

Cotlier, E., and Rice, P. (1971). Cataracts in the Smith-Lemli-Opitz syndrome. American journal
of ophthalmology 72, 955-959.
Cvekl, A., and Ashery-Padan, R. (2014). The cellular and molecular mechanisms of vertebrate
lens development. Development 141, 4432-4447.
Daien, V., Le Pape, A., Heve, D., Carriere, I., and Villain, M. (2015). Incidence, risk factors, and
impact of age on retinal detachment after cataract surgery in France: a national population
study. Ophthalmology 122, 2179-2185.
Darbelli, L., and Richard, S. (2016a). Emerging functions of the Quaking RNA-binding proteins
and link to human diseases. Wiley Interdiscip Rev RNA 7, 399-412.
Darbelli, L., and Richard, S. (2016b). Emerging functions of the Quaking RNA-binding proteins
and link to human diseases. Wiley Interdisciplinary Reviews: RNA 7, 399-412.
Darbelli, L., Vogel, G., Almazan, G., and Richard, S. (2016). Quaking Regulates Neurofascin 155
Expression for Myelin and Axoglial Junction Maintenance. J Neurosci 36, 4106-4120.
DeBose-Boyd, R.A. (2008). Feedback regulation of cholesterol synthesis: sterol-accelerated
ubiquitination and degradation of HMG CoA reductase. Cell research 18, 609-621.
Dietschy, J.M., and Turley, S.D. (2004a). Thematic review series: brain Lipids. Cholesterol
metabolism in the central nervous system during early development and in the mature animal.
J Lipid Res 45, 1375-1397.
Dietschy, J.M., and Turley, S.D. (2004b). Thematic review series: brain Lipids. Cholesterol
metabolism in the central nervous system during early development and in the mature animal.
Journal of lipid research 45, 1375-1397.

132

Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M.,
and Gingeras, T.R. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21.
Doerflinger, N.H., Macklin, W.B., and Popko, B. (2003). Inducible site-specific recombination in
myelinating cells. Genesis 35, 63-72.
Dooley, K.A., Millinder, S., and Osborne, T.F. (1998). Sterol regulation of 3-hydroxy-3methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol
regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y.
Journal of Biological Chemistry 273, 1349-1356.
Doukhanine, E., Gavino, C., Haines, J.D., Almazan, G., and Richard, S. (2010). The QKI-6 RNA
binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte
differentiation. Mol Biol Cell 21, 3029-3040.
Ebersole, T.A., Chen, Q., Justice, M.J., and Artzt, K. (1996). The quaking gene product necessary
in embryogenesis and myelination combines features of RNA binding and signal transduction
proteins. Nat Genet 12, 260-265.
Engwerda, A., Frentz, B., den Ouden, A.L., Flapper, B.C., Swertz, M.A., Gerkes, E.H., Plantinga,
M., Dijkhuizen, T., and van Ravenswaaij-Arts, C.M. (2018). The phenotypic spectrum of proximal
6q deletions based on a large cohort derived from social media and literature reports. European
Journal of Human Genetics 26, 1478-1489.
Espenshade, P.J., and Hughes, A.L. (2007). Regulation of sterol synthesis in eukaryotes. Annu
Rev Genet 41, 401-427.
Feng, J., Liu, T., Qin, B., Zhang, Y., and Liu, X.S. (2012). Identifying ChIP-seq enrichment using
MACS. Nature protocols 7, 1728.

133

Fernø, J., Raeder, M., Vik-Mo, A., Skrede, S., Glambek, M., Tronstad, K., Breilid, H., Løvlie, R.,
Berge, R., and Stansberg, C. (2005). Antipsychotic drugs activate SREBP-regulated expression of
lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? The
pharmacogenomics journal 5, 298-304.
Fledrich, R., Abdelaal, T., Rasch, L., Bansal, V., Schutza, V., Brugger, B., Luchtenborg, C., Prukop,
T., Stenzel, J., Rahman, R.U., et al. (2018). Targeting myelin lipid metabolism as a potential
therapeutic strategy in a model of CMT1A neuropathy. Nat Commun 9, 3025.
Galarneau, A., and Richard, S. (2005). Target RNA motif and target mRNAs of the Quaking STAR
protein. Nature structural & molecular biology 12, 691-698.
Giandomenico, V., Simonsson, M., Grönroos, E., and Ericsson, J. (2003). Coactivator-dependent
acetylation stabilizes members of the SREBP family of transcription factors. Molecular and
cellular biology 23, 2587-2599.
Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, C. (2001). An
overview of real-time quantitative PCR: applications to quantify cytokine gene expression.
Methods 25, 386-401.
Goldstein, J.L., and Brown, M.S. (1990). Regulation of the mevalonate pathway. Nature 343,
425-430.
Goldstein, J.L., DeBose-Boyd, R.A., and Brown, M.S. (2006). Protein sensors for membrane
sterols. Cell 124, 35-46.
Gonzalez-Teuber, V., Albert-Gasco, H., Auyeung, V.C., Papa, F.R., Mallucci, G.R., and Hetz, C.
(2019). Small molecules to improve ER proteostasis in disease. Trends in pharmacological
sciences.

134

Graw, J. (2009). Genetics of crystallins: cataract and beyond. Experimental eye research 88,
173-189.
Group, T.U.T.R.C.D.S. (2018). 6q deletions from 6q26 and 6q27. Company Number 5460413
Charity Number 1110661.
Guan, G., Dai, P.-H., Osborne, T.F., Kim, J.B., and Shechter, I. (1997). Multiple sequence
elements are involved in the transcriptional regulation of the human squalene synthase gene.
Journal of Biological Chemistry 272, 10295-10302.
Guo, F., Ma, J., McCauley, E., Bannerman, P., and Pleasure, D. (2009). Early postnatal
proteolipid promoter-expressing progenitors produce multilineage cells in vivo. J Neurosci 29,
7256-7270.
Hardy, R.J., Loushin, C.L., Friedrich, V.L., Jr., Chen, Q., Ebersole, T.A., Lazzarini, R.A., and Artzt, K.
(1996). Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant
mice. J Neurosci 16, 7941-7949.
Hartman, H.A., Myers, L.A., Evans, M., Robison, R.L., Engstrom, R.G., and Tse, F.L. (1996). The
safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus
monkeys. Toxicological Sciences 29, 48-62.
Haslbeck, M., Franzmann, T., Weinfurtner, D., and Buchner, J. (2005). Some like it hot: the
structure and function of small heat-shock proteins. Nature structural & molecular biology 12,
842-846.
Hatfield, J.S., Skoff, R.P., Maisel, H., and Eng, L. (1984). Glial fibrillary acidic protein is localized
in the lens epithelium. The Journal of cell biology 98, 1895-1898.

135

He, M., Kratz, L.E., Michel, J.J., Vallejo, A.N., Ferris, L., Kelley, R.I., Hoover, J.J., Jukic, D., Gibson,
K.M., and Wolfe, L.A. (2011). Mutations in the human SC4MOL gene encoding a methyl sterol
oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay. The Journal of
clinical investigation 121, 976-984.
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H.,
and Glass, C.K. (2010). Simple combinations of lineage-determining transcription factors prime
cis-regulatory elements required for macrophage and B cell identities. Molecular cell 38, 576589.
Hogan, E.L. (1977). Animal models of genetic disorders of myelin. In Myelin (Springer), pp. 489520.
Horton, J.D., Goldstein, J.L., and Brown, M.S. (2002a). SREBPs: activators of the complete
program of cholesterol and fatty acid synthesis in the liver. The Journal of clinical investigation
109, 1125-1131.
Horton, J.D., Goldstein, J.L., and Brown, M.S. (2002b). SREBPs: activators of the complete
program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109, 1125-1131.
Horwitz, J. (2003). Alpha-crystallin. Experimental eye research 76, 145-153.
Hu, L.-D., Wang, J., Chen, X.-J., and Yan, Y.-B. (2020). Lanosterol modulates proteostasis via
dissolving cytosolic sequestosomes/aggresome-like induced structures. Biochimica et
Biophysica Acta (BBA)-Molecular Cell Research 1867, 118617.
Hübner, C., Hoffmann, G.F., Charpentier, C., Gibson, K.M., Finckh, B., Puhl, H., Lehr, H.-A., and
Kohlschütter, A. (1993). Decreased plasma ubiquinone-10 concentration in patients with
mevalonate kinase deficiency. Pediatric research 34, 129-133.

136

Ikonen, E. (2008). Cellular cholesterol trafficking and compartmentalization. Nature reviews
Molecular cell biology 9, 125-138.
Ikonen, E. (2018). Mechanisms of cellular cholesterol compartmentalization: recent insights.
Current opinion in cell biology 53, 77-83.
Imayoshi, I., Sakamoto, M., Ohtsuka, T., Takao, K., Miyakawa, T., Yamaguchi, M., Mori, K., Ikeda,
T., Itohara, S., and Kageyama, R. (2008). Roles of continuous neurogenesis in the structural and
functional integrity of the adult forebrain. Nature neuroscience 11, 1153.
Inoue, J., Sato, R., and Maeda, M. (1998). Multiple DNA elements for sterol regulatory elementbinding protein and NF-Y are responsible for sterol-regulated transcription of the genes for
human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase. Journal of
biochemistry 123, 1191-1198.
Jacob, R.F., Cenedella, R.J., and Mason, R.P. (2001). Evidence for distinct cholesterol domains in
fiber cell membranes from cataractous human lenses. Journal of Biological Chemistry 276,
13573-13578.
Jeon, T.-I., Zhu, B., Larson, J.L., and Osborne, T.F. (2008). SREBP-2 regulates gut peptide
secretion through intestinal bitter taste receptor signaling in mice. The Journal of clinical
investigation 118, 3693-3700.
Kamisuki, S., Mao, Q., Abu-Elheiga, L., Gu, Z., Kugimiya, A., Kwon, Y., Shinohara, T., Kawazoe, Y.,
Sato, S.-i., and Asakura, K. (2009). A small molecule that blocks fat synthesis by inhibiting the
activation of SREBP. Chemistry & biology 16, 882-892.
Kandutsch, A., and Russell, A. (1960). Preputial gland tumor sterols III. A metabolic pathway
from lanosterol to cholesterol. Journal of Biological Chemistry 235, 2256-2261.

137

Kelley, R.I., and Hennekam, R.C. (2000). The smith-lemli-opitz syndrome. Journal of medical
genetics 37, 321-335.
Khairallah, M., Kahloun, R., Bourne, R., Limburg, H., Flaxman, S.R., Jonas, J.B., Keeffe, J.,
Leasher, J., Naidoo, K., and Pesudovs, K. (2015). Number of people blind or visually impaired by
cataract worldwide and in world regions, 1990 to 2010. Investigative ophthalmology & visual
science 56, 6762-6769.
Kim, M., Wende, H., Walcher, J., Kühnemund, J., Cheret, C., Kempa, S., McShane, E., Selbach,
M., Lewin, G.R., and Birchmeier, C. (2018). Maf links Neuregulin1 signaling to cholesterol
synthesis in myelinating Schwann cells. Genes & development 32, 645-657.
Kim, Y.-C., Byun, S., Zhang, Y., Seok, S., Kemper, B., Ma, J., and Kemper, J.K. (2015). Liver ChIPseq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2.
Genome biology 16, 268.
Klemm, S.L., Shipony, Z., and Greenleaf, W.J. (2019). Chromatin accessibility and the regulatory
epigenome. Nature Reviews Genetics 20, 207-220.
Krakowiak, P.A., Wassif, C.A., Kratz, L., Cozma, D., Kovářová, M., Harris, G., Grinberg, A., Yang,
Y., Hunter, A.G., and Tsokos, M. (2003). Lathosterolosis: an inborn error of human and murine
cholesterol synthesis due to lathosterol 5-desaturase deficiency. Human molecular genetics 12,
1631-1641.
Kraus, A., and Michalak, M. (2011). Endoplasmic reticulum quality control and dysmyelination.
BioMolecular Concepts 2, 261-274.

138

Kuusisto, E., Salminen, A., and Alafuzoff, I. (2001). Ubiquitin-binding protein p62 is present in
neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12,
2085-2090.
Lan, F., Bayliss, P.E., Rinn, J.L., Whetstine, J.R., Wang, J.K., Chen, S., Iwase, S., Alpatov, R.,
Issaeva, I., and Canaani, E. (2007). A histone H3 lysine 27 demethylase regulates animal
posterior development. Nature 449, 689.
Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2009). Ultrafast and memory-efficient
alignment of short DNA sequences to the human genome. Genome biology 10, R25.
Larocque, D., Galarneau, A., Liu, H.N., Scott, M., Almazan, G., and Richard, S. (2005). Protection
of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation.
Nat Neurosci 8, 27-33.
Larocque, D., Pilotte, J., Chen, T., Cloutier, F., Massie, B., Pedraza, L., Couture, R., Lasko, P.,
Almazan, G., and Richard, S. (2002a). Nuclear retention of MBP mRNAs in the quaking viable
mice. Neuron 36, 815-829.
Larocque, D., Pilotte, J., Chen, T., Cloutier, F., Massie, B., Pedraza, L., Couture, R., Lasko, P.,
Almazan, G., and Richard, S. (2002b). Nuclear retention of MBP mRNAs in the quaking viable
mice. Neuron 36, 815-829.
Le Hellard, S., Mühleisen, T., Djurovic, S., Fernø, J., Ouriaghi, Z., Mattheisen, M., Vasilescu, C.,
Raeder, M., Hansen, T., and Strohmaier, J. (2010). Polymorphisms in SREBF1 and SREBF2, two
antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with
schizophrenia in German and Scandinavian samples. Molecular psychiatry 15, 463-472.

139

Leoni, V., and Caccia, C. (2014). Study of cholesterol metabolism in Huntington's disease.
Biochem Biophys Res Commun 446, 697-701.
Leuschen, J., Mortensen, E.M., Frei, C.R., Mansi, E.A., Panday, V., and Mansi, I. (2013).
Association of statin use with cataracts: a propensity score–matched analysis. JAMA
ophthalmology 131, 1427-1434.
Li, J., Chen, Y., Xu, X., Jones, J., Tiwari, M., Ling, J., Wang, Y., Harismendy, O., and Sen, G.L.
(2019). HNRNPK maintains epidermal progenitor function through transcription of proliferation
genes and degrading differentiation promoting mRNAs. Nature communications 10, 1-14.
Li, Z., Takakura, N., Oike, Y., Imanaka, T., Araki, K., Suda, T., Kaname, T., Kondo, T., Abe, K., and
Yamamura, K.i. (2003). Defective smooth muscle development in qkI-deficient mice.
Development, growth & differentiation 45, 449-462.
Li, Z., Zhang, Y., Li, D., and Feng, Y. (2000). Destabilization and mislocalization of myelin basic
protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 20,
4944-4953.
Lim, J., and Yue, Z. (2015). Neuronal aggregates: formation, clearance, and spreading.
Developmental cell 32, 491-501.
Liu, J.-P., Tang, Y., Zhou, S., Toh, B.H., McLean, C., and Li, H. (2010). Cholesterol involvement in
the pathogenesis of neurodegenerative diseases. Molecular and Cellular Neuroscience 43, 3342.
Liu, P., Edassery, S.L., Ali, L., Thomson, B.R., Savas, J.N., and Jin, J. (2019). Long-lived metabolic
enzymes in the crystalline lens identified by pulse-labeling of mice and mass spectrometry. Elife
8, e50170.

140

Liu, Z., Wang, C., Li, Y., Zhao, C., Li, T., Li, D., Zhang, S., and Liu, C. (2018). Mechanistic insights
into the switch of αB-crystallin chaperone activity and self-multimerization. Journal of Biological
Chemistry 293, 14880-14890.
Livneh, I., Cohen-Kaplan, V., Cohen-Rosenzweig, C., Avni, N., and Ciechanover, A. (2016). The
life cycle of the 26S proteasome: from birth, through regulation and function, and onto its
death. Cell research 26, 869-885.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome biology 15, 550.
Lu, Y., Dong, S., Hao, B., Li, C., Zhu, K., Guo, W., Wang, Q., Cheung, K.-H., Wong, C.W., and Wu,
W.-T. (2014). Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by
activating RAB5A. Autophagy 10, 1895-1905.
Luo, J., Yang, H., and Song, B.-L. (2019). Mechanisms and regulation of cholesterol homeostasis.
Nature Reviews Molecular Cell Biology, 1-21.
MacQuarrie, K.L., Fong, A.P., Morse, R.H., and Tapscott, S.J. (2011). Genome-wide transcription
factor binding: beyond direct target regulation. Trends in Genetics 27, 141-148.
Madhavarao, C.N., Arun, P., Moffett, J.R., Szucs, S., Surendran, S., Matalon, R., Garbern, J.,
Hristova, D., Johnson, A., Jiang, W., et al. (2005). Defective N-acetylaspartate catabolism
reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci
U S A 102, 5221-5226.
Makinodan, M., Rosen, K.M., Ito, S., and Corfas, G. (2012). A critical period for social
experience–dependent oligodendrocyte maturation and myelination. science 337, 1357-1360.

141

Makley, L.N., McMenimen, K.A., DeVree, B.T., Goldman, J.W., McGlasson, B.N., Rajagopal, P.,
Dunyak, B.M., McQuade, T.J., Thompson, A.D., and Sunahara, R. (2015). Pharmacological
chaperone for α-crystallin partially restores transparency in cataract models. Science 350, 674677.
Marques, S., Zeisel, A., Codeluppi, S., van Bruggen, D., Mendanha Falcao, A., Xiao, L., Li, H.,
Haring, M., Hochgerner, H., Romanov, R.A., et al. (2016). Oligodendrocyte heterogeneity in the
mouse juvenile and adult central nervous system. Science 352, 1326-1329.
Martín, M.G., Pfrieger, F., and Dotti, C.G. (2014). Cholesterol in brain disease: sometimes
determinant and frequently implicated. EMBO reports 15, 1036-1052.
Meehan, S., Berry, Y., Luisi, B., Dobson, C.M., Carver, J.A., and MacPhee, C.E. (2004). Amyloid
fibril formation by lens crystallin proteins and its implications for cataract formation. Journal of
Biological Chemistry 279, 3413-3419.
Meerbrey, K.L., Hu, G., Kessler, J.D., Roarty, K., Li, M.Z., Fang, J.E., Herschkowitz, J.I., Burrows,
A.E., Ciccia, A., and Sun, T. (2011). The pINDUCER lentiviral toolkit for inducible RNA
interference in vitro and in vivo. Proceedings of the National Academy of Sciences 108, 36653670.
Merath, K.M., Chang, B., Dubielzig, R., Jeannotte, R., and Sidjanin, D.J. (2011). A spontaneous
mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13)
mouse. Mammalian genome 22, 661-673.
Michael, R., and Bron, A. (2011). The ageing lens and cataract: a model of normal and
pathological ageing. Philosophical Transactions of the Royal Society of London B: Biological
Sciences 366, 1278-1292.

142

Miron, V.E., Zehntner, S.P., Kuhlmann, T., Ludwin, S.K., Owens, T., Kennedy, T.E., Bedell, B.J.,
and Antel, J.P. (2009). Statin therapy inhibits remyelination in the central nervous system. The
American journal of pathology 174, 1880-1890.
Misawa, K., Horiba, T., Arimura, N., Hirano, Y., Inoue, J., Emoto, N., Shimano, H., Shimizu, M.,
and Sato, R. (2003). Sterol regulatory element-binding protein-2 interacts with hepatocyte
nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. Journal of
Biological Chemistry 278, 36176-36182.
Mitsche, M.A., McDonald, J.G., Hobbs, H.H., and Cohen, J.C. (2015). Flux analysis of cholesterol
biosynthesis in vivo reveals multiple tissue and cell-type specific pathways. Elife 4, e07999.
Mohamed, A., Viveiros, A., Williams, K., and Posse de Chaves, E. (2018). Abeta inhibits SREBP-2
activation through Akt inhibition. J Lipid Res 59, 1-13.
Mok, S.-A., Condello, C., Freilich, R., Gillies, A., Arhar, T., Oroz, J., Kadavath, H., Julien, O.,
Assimon, V.A., and Rauch, J.N. (2018). Mapping interactions with the chaperone network
reveals factors that protect against tau aggregation. Nature structural & molecular biology 25,
384-393.
Monsma, P.C., and Brown, A. (2012). FluoroMyelin Red is a bright, photostable and non-toxic
fluorescent stain for live imaging of myelin. J Neurosci Methods 209, 344-350.
Moon, S.-H., Huang, C.-H., Houlihan, S.L., Regunath, K., Freed-Pastor, W.A., Morris IV, J.P.,
Tschaharganeh, D.F., Kastenhuber, E.R., Barsotti, A.M., and Culp-Hill, R. (2019). p53 represses
the mevalonate pathway to mediate tumor suppression. Cell 176, 564-580. e519.
Moreau, K.L., and King, J.A. (2012). Protein misfolding and aggregation in cataract disease and
prospects for prevention. Trends in molecular medicine 18, 273-282.

143

Mori, M., Li, G., Abe, I., Nakayama, J., Guo, Z., Sawashita, J., Ugawa, T., Nishizono, S., Serikawa,
T., and Higuchi, K. (2006). Lanosterol synthase mutations cause cholesterol deficiency–
associated cataracts in the Shumiya cataract rat. The Journal of clinical investigation 116, 395404.
Muchowski, P.J., and Wacker, J.L. (2005). Modulation of neurodegeneration by molecular
chaperones. Nature Reviews Neuroscience 6, 11-22.
Mukherjee, A., Morales-Scheihing, D., Butler, P.C., and Soto, C. (2015). Type 2 diabetes as a
protein misfolding disease. Trends in molecular medicine 21, 439-449.
Mullen, P.J., Yu, R., Longo, J., Archer, M.C., and Penn, L.Z. (2016). The interplay between cell
signalling and the mevalonate pathway in cancer. Nature Reviews Cancer 16, 718.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007). A global double-fluorescent
Cre reporter mouse. genesis 45, 593-605.
Myers, K.R., Liu, G., Feng, Y., and Zheng, J.Q. (2016). Oligodendroglial defects during
quakingviable cerebellar development. Dev Neurobiol 76, 972-982.
Nohturfft, A., and Zhang, S.C. (2009). Coordination of lipid metabolism in membrane biogenesis.
Annual review of cell and developmental biology 25.
Nwokoro, N.A., Wassif, C.A., and Porter, F.D. (2001). Genetic disorders of cholesterol
biosynthesis in mice and humans. Mol Genet Metab 74, 105-119.
Ogino, H., Ochi, H., Reza, H.M., and Yasuda, K. (2012). Transcription factors involved in lens
development from the preplacodal ectoderm. Developmental biology 363, 333-347.

144

Oliner, J.D., Andresen, J.M., Hansen, S.K., Zhou, S., and Tjian, R. (1996). SREBP transcriptional
activity is mediated through an interaction with the CREB-binding protein. Genes &
development 10, 2903-2911.
Ozgen, H., Baron, W., Hoekstra, D., and Kahya, N. (2016). Oligodendroglial membrane dynamics
in relation to myelin biogenesis. Cell Mol Life Sci 73, 3291-3310.
Pal, A., and Levy, Y. (2019). Structure, stability and specificity of the binding of ssDNA and ssRNA
with proteins. PLoS computational biology 15, e1006768.
Pertea, M., Kim, D., Pertea, G.M., Leek, J.T., and Salzberg, S.L. (2016). Transcript-level
expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nature
protocols 11, 1650.
Peterson, T.R., Sengupta, S.S., Harris, T.E., Carmack, A.E., Kang, S.A., Balderas, E., Guertin, D.A.,
Madden, K.L., Carpenter, A.E., and Finck, B.N. (2011). mTOR complex 1 regulates lipin 1
localization to control the SREBP pathway. Cell 146, 408-420.
Pfrieger, F.W., and Ungerer, N. (2011). Cholesterol metabolism in neurons and astrocytes.
Progress in lipid research 50, 357-371.
Porter, F.D., and Herman, G.E. (2011a). Malformation syndromes caused by disorders of
cholesterol synthesis. J Lipid Res 52, 6-34.
Porter, F.D., and Herman, G.E. (2011b). Malformation syndromes caused by disorders of
cholesterol synthesis. Journal of lipid research 52, 6-34.
Quan, G., Xie, C., Dietschy, J.M., and Turley, S.D. (2003). Ontogenesis and regulation of
cholesterol metabolism in the central nervous system of the mouse. Developmental Brain
Research 146, 87-98.

145

Radhakrishnan, A., Goldstein, J.L., McDonald, J.G., and Brown, M.S. (2008). Switch-like control
of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell
metabolism 8, 512-521.
Rao, G., Croft, B., Teng, C., and Awasthi, V. (2015). Ubiquitin-proteasome system in
neurodegenerative disorders. Journal of drug metabolism & toxicology 6.
Reddy, A.K., Liss, E., and Shildkrot, E.Y. (2016). Bilateral iris prolapse secondary to eye rubbing
following cataract surgery. JAMA ophthalmology 134, e153610-e153610.
Ryan, A., Bartlett, K., Clayton, P., Eaton, S., Mills, L., Donnai, D., Winter, R., and Burn, J. (1998).
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. Journal of Medical
Genetics 35, 558-565.
Ryan, D.P., Sundaramoorthy, R., Martin, D., Singh, V., and Owen-Hughes, T. (2011). The DNAbinding domain of the Chd1 chromatin-remodelling enzyme contains SANT and SLIDE domains.
The EMBO journal 30, 2596-2609.
Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M.C., Wieland, F.,
Ishibashi, S., and Nave, K.A. (2005). High cholesterol level is essential for myelin membrane
growth. Nat Neurosci 8, 468-475.
Saher, G., Rudolphi, F., Corthals, K., Ruhwedel, T., Schmidt, K.F., Lowel, S., Dibaj, P., Barrette, B.,
Mobius, W., and Nave, K.A. (2012). Therapy of Pelizaeus-Merzbacher disease in mice by feeding
a cholesterol-enriched diet. Nat Med 18, 1130-1135.
Saint-Gerons, D.M., Cortez, F.B., López, G.J., Castro, J.L., and Tabarés-Seisdedos, R. (2019).
Cataracts and statins. A disproportionality analysis using data from VigiBase. Regulatory
Toxicology and Pharmacology 109, 104509.

146

Sakai, J., Duncan, E.A., Rawson, R.B., Hua, X., Brown, M.S., and Goldstein, J.L. (1996). Sterolregulated release of SREBP-2 from cell membranes requires two sequential cleavages, one
within a transmembrane segment. Cell 85, 1037-1046.
Salles, J., Sargueil, F., Knoll-Gellida, A., Witters, L.A., Cassagne, C., and Garbay, B. (2003). AcetylCoA carboxylase and SREBP expression during peripheral nervous system myelination.
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1631, 229-238.
Sanjana, N.E., Shalem, O., and Zhang, F. (2014). Improved vectors and genome-wide libraries for
CRISPR screening. Nature methods 11, 783.
Santhoshkumar, P., Xie, L., Raju, M., Reneker, L., and Sharma, K.K. (2014). Lens crystallin
modifications and cataract in transgenic mice overexpressing acylpeptide hydrolase. Journal of
Biological Chemistry 289, 9039-9052.
Sato, R. (2009). SREBPs: protein interaction and SREBPs. The FEBS journal 276, 622-627.
Segatto, M., Tonini, C., Pfrieger, F.W., Trezza, V., and Pallottini, V. (2019). Loss of
Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and
Rett Syndrome. Int J Mol Sci 20.
Seo, Y.-K., Jeon, T.-I., Chong, H.K., Biesinger, J., Xie, X., and Osborne, T.F. (2011). Genome-wide
localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell metabolism 13,
367-375.
Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert,
B.L., Root, D.E., and Doench, J.G. (2014). Genome-scale CRISPR-Cas9 knockout screening in
human cells. Science 343, 84-87.

147

Shao, W., and Espenshade, P.J. (2012). Expanding roles for SREBP in metabolism. Cell
metabolism 16, 414-419.
Sharma, M., Sharma, S., and Alawada, A. (2019). Understanding the binding specificities of
mRNA targets by the mammalian Quaking protein. Nucleic acids research 47, 10564-10579.
Sharpe, L.J., and Brown, A.J. (2013). Controlling cholesterol synthesis beyond 3-hydroxy-3methylglutaryl-CoA reductase (HMGCR). Journal of Biological Chemistry 288, 18707-18715.
Shen, L., Shao, N., Liu, X., and Nestler, E. (2014). ngs. plot: Quick mining and visualization of
next-generation sequencing data by integrating genomic databases. BMC genomics 15, 284.
Shen, X., Zhu, M., Kang, L., Tu, Y., Li, L., Zhang, R., Qin, B., Yang, M., and Guan, H. (2018).
Lanosterol synthase pathway alleviates lens opacity in age-related cortical cataract. Journal of
ophthalmology 2018.
Shimano, H., and Sato, R. (2017). SREBP-regulated lipid metabolism: convergent physiology—
divergent pathophysiology. Nature Reviews Endocrinology 13, 710.
Shingu, T., Ho, A.L., Yuan, L., Zhou, X., Dai, C., Zheng, S., Wang, Q., Zhong, Y., Chang, Q., and
Horner, J.W. (2017). Qki deficiency maintains stemness of glioma stem cells in suboptimal
environment by downregulating endolysosomal degradation. Nature genetics 49, 75-86.
Sidman, R.L., Dickie, M.M., and Appel, S.H. (1964a). Mutant mice (quaking and jimpy) with
deficient myelination in the central nervous system. Science 144, 309-311.
Sidman, R.L., Dickie, M.M., and Appel, S.H. (1964b). Mutant Mice (Quaking and Jimpy) with
Deficient Myelination in the Central Nervous System. Science 144, 309-311.
Simons, K., and Toomre, D. (2000). Lipid rafts and signal transduction. Nature reviews
Molecular cell biology 1, 31.

148

Simons, M., Kramer, E.M., Thiele, C., Stoffel, W., and Trotter, J. (2000). Assembly of myelin by
association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane
domains. J Cell Biol 151, 143-154.
Singh, H., Spritz, N., and Geyer, B. (1971). Studies of brain myelin in the "quaking mouse". J
Lipid Res 12, 473-481.
Song, S., Landsbury, A., Dahm, R., Liu, Y., Zhang, Q., and Quinlan, R.A. (2009). Functions of the
intermediate filament cytoskeleton in the eye lens. The Journal of clinical investigation 119,
1837-1848.
Srivastava, O.P., Kirk, M.C., and Srivastava, K. (2004). Characterization of covalent multimers of
crystallins in aging human lenses. Journal of Biological Chemistry 279, 10901-10909.
Steen, V.M., Skrede, S., Polushina, T., López, M., Andreassen, O.A., Fernø, J., and Le Hellard, S.
(2017). Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in
schizophrenia and antipsychotic treatment. European Neuropsychopharmacology 27, 589-598.
Su, S., Liu, P., Zhang, H., Li, Z., Song, Z., Zhang, L., and Chen, S. (2011). Proteomic analysis of
human age-related nuclear cataracts and normal lens nuclei. Investigative ophthalmology &
visual science 52, 4182-4191.
Sundqvist, A., and Ericsson, J. (2003). Transcription-dependent degradation controls the
stability of the SREBP family of transcription factors. Proceedings of the National Academy of
Sciences 100, 13833-13838.
Suzuki, R., Lee, K., Jing, E., Biddinger, S.B., McDonald, J.G., Montine, T.J., Craft, S., and Kahn, C.R.
(2010). Diabetes and insulin in regulation of brain cholesterol metabolism. Cell metabolism 12,
567-579.

149

TANG, D., BORCHMAN, D., YAPPERT, M.C., and CENEDELLA, R.J. (1998). Influence of cholesterol
on the interaction of α-crystallin with phospholipids. Experimental eye research 66, 559-567.
Teplova, M., Hafner, M., Teplov, D., Essig, K., Tuschl, T., and Patel, D.J. (2013). Structure–
function studies of STAR family Quaking proteins bound to their in vivo RNA target sites. Genes
& development 27, 928-940.
Thibaudeau, T.A., Anderson, R.T., and Smith, D.M. (2018). A common mechanism of
proteasome impairment by neurodegenerative disease-associated oligomers. Nature
communications 9, 1-14.
Tierney, E., Conley, S.K., Goodwin, H., and Porter, F.D. (2010). Analysis of short-term behavioral
effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome. Am J Med Genet
A 152A, 91-95.
Toiber, D., Erdel, F., Bouazoune, K., Silberman, D.M., Zhong, L., Mulligan, P., Sebastian, C.,
Cosentino, C., Martinez-Pastor, B., and Giacosa, S. (2013). SIRT6 recruits SNF2H to DNA break
sites, preventing genomic instability through chromatin remodeling. Molecular cell 51, 454-468.
Toyama, B.H., and Hetzer, M.W. (2013). Protein homeostasis: live long, won't prosper. Nature
Reviews Molecular Cell Biology 14, 55-61.
Tsunemi, T., Ashe, T.D., Morrison, B.E., Soriano, K.R., Au, J., Roque, R.A., Lazarowski, E.R.,
Damian, V.A., Masliah, E., and La Spada, A.R. (2012). PGC-1alpha rescues Huntington's disease
proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4,
142ra197.

150

Vallett, S.M., Sanchez, H.B., Rosenfeld, J.M., and Osborne, T.F. (1996). A direct role for sterol
regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A
reductase gene. Journal of Biological Chemistry 271, 12247-12253.
van Tilborg, E., de Theije, C.G., van Hal, M., Wagenaar, N., de Vries, L.S., Benders, M.J., Rowitch,
D.H., and Nijboer, C.H. (2018a). Origin and dynamics of oligodendrocytes in the developing
brain: Implications for perinatal white matter injury. Glia 66, 221-238.
van Tilborg, E., de Theije, C.G.M., van Hal, M., Wagenaar, N., de Vries, L.S., Benders, M.J.,
Rowitch, D.H., and Nijboer, C.H. (2018b). Origin and dynamics of oligodendrocytes in the
developing brain: Implications for perinatal white matter injury. Glia 66, 221-238.
Ventura, A., Kirsch, D.G., McLaughlin, M.E., Tuveson, D.A., Grimm, J., Lintault, L., Newman, J.,
Reczek, E.E., Weissleder, R., and Jacks, T. (2007). Restoration of p53 function leads to tumour
regression in vivo. Nature 445, 661-665.
Verheijen, M.H., Chrast, R., Burrola, P., and Lemke, G. (2003). Local regulation of fat metabolism
in peripheral nerves. Genes & development 17, 2450-2464.
Vernet, C., and Artzt, K. (1997). STAR, a gene family involved in signal transduction and
activation of RNA. Trends in Genetics 13, 479-484.
Wang, Y., Rogers, P.M., Su, C., Varga, G., Stayrook, K.R., and Burris, T.P. (2008). Regulation of
cholesterologenesis by the oxysterol receptor, LXRα. Journal of Biological Chemistry 283,
26332-26339.
Webster, H.d. (1971). The geometry of peripheral myelin sheaths during their formation and
growth in rat sciatic nerves. The Journal of cell biology 48, 348-367.

151

Webster, J.M., Darling, A.L., Uversky, V.N., and Blair, L.J. (2019). Small heat Shock proteins, big
impact on protein aggregation in neurodegenerative disease. Frontiers in Pharmacology 10.
Westermark, G.T., Johnson, K.H., and Westermark, P. (1999). [1] Staining methods for
identification of amyloid in tissue. In Methods in enzymology (Elsevier), pp. 3-25.
Whitaker, K.J., Vértes, P.E., Romero-Garcia, R., Váša, F., Moutoussis, M., Prabhu, G., Weiskopf,
N., Callaghan, M.F., Wagstyl, K., and Rittman, T. (2016). Adolescence is associated with
genomically patterned consolidation of the hubs of the human brain connectome. Proceedings
of the National Academy of Sciences 113, 9105-9110.
Wu, J., Zhou, L., Tonissen, K., Tee, R., and Artzt, K. (1999). The quaking I-5 protein (QKI-5) has a
novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. Journal
of Biological Chemistry 274, 29202-29210.
Xiang, X., Deng, Z., Zhuang, X., Ju, S., Mu, J., Jiang, H., Zhang, L., Yan, J., Miller, D., and Zhang, H.G. (2012). Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor
progression. PloS one 7.
Xiang, Z., Valenza, M., Cui, L., Leoni, V., Jeong, H.K., Brilli, E., Zhang, J., Peng, Q., Duan, W.,
Reeves, S.A., et al. (2011). Peroxisome-proliferator-activated receptor gamma coactivator 1
alpha contributes to dysmyelination in experimental models of Huntington's disease. J Neurosci
31, 9544-9553.
Xie, Y., Zheng, M., Chu, X., Chen, Y., Xu, H., Wang, J., Zhou, H., and Long, J. (2018). Paf1 and Ctr9
subcomplex formation is essential for Paf1 complex assembly and functional regulation. Nature
communications 9, 1-13.

152

Xu, D., Wang, Z., Zhang, Y., Jiang, W., Pan, Y., Song, B.-L., and Chen, Y. (2015). PAQR3 modulates
cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus. Nature
communications 6.
Yang, C., Yang, Y., Brennan, L., Bouhassira, E.E., Kantorow, M., and Cvekl, A. (2010). Efficient
generation of lens progenitor cells and lentoid bodies from human embryonic stem cells in
chemically defined conditions. The FASEB journal 24, 3274-3283.
Yanshole, L.V., Cherepanov, I.V., Snytnikova, O.A., Yanshole, V.V., Sagdeev, R.Z., and
Tsentalovich, Y.P. (2013). Cataract-specific posttranslational modifications and changes in the
composition of urea-soluble protein fraction from the rat lens. Molecular vision 19, 2196.
Zerenturk, E.J., Sharpe, L.J., and Brown, A.J. (2012). Sterols regulate 3β-hydroxysterol Δ24reductase (DHCR24) via dual sterol regulatory elements: cooperative induction of key enzymes
in lipid synthesis by sterol regulatory element binding proteins. Biochimica et Biophysica Acta
(BBA)-Molecular and Cell Biology of Lipids 1821, 1350-1360.
Zerenturk, E.J., Sharpe, L.J., Ikonen, E., and Brown, A.J. (2013). Desmosterol and DHCR24:
unexpected new directions for a terminal step in cholesterol synthesis. Progress in lipid
research 52, 666-680.
Zhang, D., Tomisato, W., Su, L., Sun, L., Choi, J.H., Zhang, Z., Wang, K.-w., Zhan, X., Choi, M., and
Li, X. (2017). Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol
kinase 5. Proceedings of the National Academy of Sciences 114, E5197-E5206.
Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P.,
Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014). An RNA-sequencing transcriptome and

153

splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34,
11929-11947.
Zhao, C., Deng, Y., Liu, L., Yu, K., Zhang, L., Wang, H., He, X., Wang, J., Lu, C., and Wu, L.N.
(2016). Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners
propels oligodendroglial maturation. Nature communications 7, 1-15.
Zhao, C., Dong, C., Frah, M., Deng, Y., Marie, C., Zhang, F., Xu, L., Ma, Z., Dong, X., and Lin, Y.
(2018). Dual requirement of CHD8 for chromatin landscape establishment and histone
methyltransferase recruitment to promote CNS myelination and repair. Developmental cell 45,
753-768. e758.
Zhao, L., Chen, X.-J., Zhu, J., Xi, Y.-B., Yang, X., Hu, L.-D., Ouyang, H., Patel, S.H., Jin, X., and Lin,
D. (2015). Lanosterol reverses protein aggregation in cataracts. Nature 523, 607-611.
Zhao, L., Mandler, M.D., Yi, H., and Feng, Y. (2010). Quaking I controls a unique cytoplasmic
pathway that regulates alternative splicing of myelin-associated glycoprotein. Proc Natl Acad Sci
U S A 107, 19061-19066.
Zhou, X., He, C., Ren, J., Dai, C., Stevens, S.R., Wang, Q., Zamler, D., Shingu, T., Yuan, L.,
Chandregowda, C.R., et al. (2020). Mature myelin maintenance requires Qki to coactivate
PPARβ-RXRα–mediated lipid metabolism. Journal of Clinical Investigation 130, 2220-2236.

154

Vita
Seula Shin was born in Seoul, South Korea, the daughter of Wonmin Lee and
Hyeung Sik Shin and the granddaughter of Mookseok Suh, Geumsan Lee,
Haejoo Kwon, and Namhak Shin. After completing the study in Daeil Foreign
language High School, she entered Yonsei University in Seoul, South Korea in
2004. She received the degree of Bachelor of Science with a major in
biochemistry at Yonsei University in 2008. She worked as a research assistant
at Yonsei University from 2008 to 2009. She also worked as a research
associate at NYU School of Medicine from 2010 to 2013. In August of 2014 she
entered The University of Texas MD Anderson Cancer Center UTHealth
Graduate School of Biomedical Sciences.

155

